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ABSTRACT
Alvey, Christina M. Ph.D., Purdue University, May 2015. Investigating Synergy: Math-
ematical Models For the Coupled Dynamics of HIV and HSV-2 and Other Endemic Dis-
eases. Major Professor: Zhilan Feng.
This dissertation presents epidemiological models that investigate synergy: synergy
between HIV and HSV-2 or between humans and mosquitoes in a malaria study. Each of
the three coupled disease models addresses different epidemiological questions with regard
to gender or disease structure in the context of sexually-transmitted diseases (STDs), while
the malaria model focuses on age-structure of the human population.
Mounting evidence indicates that HSV-2 infection may increase susceptibility to HIV
infection and that co-infection may increase infectiousness. Accordingly, antiviral treat-
ment of people with HSV-2 may mitigate the incidence of HIV in populations where both
pathogens occur. To better understand the epidemiological synergy between HIV and HSV-
2, we formulate, in Chapter 2, a deterministic compartmental model that describes the
transmission dynamics of these diseases. Unlike earlier models, ours incorporates gender
and heterogeneous mixing between activity groups. We derive explicit expressions for the
basic and invasion reproduction numbers of HSV-2 and HIV. A qualitative analysis of the
system includes the local and global behavior of the model. Simulations reinforce these
analytical results and demonstrate epidemiological synergy between HSV-2 and HIV. Most
importantly, we illustrate that the disease dynamics can be significantly influenced by the
sexual structure of the population.
Chapter 3 deals with another model for HIV and HSV-2 using a different approach,
which allows us to better capture the unique epidemiological feature of HSV-2 and its effect
on the disease dynamics of HIV. As HSV-2 is an incurable viral infection, characterized by
periodic reactivation, we construct a model of the co-infection dynamics by incorporating
a time-since-infection variable to track the alternating periods of infectiousness of HSV-2.
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We also incorporate gender and activity groups in this model. The basic and invasion repro-
duction numbers are derived and interpreted. The calculations of the invasion reproduction
numbers suggest a new interpretation: the class from which the initial disease carrier arises
is important for understanding the invasion dynamics. Numerical simulations and a sensi-
tivity analysis are conducted. Results illustrate the importance of including risk groups in
the model. Treatment implications are discussed.
As the previous studies of HIV and HSV-2 focus only on a heterosexual population,
Chapter 4 introduces a model with both heterosexual and homosexual interactions. We
derive and interpret the basic and invasion reproduction numbers for HIV and HSV-2 using
the approach of next-generation matrices. We then perform scenario analyses and conduct
a sensitivity analysis to investigate the impact of model parameters on the reproduction
numbers and disease prevalences. We conclude that homosexual transmission drastically
changes the disease prevalences and that models that ignore homosexuality may greatly
underestimate the disease burden; hence, it is important to account for this interaction.
In Chapter 5, an age-structured mathematical model for malaria is presented. The model
includes the human and mosquito populations, structured by chronological age of humans.
The infected human population is divided into symptomatic infectious, asymptomatic in-
fectious, and asymptomatic chronically infected individuals. The original PDE model is
reduced to an ODE model with multiple age groups coupled by aging. The basic repro-
duction number R0 is derived for both the PDE and ODE models. A major new feature of
this model is that, based on biological observations, we assume that relapse of chronically
infected individuals is triggered by mosquito bites. Our analysis indicates that this assump-
tion contributes greatly to the magnitude of R0 and, therefore, needs to be further studied
and understood. Numerical simulations for n = 2 age groups and a sensitivity/uncertainty
analysis suggest that it is important to consider asymptomatic individuals as a hidden source
of malaria transmission, particularly those who are chronically infected. Age-dependent
control measures are also investigated.
11. INTRODUCTION
Mathematical models can be very useful tools in the study of infectious diseases. They
allow us to investigate disease transmission dynamics under various scenarios and give
insight into conditions that lead to disease eradication. Each model is motivated by a set
of biological questions. For example: how does gender or age structure affect transmission
dynamics? Or, how can we successfully implement a control measure to lower disease
prevalence and severity in the population? Will treating a particular group of individuals
have a stronger impact over another? Which strategy would be most cost effective? With
each question, we develop a simplest possible model by simplifying other aspects to focus
on the question at hand.
Some of the first epidemiological studies were performed by physicians, like Sir Ronald
Ross, who created a model to study the spread of malaria by mosquitoes [1]. Kermack and
McKendrick developed a simple SIR model in 1927 [2] and many of the more recent mod-
els in mathematical biology adapt a similar kind of formulation. In the case of Kermack-
McKendrick, a mathematical model was developed by stratifying the population into three
groups of individuals: susceptible, infected, and recovered. Individuals could then change
their classification by being infected (and moving from S to I) or through recovery (from
I to R). By considering extensions of this SIR model, for example, through the introduc-
tion of more compartments (i.e., exposed individuals, vaccinated, etc.), the incorporation of
population structure (i.e., due to age, gender, etc.), or the inclusion of demographic param-
eters (i.e., birth, death, social interaction, etc.), we are able to answer some of the questions
posed above.
In this dissertation, we will focus primarily on models that investigate synergy, whether
that be synergy between two diseases or two species. It will be crucial to make assumptions
in these models that allow us to more easily explore the answers to our questions, while at
2the same time ensuring that our models are capable of generating results that are useful for
public health policy decisions.
1.1 Modeling the Coupled Dynamics of HIV and HSV-2
Human Immunodeficiency Virus (HIV) and Herpes Simplex Virus Type-2 (HSV-2) are
sexually-transmitted diseases that affect thousands of individuals in the United States and
millions worldwide. While both diseases have treatments available to reduce viral shedding
or to prevent reactivation, currently neither is curable. Thus, it is important to understand
the mechanisms of transmission and synergy between the two diseases so that we may
implement successful treatment strategies that also lower HIV and HSV-2 prevalence.
1.1.1 Human Immunodeficiency Virus (HIV)
Few are unaware of the dangers of HIV - a sexually-transmitted disease (STD) that
causes Acquired Immunodeficiency Syndrome (AIDS). HIV is a retrovirus that targets cells
of the immune system. Since HIV was first identified in the United States in 1983, over
60 million people have been infected and it has been estimated that roughly 14% of in-
fected individuals are unaware of their infection [3]. HIV progression to AIDS is critical:
the Centers for Disease Control and Prevention estimates that deaths due to AIDS exceed
39 million [3, 4]. AIDS leads to gradual failure of the immune system, leaving humans
vulnerable to a variety of opportunistic infections. While many advancements have been
made in preventing and treating HIV/AIDS, with close to 50,000 new cases every year in
the United States [5] and 2.5 million worldwide [6], more education and development of
additional strategies are necessary to further reduce the numbers.
AIDS, as an important infectious disease, has interested mathematical epidemiologists
throughout the years. Different aspects have been studied: antiviral therapy - strategy
and drug resistance at the population level [7, 8], at the individual level (cell-to-cell viral
transmission) [9–11], and sexual behavior [12]. In [9], Roy et al. consider a time delay in
the disease infection term, relating their results to a model without delay. In [7], Granich
3et al. predict reduced incidence based on strategies of early detection and widely available
antiviral therapy, through both deterministic and stochastic models. Chibaya et al. explore
a model of vertical HIV transmission (mother to unborn child), including treatment and
drug-resistance [8]. In [11], Rong et al. construct two age-of-infection models of HIV at
the cellular level, exploring two strategies of treatment. Johnson et al. explore a model
of sexual behavior (extramarital relationships, condom use, concurrent relationships, etc.)
and its effect on the spread of HIV in South Africa [12]; and, Kirschner et al. present
a system of ordinary differential equations that explores drug sensitive and drug resistant
viral cell dynamics [10]. While these models have given insight into HIV transmission and
treatment, there are other important aspects that should also be considered. One of these is
the relationship of HIV to other infectious diseases.
1.1.2 Herpes Simplex Virus Type-2 (HSV-2)
HSV-2 is an incurable viral STD with a unique characteristic: individuals with HSV-2
experience a lifelong infection, alternating between periods of acute HSV-2 in which they
are infectious and periods of latent HSV-2 in which the virus remains dormant. HSV-2
is a double-stranded DNA virus that almost exclusively infects the genital region. While
an outbreak of HSV-2 can be either symptomatic or asymptomatic, the main symptom is
genital ulcers [13–15]. In fact, HSV-2 has been recognized as the most common cause of
genital ulcer disease [16]. HSV-2 seroprevalence is 16.2% in the United States, or about
one in six Americans 14 to 49 years of age [17, 18]; however, many infected individuals
may be unaware of their infections due to a lack of symptoms [17]. In developing countries,
the prevalence of infection can be as high as 40-60% [19]. Due to the high prevalence and
lifelong infection, HSV-2 has a detrimental effect on human health globally [17]. Moreover,
HSV-2 may facilitate HIV transmission [20–22].
Several mathematical models have dealt with HSV-2. In [20], Foss et al. review the
mathematical models of HSV-2 up to 2009 and are critical of those that exclude some
of the important aspects of the disease: latency, symptomatic and asymptomatic infectiv-
4ity, reduction of shedding since initial infection, type of initial infection (symptomatic or
asymptomatic), and the possibility for the disease to develop differently from the way it
started (asymptomatic initial outbreak can become symptomatic recurrent outbreaks and
vice versa). The system of ordinary differential equations proposed in [20] incorporates
these aspects and explores the differences between an initial, complex system, and a sim-
plified version. In [23], Schiffer et al. present a stochastic model of mucosal HSV-2 patho-
genesis to mimic the pattern of HSV-2 genital shedding frequency, recurrences, peak copy
number during episodes, duration of shedding episodes, and lesion diameter in particular
patients. They conclude, consistent with observations, that HSV-2 expression has a high
variability among patients, and even within individual patients as time progresses.
1.1.3 The Relationship Between HIV and HSV-2
There is mounting evidence of the correlation between HSV-2 and the acquisition and
transmission of HIV [3,17]. Facilitation of HIV by HSV-2 is partly due to the enhanced sus-
ceptibility to HIV infection of HSV-2 infected individuals and partly due to the enhanced
HIV infectivity of individuals co-infected with HSV-2. In HIV-susceptible individuals,
HSV-2 causes genital ulceration and mucosal disruption, providing a direct portal for HIV
entry [16]. A large number of CD4+ lymphocytes, HIV target cells, have been detected in
herpetic lesions, and the presence of these cells could also increase susceptibility to HIV
during sexual activity. The biological plausibility of this hypothesis is corroborated by epi-
demiological observations. A systematic review and meta-analysis of longitudinal studies
by Freeman et al. [21] showed that HSV-2 seropositivity was a statistically significant risk
factor for HIV acquisition in general population studies of men and women. Another study
suggests that other STDs may affect susceptibility to HIV and that the extent of this effect
may depend on specific population characteristics [24]. Similarly, biological evidence and
epidemiological observations support the hypothesis that HSV-2 infection increases the risk
of HIV transmission. Investigators studying heterosexual HIV transmission between dis-
cordant couples in Rakai, Uganda, found that genital ulcer disease in HIV-infected partners,
5primarily resulting from HSV-2, was associated with a 4-fold increase in HIV transmis-
sion [25]. These epidemiological results are substantiated by biological evidence. In HIV-
infected individuals, HSV-2 seropositivity and genital ulcer disease resulting from HSV-2
may significantly upregulate HIV plasma viral loads, accelerate HIV disease progression,
and increase the rate of HIV transmission from co-infected individuals [26, 27].
Studies show that the risk of HIV infection in HSV-2 seropositive individuals is signif-
icantly increased, even when controlling for sexual behavior. Genital ulcers increase the
number of target cells available for HIV attachment and entry into the genital tract. Some
HSV-2 proteins increase the expression of HIV; hence, HIV can be found in the genital
ulcers themselves. In fact, the lesions that are caused by HSV-2 infection and which facili-
tate infection by other STDs, make infected individuals 2 to 5 times more likely to contract
HIV [3, 17, 21, 28]. HSV-2 reactivation has also been shown to stimulate HIV replication;
however, even latent HSV-2 has been associated with higher risk of HIV acquisition.
Co-infection also allows for enhanced transmission of HIV as co-infected individuals
have a higher concentration of HIV in their genital fluids than individuals with HIV only
[3,21,28]. Moreover, between 40−80% of individuals diagnosed with HIV are co-infected
with HSV-2, with a large portion of these individuals being homosexual males [16, 21, 28–
33]. It is also possible that HIV co-infection affects HSV-2 shedding, reactivation rates, and
duration of ulcers, potentially increasing HSV-2 infectivity [34]. All of these biological
and epidemiological observations suggest that HSV-2 and HIV have synergistic effects.
Therefore, to optimally control these diseases, one must investigate the nature of their
epidemiological synergy at the population level. In addition, if HSV-2 fuels the spread of
HIV, antiviral therapy against HSV-2 should mitigate the incidence of HIV at the population
level. Hence, it is necessary to study the contribution of HSV-2 to HIV transmission and
to evaluate the potential population-level impact of HSV-2 therapy on HIV control in the
general population. Mathematical models are wonderful tools for gaining insights into the
transmission and control of infectious diseases, and can be used to address such important
issues.
6Several mathematical models have been developed to investigate the transmission dy-
namics of HSV-2 ( [19, 20, 35, 36] and references therein) and HIV ( [4, 7, 37–42] and
references therein). However, there have been only a few modeling studies of the epi-
demiological synergy between HSV-2 and HIV [16,29,34,43]. Using the individual-based
model STDSIM, White et al. studied the population-level effect of HSV-2 therapy on the
incidence of HIV in sub-Saharan Africa [44]. Foss et al. developed a dynamic HSV-2/HIV
model to estimate the contribution of HSV-2 to HIV transmission from clients to female
sex workers in southern India and the potential impact of “perfect” HSV-2 suppressive
therapy on HIV incidence [34]. Blower and Ma coupled an HIV compartmental model
with an HSV-2 model to investigate the effects of HSV-2 prevalence on the number of
new cases of HIV and to predict the effect of a high-prevalence HSV-2 epidemic on HIV
incidence [16]. Abu-Raddad et al. constructed a deterministic compartmental model to
describe HIV and HSV-2 transmission dynamics and their interaction [45]. However, the
model studied in [16] does not include heterogeneity in sexual activity and assumes that in-
dividuals mix randomly, whereupon each infective individual is equally likely to spread the
disease to all others. Also, gender is not incorporated into the models studied by either [16]
or [45]. Abu-Raddad et al. consider a homosexual male population and suggest that HSV-2
prevalence, if near an endemic level, may predict the spread of HIV [29]; and Foss et al.
estimate the HIV infections directly due to HSV-2 in a heterosexual population [34]. The
models in [34] and [44] incorporate various heterogeneities, including gender and/or age,
but not sexual activity, and only numerical simulations are conducted.
1.2 Modeling Malaria
Malaria is a vector-borne infectious disease caused by parasites of the genus Plasmod-
ium. Malaria is a major international health problem, with an annual estimate of 216million
documented cases and around 1 million deaths [1]. The disease is mostly common in tropi-
cal and subtropical regions including much of Sub-Saharan Africa, Asia and the Americas.
Most vulnerable to severe malaria when exposed to the parasite are people with little or
7no immunity to the disease, such as young children, pregnant women, or travelers coming
from regions with no malaria infections [1]. Malaria is a huge economic burden for many
countries, with direct costs estimated to be at least $12 billion per year worldwide [1]. The
most common Plasmodium species that cause malaria in humans are: P. falciparum, P.
vivax, P. malariae and P. ovale. P. falciparum is responsible for over 1 million deaths annu-
ally and 75% of the malaria cases worldwide [46]. The parasite is transmitted to humans by
the bites of female Anopheles mosquitoes. Different species of the genus Anopheles are re-
sponsible for spreading malaria, which differ in breeding habits, lifespan and human-biting
habits, depending on the geographical region [47, 48]. An. gambiae, one of the highly
anthropophilic species (i.e., feeds almost exclusively on humans) is found in Africa where
the malaria burden is highest [47]. 3.3 billion people live in areas at risk of malaria disease,
and malaria is the 5th leading cause of death from infectious diseases worldwide [1].
The first malaria model, developed by Sir Ronald Ross in 1911 [49], captured the basic
features of malaria and indicated that malaria could be eradicated if the mosquito popula-
tion were reduced below a certain threshold. Since then, with the availability of additional
observations and increased knowledge about the parasites, many extensions of the Ross
model have been developed to better understand the disease dynamics of malaria [50].
More detailed biological and epidemiological factors have been included such as the ef-
fects of human age [51–53], acquired immunity to malaria [52, 54, 55], and genetic and
spatial heterogeneity of parasite and host [56], among others. More careful discussions
about the model formulation of transmissions between human hosts and mosquitoes (par-
ticularly the dependence on the ratio between the host and vector) can be found in Chit-
nis et al. [57]. It has been shown that the age structure of human hosts and immunity
play an important role in understanding the disease dynamics and control in regions where
malaria is endemic [58–60]. Age structure was included in a partial differential equation
model by Anderson and May [51]. It was noticed that this model did not fit well with age-
dependent prevalence [61] and it was suggested that host immunity should be considered
with age [50]. There also exist models that include an immunity function (e.g., see [55])
8or consider separate immune classes (e.g., see [62, 63]), but most of these models do not
include age-structure of the human host.
1.3 The Presented Models: Motivation and Organization
This dissertation presents a study of the complexities that arise from various models
that examine the synergistic qualities of disease transmission. In Chapters 2, 3, and 4, we
explore the interaction of HIV and HSV-2 with the goal of incorporating HSV-2 control
to lower HIV prevalence. In Chapter 5, we use a similar approach to understand the com-
plexities of the host/vector synergy with regards to a malaria model. The dissertation is
organized as follows.
In Chapter 2, we develop and analyze a system of non-linear ordinary differential equa-
tions that describes the coupled dynamics of HIV and HSV-2. Results are used to inves-
tigate the impact of HSV-2 treatment on HIV prevalence. As one of the main features of
HSV-2 is lifelong infection, with individuals alternating between the acute and latent stages,
we separate the HSV-2 infected (and similarly, co-infected) population into an acute or la-
tent class, with only the acute class being able to infect others. The considered HSV-2
treatment would not only increase the rate of progression from the acute to latent stage,
but also reduce the reactivation rate to the acute stage. Hence, HSV-2 treatment would be
responsible for extending the latent HSV-2 period and reducing the HSV-2 infectious pop-
ulation. This model considers only heterosexual interaction and separates the female pop-
ulation into two risk groups: general population females (low risk) and female sex workers
(high risk). Several treatment scenarios are considered in which the level of treatment for
the male and both female populations is varied.
With this model, we aim to incorporate HSV-2 control as a means of reducing HIV
prevalence. In this effort, we conduct numerical simulations of the system and carry out
a sensitivity and uncertainty analysis with respect to the basic and invasion reproduction
numbers. The basic reproduction number determines whether one pathogen will persist
in a host population without the other, and the invasion reproduction number determines
9whether a pathogen can invade a host population where the other is already present. The
sensitivity analysis identifies parameters that could be used as control measures to lower
the prevalence of HIV. We also observe the sensitivity of the reproduction numbers to
the male preference for low versus high risk female contact, which indicates the need for
data regarding this preference and emphasizes the importance of including risk groups in
the model. Using risk groups, we are also able to determine the effects of treating each
population.
In Chapter 3, we return to the model of Chapter 2 with a significant change. Recall
that our previous model uses ordinary differential equations with parameters representing
HSV-2 progression to latency as well as a reactivation, where the acute and latent stages of
the disease were considered separate classes. In the extended model of Chapter 3, we incor-
porate an age structure for HSV-2 using a function representing the time-since-infection.
Thus, the coupled model consists of both partial differential equations to model HSV-2 in-
fection and ordinary differential equations to model HIV infection. The goals of this model
are to explore the effect of co-infection on the HIV epidemic, to investigate the role of the
high risk female population (female sex workers) on HIV prevalence, and to introduce a
time-since-infection parameter, which allows us to more accurately describe the transition
from acute to latent HSV-2.
The introduction of the time-since-infection parameter for HSV-2 complicates the cal-
culations of the reproduction numbers. However, we are able to derive the basic and in-
vasion reproduction numbers for both diseases and explain each of the terms biologically.
Because each HSV-2 parameter also depends on time-since-infection, this allows for the
possibility of different control measures over the course of the HSV-2 infection. In addi-
tion to calculating the reproduction numbers, we also perform numerical simulations repre-
senting the population dynamics for the simplified ODE model and complete a sensitivity
analysis on the reproduction numbers. We conclude that co-infection has an indirect im-
pact on the HIV epidemic and that understanding the role of the high risk female population
may be useful in determining a successful treatment strategy.
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In Chapter 4, we continue our investigation into the synergy between HIV and HSV-2
by accounting for the interaction of males and females in both heterosexual and homosex-
ual relations, and exploring the impact of these interactions on the joint HIV and HSV-2
dynamics. This model ignores risk groups and age-structure in an effort to focus on the
complexity of these new interactions between genders. The population is separated by
gender, with probabilities as to whether a relationship is heterosexual or homosexual. The
objectives of this study are to derive and interpret analytical expressions for the repro-
duction numbers, to determine how the preference for homosexual versus heterosexual
relationships affects the reproduction numbers and disease prevalences, to investigate the
sensitivity of the reproduction numbers to the other transmission parameters, and to observe
the effect of co-infection on efforts to lower HIV prevalence.
This model allows us to compare the various scenarios that differ in preference for ho-
mosexual contacts. Even when homosexual contacts are few, we notice a higher prevalence
for both diseases than when all individuals are heterosexual. This suggests that a model that
does not consider homosexual interactions may underestimate the prevalence for each dis-
ease. Further, the inclusion of homosexual relations produces higher reproduction numbers
than models of heterosexual contact. In this case, not only are disease prevalences higher,
but higher invasion reproduction numbers also indicate that each pathogen is better able to
invade in a population where the other is present.
In Chapter 5, we present a model that describes the transmission dynamics of malaria.
The interaction between host and vector permits a similar modeling approach and mathe-
matical complexity to that of the mixing between males and females in Chapters 2, 3, and 4.
This malaria model presents a system of partial differential equations, with structure due to
chronological age of humans, for the human population, and ordinary differential equations
for the mosquito population. One of the main questions of this model is to determine how
asymptomatic chronically infected individuals (i.e., individuals with very low levels of par-
asite in their body not sufficient to infect mosquitoes) affect the disease dynamics. When
these chronically infected individuals are bitten by mosquitoes, they have the ability to re-
lapse and become infectious, introducing a “loop” between the asymptomatic infectious
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and chronically infected stages of malaria. This adds further complexity to the model, par-
ticularly in deriving and interpreting the reproduction numbers. However, the expressions
for the reproduction numbers as well as the numerical simulations and sensitivity analysis
provide insight into potential treatment strategies. Further, including chronological age for
the human population allows us to consider immune responses that may be age-dependent,
especially as children and elderly experience different kinds of immunity to the malaria
parasite. The age structure also gives us the opportunity to explore age specific treatment
options and allows us to identify which age group to target for a given vaccine.
Finally, Chapter 6 provides the final summary and discussion of the dissertation.
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2. MODELING THE SYNERGY BETWEEN HSV-2 AND HIV AND
POTENTIAL IMPACT OF HSV-2 THERAPY
The work presented in this chapter is in collaboration with Zhilan Feng, Zhipeng Qiu,
Zi Sang, and John Glasser and is published in Mathematical Biosciences [43]. My contri-
butions to this work were in conducting numerical simulations of the system, carrying out
a sensitivity and uncertainty analysis, and interpreting results.
2.1 Introduction
Our model aims to investigate the impact of an HSV-2 treatment on the prevalence of
HIV. The motivation for including different levels of sexual activity is based on the con-
sideration that individuals differ in number of sexual partners, and thereby risk of being
infected by and infecting others. Thus, heterogeneity in sexual activity may have important
implications for the transmission and control of STDs. Mixing between different activity
groups has been shown theoretically to influence the rate and pattern of infection in defined
communities. If mixing is assortative by activity, for example, infection will be largely
restricted to a core of highly active individuals with only occasional transmission to others.
The pathogen will spread more slowly, but affect a higher fraction of the total community
if mixing is random [64]. Most importantly, the well-mixed assumption of unstratified
models is particularly inappropriate for sexual activity as the number of contacts that each
individual has is considerably smaller than the population size [65]. Finally, gender may
be an important factor in modeling the epidemiological synergy between HSV-2 and HIV
as shown in the meta-analysis of several studies that male parameters differ from the corre-
sponding female parameters. For example, the male-to-female HSV-2 transmission proba-
bility is greater than the female-to-male transmission probability [66,67], and thus the risk
of female-to-male transmission per sex act is less than the risk of male-to-female trans-
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mission [40, 41]. Thus, to fully understand the epidemiological synergy between HSV-2
and HIV and to investigate measures for controlling these sexually-transmitted diseases, it
is important to analyze models that consider heterogeneities in sexual activity and mixing
within and between different activity groups and genders.
In this chapter, we use differential equations to formulate a new deterministic com-
partmental model to describe the transmission dynamics and interactions between HIV and
HSV-2. Our model incorporates multiple sexual activities within the female population, and
heterogeneous mixing between females and males from different activity groups. We de-
rive several reproduction numbers for HIV and HSV-2 (either a disease alone or invasion)
that determine the dynamical outcomes of the interaction between HIV and HSV-2. We
provide a systematic qualitative analysis of the model including the existence of equilibria,
and their local and global behavior. The model is also used to explore the epidemiological
synergy between HSV-2 and HIV by investigating the contribution of HSV-2 to HIV preva-
lence, as well as by evaluating the potential population-level impact of HSV-2 therapy on
HIV control.
The chapter is organized as follows. In Section 2.2, we present an epidemiological
model that describes the joint dynamics of HIV and HSV-2 in a gender-structured popu-
lation with multiple activity groups in the female population. Explicit expressions for the
reproduction numbers of HIV and HSV-2 are derived in Section 2.3. A detailed analysis
of the model properties is provided in Section 2.4, including conditions for the persistence
of HIV or HSV-2 alone and for the invasion of HIV (HSV-2) into a population in which
HSV-2 (HIV) is already established. Section 2.5 includes results of numerical simulations
that confirm and extend our analytical results. A sensitivity and uncertainty analysis is
also presented in Section 2.5. In Section 2.6, we conclude with a brief discussion of our
theoretical and simulation results.
14
2.2 Model Formulation
Consider a population consisting of sexually active female and male individuals. We
consider the case in which the female population is divided into sub-groups based on levels
of sexual activity (e.g., number of partners) with a low-risk group (e.g., members of the
general population) and a high-risk group (e.g., sex workers), while all individuals in the
male population have the same activity level. These sub-populations are labeled by the
subscripts f1, f2,m, which denote low- and high-risk females and males, respectively. Let
Ni denote the population sizes of groups i, i = m, f1, f2. The population in each group is
assumed to be homogeneous in the sense that individuals have the same infectious period,
duration of immunity, contact rate, and so on. We divide the progression of HIV into
two stages: acute infection and AIDS. Similarly, HSV-2 is represented by acute and latent
infection stages. Because individuals infected with HIV alone or HSV-2 alone can become
co-infected with both HIV and HSV-2, each group i (i = m, f1, f2) is further divided
into seven epidemiological classes or subgroups: susceptible, infected with acute HSV-2
only (Ai), infected with latent HSV-2 only (Li), infected with HIV only (Hi), co-infected
with HIV and acute HSV-2 (Pi), co-infected with HIV and latent HSV-2 (Qi) and AIDS.
A transition diagram between these epidemiological classes within group i is depicted in
Figure 2.1.
For each sub-population i (i = f1, f2,m) there is a per capita recruitment rate μi into
the susceptible group. For all classes there is a constant per capita rate μi of exiting the
sexually active population. Thus, the total population Ni in group i remains constant for all
time. Susceptible people in group i acquire infection with HSV-2 or HIV at the rate λAi (t) or
λHi (t), respectively. Upon being infected with HSV-2, people in group i enter the class Ai
(infected with acute HSV-2 only). These individuals become latent Li at the constant rate
ωAi (an average duration in Ai is 1/ω
A
i ). Following an appropriate stimulus, reactivation
may occur in individuals with latent HSV-2 [19]. We assume that individuals with latent
HSV-2 only reactivate at the rate γLi . Individuals with HIV are assumed to develop AIDS



















































Figure 2.1. A transition diagram between epidemiological classes. The rates
are per-capita.
individuals in group i with acute or latent HSV-2 infection. Classes Pi andQi are similar to
Ai and Li, respectively, except thatAi and Li denote individuals with HSV-2 only infection
whereas Pi and Qi denote individuals with co-infections. The difference in stage durations
are indicated by the superscripts (e.g., 1/γLi for the Li class and 1/γ
Q
i for the Qi class).
Moreover, the anti-viral treatment rates for the Ai and Pi individuals are denoted by θAi and
θPi , respectively. Because anti-viral medications will also suppress reactivation of latent
HSV-2, we assume that the reactivation rate of people with latent HSV-2 γLi (or γ
Q
i ) is a
decreasing function of θAi (or θ
P








i )). Finally, individuals
co-infected with HIV and acute (latent) HSV-2 are assumed to develop AIDS at the rate dPi
(dQi ).
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= μiNi − (λAi (t) + λHi (t))Si − μiSi,
dAi
dt




i )Li − δAi λHi (t)Ai − (ωAi + θAi + μi)Ai,
dLi
dt
= (ωAi + θ
A
i )Ai − δLi λHi (t)Li − (γLi (θAi ) + μi)Li,
dHi
dt






















i )Pi − (γQi (θPi ) + μi + dQi )Qi, i = m, f1, f2,
(2.2.1)
where the functions λji (t) represent the forces of infection given in (2.2.3). Let bi
(i = m, f1, f2) be the rate at which individuals in group i acquire new sexual partners (also
referred to as contact rates), and let cj denote the probability that a male chooses a female
partner in group fj (j = 1, 2). Then c1 + c2 = 1. For ease of notation, let
c1 = c, c2 = 1− c.
Overall, the number of female partners in group j (j = f1, f2) that males acquire should be
equal to the number of male partners that females in groups j acquire. These observations
lead to the following balance conditions:
bmcNm = bf1Nf1 , bm(1− c)Nm = bf2Nf2 . (2.2.2)
To ensure that these constraints (2.2.2) are satisfied, we assume in numerical simulations
that bm and c are fixed constants with bf1 and bf2 being varied according to Nm, Nf1 and
Nf2 .
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, j = 1, 2,
(2.2.3)
Table 2.1.
Definitions of frequently used symbols
Symbol Description Value Source
m, f1, f2 Male, Low-risk female, High-risk fe-
male
Ni Total population size of group i
Si Number of susceptibles
Ai, Li Number with acute, latent HSV-2 only
Hi Number with HIV only
Pi, Qi Number with HIV and acute, latent
HSV-2











(0) = γLf2(0) Baseline reactivation rate for individu-





(0) = γQf2(0) Baseline reactivation rate for individu-
















i Treatment rate of acute HSV-2 Varied
In this table, i = m, f1, f2. The time unit is months.
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where Ni = Si + Ai + Li + Hi + Pi + Qi (i = m, f1, f2) denotes the total population
size of group i. In (2.2.3), βHi,m (β
H
m,i), i = f1, f2 are the HIV transmission probabilities per
partner between females infected with HIV in group i and susceptible males (between
Table 2.2.
Continued: Definitions of frequently used symbols




= δAf2 Enhanced susceptibility of people with
acute HSV-2 to HIV infection
2.7, 3.1 [21]
δLi Enhanced susceptibility of people with
latent HSV-2 to HIV infection
1.0
δHi Enhanced susceptibility of HIV in-




i Enhancement of HIV infectiousness of
individuals with HSV-2 co-infections
1.0
σPi Enhancement of HSV-2 infectiousness






i Rate of progression from HIV to AIDS 0.0104 [45]
bm Rate of male sexual contacts with fe-
males
Varied





bf2 Rate of group 2 female sexual contact
of with males
= bm(1− c)NmNf2
c1 = c, c2 = 1− c Fraction of male contacts with females





Probability of HIV infection per male





Probability of HIV infection per fe-





Probability of HSV-2 infection per






Probability of HSV-2 infection per
female contact with HSV-2 infected
males
1.0, 0.4 [20]
In this table, i = m, f1, f2. The time unit is months.
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males infected with HIV and susceptible females in group i); βAi,m(β
A
m,i), i = f1, f2 are the
HSV-2 transmission probabilities per partner between females infected with acute HSV-2 in
group i and susceptible males (between males infected with acute HSV-2 and susceptible
females in group i); δPi and δ
Q
i (i = m, f1, f2) are the enhanced HIV infectiousness of
co-infected individuals, and σPi (i = m, f1, f2) are the enhanced HSV-2 infectiousness of
co-infected individuals. The symbols for and definitions of all variables and parameters are
summarized in Tables 2.1 and 2.2. All parameters are non-negative.
It can be verified that all variables (e.g., Si, Ai, Li, Hi, etc.) remain nonnegative for all
time t with nonnegative initial conditions. Let Γ denote the biologically feasible region
for the system (2.2.1). Therefore, in what follows, we consider only solutions with initial
conditions inside Γ, in which the usual existence, uniqueness of solutions and continuation
results hold.
2.3 Reproduction Numbers
One of the most important concepts in epidemiology is the reproduction number for a
given parasite strain and host population. This is generally defined as the average number of
secondary cases (infections) produced by a typical infected person during the entire period
of infection when introduced into a completely susceptible population [69]. In this section,
we derive the reproduction numbers for HIV and HSV-2.
LetRH0 denote the reproduction number for HIV in the absence of HSV-2. The invasion
reproduction numberRHA , which is derived in Section 2.3.1, reduces toRH0 when evaluated


















, j = 1, 2.
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Notice that in the formula for RH0 the balance conditions in (2.2.2) have been used. Other




is the number of new HIV infections that a male will cause in females of




is the number of new HIV infections that a female in group j (j = 1, 2)
will cause in males per unit of time;
• 1
dHi +μi




RHm,fj ,m represents the average secondary HIV male infections by one male indi-
vidual through females in group j (j = 1, 2) while in the infectious (H) stage in a com-
pletely susceptible population. The square root is associated with the fact that we need
to consider both the male-to-female and female-to-male processes to obtain the number
of secondary infections. The overall reproduction number RH0 is an average of RHm,fj ,m
(j = 1, 2).























· PAfj , j = 1, 2
with PAi (i = m, f1, f2) representing the expected time that an individual of group i is in




















, i = m, f1, f2. (2.3.3)
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The formula for PAi in (2.3.3) is derived in Appendix A.1. The biological meanings of




is the number of new HSV-2 infections that a male will cause in females of




is the number of new HSV-2 infections that a female in group j (j = 1, 2)





(i = m, f1, f2) represents the mean time that an individual in group i





PAi represents the overall time spent in the Ai, rather than Li class. This
distinction is necessary as only individuals with acute HSV-2 may infect others. Thus,
it is clear that RA0 represents the average secondary HSV-2 male infections by one male
individual (through both female groups) during the whole HSV-2 infectious (A) period in
a completely susceptible population.
2.3.1 Invasion Reproduction Numbers
The invasion reproduction numbers can be derived by analyzing the stability of the
boundary equilibrium points, where only one pathogen is present, for the full system
(2.2.1). For ease of presentation, we first consider two subsystems involving only a single
pathogen. That is, one subsystem involves HSV-2 alone and the other subsystem involves








= μiNi − λAi (t)Si − μiSi,
dAi
dt




i )Li − (ωAi + θAi + μi)Ai,
dLi
dt
= (ωAi + θ
A
















, j = 1, 2,









= μiNi − λHi (t)Si − μiSi,
dHi
dt
















, j = 1, 2,
Ni = Si +Hi, i = m, f1, f2.
(2.3.5)
Notice that the endemic or disease-free equilibrium (DFE) for each of these subsystems
can be considered as a boundary equilibrium of the full system, and the invasion properties
of the pathogens can be analyzed by examining the stability of these equilibria in the whole
region Γ. For ease of presentation, we introduce the following notation:
E0 The DFE of the full system (2.2.1)
EA0 The DFE of the subsystem (2.3.4)
EH0 The DFE of the subsystem (2.3.5)
EA∂ The endemic equilibrium of (2.3.4) (and boundary equilibrium of system (2.2.1))
EH∂ The endemic equilibrium of (2.3.5) (and boundary equilibrium of system (2.2.1))
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The subscript ∂ indicates “boundary”. At EA0 or E
H
0 , all components are zero except that
Si = Ni, i = m, f1, f2. When EA∂ (or E
H
∂ ) is considered as the non-trivial boundary
equilibrium of the full system, the only non-zero components are S∂Ai > 0, A
∂
i > 0, L
∂
i > 0
(or S∂Hi > 0, H
∂




∂ ) is considered as the endemic









In some of the proofs given below, for ease of notation and to avoid confusion, we denote
X∂i by X
0
i for X = S,A, L,H , etc.
We first derive the invasion reproduction number for HIV in a population where the
HSV-2 infection is already established at the endemic equilibrium. Denote this invasion
reproduction number by RHA . By considering the stability of EA∂ in Γ, we can derive a
formula for RHA .
The dynamics of (2.3.4) including equilibria and their stability have been completely
analyzed in [70] (see Section 2.4 for more details). Particularly, when RA0 > 1, the subsys-




i denote the numbers of susceptible,
acute and latent HSV-2 individuals, respectively, in group i at the endemic equilibrium of






i . Note that the system (2.2.1) has 9 infected
variables with HIV (Hi, Pi, Qi, i = m, f1, f2). Consider the HIV-free equilibrium EA∂ of
system (2.2.1). Using the next generation matrix approach [71] (see Appendix A.2 for
details), we obtain the reproduction number for HIV infection:










where ρ(KH) represents the spectral radius of the next generation matrix KH and E2(KH)
is the sum of all the 2×2 principal minors of matrixKH (see Appendix A.4 for the definition
of kij).
Using the same approach, we can derive the invasion reproduction number for HSV-2 in
a population where HIV is at the endemic equilibrium. Let S0i and H
0
i denote the numbers
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In this case, the system (2.2.1) has 12 infected variables with HSV-2, namely Ai, Li, Pi, Qi,
i = m, f1, f2. Then, the reproduction number for HSV-2 infection (see Appendix A.3 for
details) is given by:










where ρ(KA) again represents the spectral radius of the next generation matrix KA and
E2(KA) is the sum of all the 2 × 2 principal minors of matrix KA (see Appendix A.4 for
the definition of k˜ij).
The reproduction numbers RHA and R
A
H will be used in the analysis of model behavior
in later sections.
2.4 Stability of Steady States and Disease Persistence
The main focus of this section is to analyze the local and global behavior of the full
system (2.2.1). The stability analysis of equilibrium points and persistence results provide
understanding of the interactions between the dynamics of HIV and HSV-2 as well as
possible coexistence of the two pathogens.
First, we state some results about the subsystem (2.3.4), which has been studied in [70].
This subsystem always has the DFE EA0 , and the following result was shown in [70].
Lemma 2.4.1. (Theorem 2.1 in [70])
a) If RA0 ≤ 1 then EA0 is the only equilibrium of subsystem (2.3.4) and it is globally
asymptotically stable (GS) for the subsystem;
b) If RA0 > 1 then EA0 is unstable and system (2.3.4) has a unique endemic equilibrium
EA∂ . Moreover, E
A
∂ is a global attractor of the subsystem.
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Note that Lemma 2.4.1 describes the global behavior of the subsystem (2.3.4). How-
ever, for the subsystem (2.3.5) (HIV only), the dynamics can be rather complicated. For
example, the global behavior of a system similar to (2.3.5) in some special cases is stud-
ied in [72, 73]. Particularly, results from [72, 73] suggest that when dm = 0, c = 0 or
dm = 0, c = 1, the subsystem (2.3.5) may have a backward bifurcation. Next, we explore
the dynamical properties of the subsystem (2.3.5). Our analysis shows that the following
result holds.




= dHf2 = 0.
a) If RH0 ≤ 1 then the DFE EH0 is globally stable;
b) If RH0 > 1 then the EH0 is unstable and a unique endemic equilibrium EH∂ of the
subsystem (2.3.5) exists and is a global attractor of the subsystem (2.3.5).
The proof of Lemma 2.4.2 can be found in Appendix A.5. We point out that, although
the results described in Lemma 2.4.2 is for the special case when dHm = d
H
f1
= dHf2 = 0, our
numerical simulations suggest that it holds also for the general case. Thus, in the following,
we assume that:
Assumption 2.4.3. If RH0 > 1 then the subsystem (2.3.5) has a unique globally stable
equilibrium EH∂ in the region excluding E
H
0 . If RH0 < 1 then EH0 is globally stable for the
subsystem (2.3.5).
Now we proceed to investigate the behavior of the full system (2.2.1) in the region Γ.
Again, consider EA∂ and E
H
∂ as boundary equilibria of the full system in Γ. The inva-
sion reproduction numbers (RHA and RAH) given in Section 2.3.1, together with the basic
reproduction numbers (RA0 and RH0 ), can be used to describe the stability of the bound-
ary equilibria (EA∂ and E
H
∂ ) for the full system and provide information about invasion by
another pathogen.
Theorem 2.4.4. The DFE E0 is locally asymptotically stable (LS) in Γ if RH0 < 1 and
RA0 < 1, and it is unstable (US) if RH0 > 1 or RA0 > 1.
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We omit the proof of Theorem 2.4.4 as it can be easily verified by applying the Theorem
2 in [71]. For the full system (2.2.1), the following result holds.
Theorem 2.4.5. Consider EA∂ and EH∂ as boundary equilibria of the system (2.2.1) in Γ.
a) Let RA0 > 1. Then EA∂ is locally asymptotically stable if RHA < 1 and unstable if
RHA > 1;
b) Let RH0 > 1 and Assumption 2.4.3 hold. Then EH∂ is locally asymptotically stable if
RAH < 1, and unstable if RAH > 1.
The proof of Theorem 2.4.5 can be found in Appendix A.6. These results on the ex-
istence and local stability of the boundary equilibria are summarized in Table 2.3, and







































Figure 2.2. Sketches of the local dynamics of the system (2.2.1). The three
boundary equilibria, E0, EA∂H and E
H
∂A
, are labeled by either a  (if it is unsta-
ble) or a • (if it is stable).
Although we do not have analytic results for the existence or stability of an interior
equilibrium of the system (2.2.1) (i.e., a coexistence equilibrium of HIV and HSV-2), the
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Table 2.3.








RA0 < 1, RH0 < 1 LS DNE DNE (conditional) (a)
RA0 > 1 RHA < 1 US LS DNE (conditional) (b)
RH0 < 1 RHA > 1 US US DNE (conditional) (c)
RA0 < 1 RAH < 1 US DNE LS (conditional) (d)
RH0 > 1 RAH > 1 US DNE US (e)
RAH < 1
RHA < 1 US LS LS (conditional) (f)
RA0 > 1 R
A
H < 1
RHA > 1 US US LS (conditional) (g)
RH0 > 1 R
A
H > 1
RHA < 1 US LS US (h)
RAH > 1
RHA > 1 US US US (i)
DNE: does not exist; US: unstable; LS: locally stable.
conditions under which both EA∂ and E
H
∂ are unstable may provide insights into the co-
existence of these pathogens. In fact, this is confirmed by our numerical simulations (a
more detailed discussion is provided in the next section). That is, when RA0 > 1, RH0 > 1,
RHA > 1 and RAH > 1, the full system (2.2.1) stabilizes at an interior equilibrium where
both HIV and HSV-2 are present. Nevertheless, we can prove the following analytic result
regarding the persistence of both pathogens.
Theorem 2.4.6. Let Assumption 2.4.3 hold. If RA0 > 1, RH0 > 1, RHA > 1 and RAH > 1,
then the system (2.2.1) is uniformly persistent, i.e., there exists a constant  > 0 such that
lim inf
t→+∞
Si(t) ≥ , lim inf
t→+∞





Hi(t) ≥ , lim inf
t→+∞
Pi(t) ≥ , lim inf
t→+∞
Qi(t) ≥ , i = m, f1, f2.
The constant  is independent of the initial value in Γ. Moreover, the system (2.2.1) admits
at least one (component-wise) positive equilibrium.
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Theorem 2.4.6 can be proved by applying Theorem 4.6 in [74] and using a similar
argument as in the proof of Theorem 2.3 in [75]. We omit the proof here.
We remark that the basic and invasion reproduction numbers allow us to examine how
the synergy between HIV and HSV-2 may influence the invasion of HIV into a population
in which HSV-2 is endemic. For example, if the enhancement factors for HIV by HSV-2
are strong and co-infection with HSV-2 has weak effect on the progression from HIV to
AIDS or HIV-induced mortality, i.e., δwi  1 (w = P,Q,A, L and i = m, f1, f2) and
dQi ≈ dPi ≈ dHi , then straightforward computations yield that
RHA > RH0 .
This implies that infections of HSV-2 can facilitate the invasion by HIV. On the other hand,
if the enhancement of HIV by HSV-2 is relatively weak, but co-infection by HSV-2 has a
strong effect on the progression from HIV to AIDS or HIV mortality, then we have
RHA < RH0 .
In this case, infections of HSV-2 may not favor invasion by HIV. These results are illustrated
by numerical simulations in the next section.
2.5 Numerical Simulations
In this section, we present some numerical results that support and extend the analytic
results presented in Section 2.4. We will also explore numerically how the presence and
treatment of HSV-2 may influence the dynamics and control of HIV.
First, we choose parameter values in various regions identified in the analysis in Sec-
tion 2.4 and examine the disease dynamics of the full system (2.2.1) in these regions. For
the numerical simulations, we base most parameters on information available in the litera-
ture, and vary those parameters whose estimates are difficult to obtain (e.g., the coefficients
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of disease transmission). To examine the sensitivity of model results to the uncertainty of
parameters, we conducted a sensitivity and uncertainty analysis.
Meta-analyses of several studies show that male-to-female transmission probabilities of
HSV-2 and HIV are greater than female-to-male transmission probabilities. For HSV-2, for
example, the estimate of per-sex-act female-to-male transmission probability is between
0.01 and 0.1, but the per-sex-act male-to-female transmission probability is between 0.01
and 0.2 [20]. Based on this information, we chose βHm,j ≥ βHj,m, βAm,j ≥ βAj,m, j = f1, f2.
Absent biological evidence about the influence of HIV on the prevalence and progres-
sion of HSV-2, we set δHi = σ
P
i = 1 for i = m, f1, f2. Similarly, we assume that co-
infections do not increase the risk of transmitting HIV, i.e., δPi = δ
Q
i = 1.0. We consider
the case when HSV-2 infection increases only the risk of acquiring HIV. A systematic re-
view and meta-analysis of longitudinal studies by Freeman et al. [21] showed that HSV-2
seropositivity was a statistically significant risk factor for HIV acquisition in general pop-
ulation studies of men [summary adjusted RR, 2.7; 95% confidence interval (CI), 1.9-3.9]





We further assume that HSV-2 shedding occurs during 3.5 reactivations per year for
women and 4.5 reactivations per year for men [20], and that HSV-2 seropositives shed
HSV-2 14% of the time if HIV-negative and 20% of the time if HIV-positive [45]. Thus,
the durations of the acute HSV-2 stage are approximately 0.48 (0.69) months per year
for HIV seronegative (seropositive) women and 0.37 (0.53) months for HIV seronega-
tive (seropositive) men, and the durations of the latent HSV-2 stage are approximately
2.95 (2.74) months per year for HIV seronegative (seropositive) women and 2.67 (2.13)
months for HIV seronegative (seropositive) men. Based on these assumptions,
ωAm = 2.678, ω
A
f1
= ωAf2 = 2.083, γ
L
m(0) = 0.436, γ
L
f1
(0) = γLf2(0) = 0.339,
ωPm = 1.875, ω
P
f1
= ωPf2 = 1.458, γ
Q
m(0) = 0.469, γ
Q
f1
(0) = γQf2(0) = 0.365.
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Assuming that the duration of the HIV-infected stage is approximately 7.8 years, it follows




i = 0.0104, i = m, f1, f2.
For lack of evidence that co-infected people progress faster to AIDS, we assume that co-
infection has no effect on HIV disease progression. The mortality rates were chosen such
that 1/μm = 1/μf1 = 312 months and 1/μf2 = 204 months. In addition, we set
Nm = Nf1 + Nf2 = 10
7, bf2/bf1 = 100. Then, for a given value of bm, we can use the
balance equations (2.2.2) to determine the values of bf1 and bf2 as well as Nf1 and Nf2 .
We will consider two scenarios in terms of the mixing parameter, c = 0.9 (a higher male
preference for low-risk females) and 0.5 (equal preference for the two female groups). For
the case of c = 0.9, bm = 0.1 contacts per month. It follows from equations (2.2.2)
that bf1 = 0.0901, bf2 = 9.01, Nf1 = 9.9889 × 106, and Nf2 = 1.1099 × 104. In the
case of c = 0.5, bm = 0.2 contacts per month, which leads to bf1 = 0.101, bf2 = 10.1,
Nf1 = 9.90099× 106, and Nf2 = 9.90099× 104.








HIV infected cases in the 
model with HSV−2
HIV infected cases in the 
model without HSV−2











HIV infected cases in the 
model with HSV−2
HIV infected cases in the 
model without HSV−2
Figure 2.3. Numerical solutions of the system (2.2.1) for parameters in differ-
ent regions corresponding to the cases when the enhancement of HIV by HSV-
2 is relatively stronger (left) or weaker (right). In both plots, the dashed and
solid curves represent levels of HIV infection with and without HSV-2 present,
respectively. For the left plot, the reproduction numbers are RA0 > 1,RH0 < 1
and RHA > 1; whereas for the right plot, the reproduction numbers are
RA0 > 1,RH0 > 1 and RHA < 1.
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Figures 2.3 and 2.4 illustrate results of numerical simulations showing how disease
dynamics may depend on the reproduction numbers. They also help to confirm and extend
the analytic results illustrated in Figure 2.2. For example, the left plot in Figure 2.3 is
for the case when enhancement of HIV by HSV-2 is relatively strong and co-infection by
HSV-2 has little effect on the rate of progression from HIV to AIDS or HIV mortality. In
this case, RA0 > 1,RH0 < 1 and RHA > 1. Our analytic results suggest that, under these
conditions, i) HIV cannot establish itself in a population when HSV-2 is absent; ii) HIV
can invade a population in which HSV-2 is endemic; and iii) the HSV-2 equilibrium EA∂ is
stable for the HSV-2 subsystem (2.3.4), but unstable for the full system (2.2.1) (see Table
2.3). These are confirmed by the simulations illustrated in Figure 2.3 (left). We observe
that, while HIV can invade and persist in the presence of HSV-2 (the dashed curve), it
dies out in the absence of HSV-2 (the solid curve), suggesting that HSV-2 infection can
favor the invasion of HIV. The right plot in Figure 2.3 is for the case when enhancement
factors are relatively weak and co-infection by HSV-2 has a significant effect on the rate
of progression from HIV to AIDS or HIV mortality. In this case, RA0 > 1,RH0 > 1 and
RHA < 1. From our analytic results, the HSV-2 equilibrium EA∂ is stable for the full system
(2.2.1) (see Table 2.3). Thus, while HIV can establish itself in the absence of HSV-2 (as
RH0 > 1), it cannot invade a population in which HSV-2 is endemic. This is confirmed by
simulations presented in Figure 2.3 (see the right plot). We observe that HIV can invade
and persist in the absence of HSV-2 (the solid curve), and that it dies out in the presence
of HSV-2 (the dashed curve), suggesting that HSV-2 infection may not always favor the
invasion of HIV.
Simulations presented in Figure 2.4 demonstrate the importance of the HSV-2 invasion
reproduction number RAH . For these simulations, parameter values were chosen such that
RA0 > 1, RH0 > 1 and RHA > 1. The plots in (a) and (b) are for the cases whenRAH < 1 and
RAH > 1, respectively. Our analytic results suggest that, in case (a), the HIV equilibrium
EH∂ is LS (see Table 2). This is indeed confirmed by our simulations, which show that HIV
converges to a positive level while HSV-2 goes to extinction. The simulations shown in (b)
extend our analytical results presented in Section 2.4. While we do not have results on the
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Figure 2.4. Time plots of the system (2.2.1) illustrating that the invasion repro-
duction number RAH determines whether or not HSV-2 can invade a population
in which HIV is already established. In both plots RH0 > 1, RA0 > 1 and
RHA > 1, in which case both HSV-2 and HIV can persist in the absence of the
other pathogen. The plot in (a) is for the case when RAH < 1 and it shows that
HSV-2 cannot invade. The plot in (b) is for the case when RAH > 1 and we
observe that HSV-2 is able to invade and both pathogens stabilize at endemic
levels (coexistence).
existence and stability of a coexistence equilibrium (i.e., one where both HIV and HSV-
2 are present), our analytical results show that, under the condition for (b), all boundary
equilibria (E0, EA∂ and E
H
∂ ) are unstable (see Table 2.3), suggesting that a coexistence
equilibrium may exist. This is indeed the case, as exhibited in Figure 2.4(b), which shows
that both HIV and HSV-2 are stabilized at positive levels.
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2.5.1 Influence of HSV-2 Therapies on HIV Prevalence and Control
To illustrate the synergy between HIV and HSV-2 at the population level, particularly
the effect of HSV-2 therapy on the epidemiological synergy of HIV, we use two measures.
One is the population attributable fraction (PAF), defined by
PAF (t) =
Incidence of HIV due to HSV-2 at time t
Total incidence of HIV at time t
, (2.5.1)
which measures the direct effect of HSV-2 on HIV incidence at each time, i.e., the fraction
of new HIV infections that are caused by HSV-2 directly [45]. This differs from the indirect
effect of HSV-2 on HIV incidence, secondary HIV infections (i.e., transmitted by HIV
infections that were caused by HSV-2) [45]. For the indirect synergy of HSV-2 and HIV, we
use the excess prevalence of HIV [45], defined as the difference between HIV prevalence
when the two diseases interact and the counterfactual scenario in which they do not.








To compare the impact of different HSV-2 treatment strategies on HIV control, we also use
the reduction in cumulative HIV infections per HSV-2 case treated. Let RCP (t) denote
this quantity at time t:
RCP (t) =
The difference between the cumulative HIV infections at time t
with and without HSV-2 treatment
Cumulative numbers of HSV-2 cases treated at time t
This quantity expresses the impact of the current HSV-2 treatment strategy on HIV control
at each time t, the reduction in cumulative HIV infections per HSV-2 treated case.
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In the simulations presented here, the parameter values associated with HIV and HSV-2
transmissions are all fixed with
βAmf2 = 0.40, β
A
f2m




βHf1m = 0.1, β
H
mf1





At the end of this section, we provide a sensitivity and uncertainty analysis to examine the
sensitivity of outcomes to the uncertainty of parameter values (including the transmission
parameters above) using a method based on Latin Hypercube Sampling.
In Figure 2.5, we present some simulation results illustrating the influence of HSV-2
on HIV prevalence using the quantities in (2.5.2). This figure also demonstrates how the
sexual structure (preference of males for females of different risk groups measured by c)
may affect the synergy between HIV and HSV-2. Figure 2.5(a) is for the case when c = 0.9,
i.e., the preference for females of groups 1 and 2 are 0.9 and 0.1, respectively. Figure 2.5(b)
is for c = 0.5, in which case the male preferences for the two female groups are identical.
We observe in both (a) and (b) that, for the parameter values used, between 10%− 15% of
new HIV infections (at the endemic steady-state) may be attributed directly to HSV-2 (see
the PAF curve). The HIV excess prevalence (thicker dashed curve) indicates that HSV-2 has
played an important role in fueling HIV indirectly, with the excess prevalence stabilizing
at 12% and 8% when c = 0.9 and c = 0.5, respectively. From the PoV curves with
and without interactions between HIV and HSV-2 (dotted and broken curves respectively),
we observe that HSV-2 may increase HIV prevalence while reducing the time-to-peak. If
we compare Figures 2.5(a) and (b), the magnitude of PoV (with or without interaction)
for c = 0.5 is dramatically higher than that for c = 0.9. This suggests that, when male
preference for high-risk females increases (i.e., c decreases), the synergy between HIV and
HSV-2 may diminish while HIV prevalence increases. It also indicates that the preference
parameter (c) may significantly influence HIV prevalence and synergy between the two
pathogens. This is confirmed by the sensitivity and uncertainty analysis (see Section 2.5.2).
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Figure 2.5. Demonstrations of the synergy between HIV and HSV-2 for dif-
ferent levels of male preference for females in the two risk groups. The plot
in (a) is for the case of a higher preference to the low-risk group (c = 0.9)
whereas the plot in (b) is for the case of equal preference of both female groups
(c = 0.5). See Section 2.5.1 for definitions of PAF, Excess Prevalence and PoV.
To examine the impact of treating HSV-2 on transmission of HIV, we consider different
treatment strategies. Figures 2.6-2.9 illustrate how various HSV-2 therapy programs may
affect directly and indirectly the epidemiological synergy and prevalence of HIV. In these
simulations, we assume that the effective treatment rates of Pi and Ai are equal, i.e.,
θAi = θ
P
i = θi for all i = m, f1, f1, and choose




















represents reduced reactivation to class Ai or Pi due
to anti-viral treatment. In the following, we set αLi = α
Q
i = 2 for all i = m, f1, f2, and
consider these three strategies:
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1) Fix θf1 = θf2 = 0.0 and increase θm;
2) Fix θm = θf2 = 0.0 and increase θf1 ;
3) Fix θm = θf1 = 0.0 and increase θf2 .
Simulations corresponding to strategies 1) – 3) are illustrated in Figures 2.6-2.9. Figure 2.6
shows the case for c = 0.9 and illustrates the effects of strategy 1) i.e., treatment is applied
only to the male population (θm is varied). In this figure, time plots are (a) the fractions of
new HIV infections that are directly caused by HSV-2, (b) the excess prevalence of HIV, (c)
HIV prevalence, and (d) the reduction in cumulative HIV infections per HSV-2 infection
treated. We observe that the fractions of new HIV infections that are caused by HSV-
2, directly or indirectly, decrease as treatment rates θi increase. For example, the PAF and
HIV excess prevalence for θm = 0 are roughly 14% and 11%, respectively, compared to 6%
and 4% for θm = 2.0 (see Figure 2.6(a) and (b)). We observe also that HSV-2 therapy can
delay the time-to-peak and decrease both the peak size of HIV epidemics and the endemic
equilibrium level (see Figure 2.6 (c)), and that RCP increases monotonically with the level
of treatment (see Figure 2.6 (d)).
The time plots of simulated strategies 2) and 3) (treating females of groups 1 and 2)
are similar. A comparison of the three strategies is illustrated in Figure 2.7. We observe
that, for the first three measures (see Figure 2.7(a)-(c)), the effect of treating the male and
female group 1 are similar. They are linearly decreasing functions of θ, while there is
almost no effect when treatment of female group 2 is increased. Thus, in terms of the
first three measures, increasing treatment in the male or female group 1 is more effective
than in the female group 2. However, the situation is different for the RCP measure (see
Figure 2.7(d)), in which RCP is increased from 0.28 to 0.41 when θf2 increases from 0.4
to 2, but the change in RCP is much smaller for all levels of treatment θi for i = m or f1.
This suggests that, in terms of RCP, focusing HSV-2 therapy on high-risk females is more
effective than focusing on low-risk females or males.
Simulations presented in Figures 2.8 and 2.9 are similar to those in Figures 2.6 and 2.7
except that c = 0.5 (equal preference to the two female groups). We observe that, for the
first two measures (PAF and HIV excess prevalence), the magnitude of the curves is higher
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Figure 2.6. Numerical simulations of the system (2.2.1) showing the depen-
dence of HIV prevalence on HSV-2 therapy when only males are receiving
treatment, i.,e. θf1 = 0.0, θf2 = 0.0 and θm varies. The plot in (a) shows
the fraction of incident HIV infections that are directly caused by HSV-2; (b)
shows HIV excess prevalence; (c) shows HIV prevalence; and (d) displays the
reduction of cumulative HIV cases per HSV-2 infection treated. These simula-
tions are for the case when the preference parameter is c = 0.9.
when c = 0.9 than c = 0.5 (see (a) and (b)). However, for HIV prevalence (see (c)), the
magnitude of the curves is much lower when c = 0.9 (between 10 and 17) than c = 0.5
(between 30 and 34), but the variation in prevalence between different levels of treatment is
greater when c = 0.9 than c = 0.5. Similarly, for the RCP measure (see (d)), the magnitude
of the curves is much higher when c = 0.9 (between 0.01 and 0.021) than c = 0.5 (between
0.005 and 0.01).
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Figure 2.7. Comparison of effects of HSV-2 on HIV prevalence when different
population groups receive HSV-2 treatment (θ represents the level of treatment)
for the case of c = 0.9 (preferential mixing). Four measures described in
Section 2.5.1 are considered. In each of the plots, the height of a bar represents
the value of the corresponding quantity at the endemic equilibrium. Parameter
values used in the simulations are the same as those used in Figure 2.6. We
observe that for the measures presented in (a)-(c), the effect of HSV-2 on HIV
decreases with the treatment rates in male (m) and low-risk female groups (f1)
while there is essentially no change with θf2 . However, in (d) it shows that the
impact of treating HSV-2 on the RCP measure is much higher for the high-risk
female group (f2) than the low-risk female and male groups, and the effect
increases with the level of treatment.
From Figure 2.9, we observe that, in terms of the first two measures (see Figure 2.9(a)
and (b)), focusing HSV-2 therapy on low-risk females or males would be more effective
than focusing on high-risk females, which is similar to that shown in Figure 2.7. However,
between the low-risk female group and the male group, the case of c = 0.5 shows that it
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Figure 2.8. Similar to Figure 2.6 except that c = 0.5 (equal preference for the
female groups). This figure illustrates the dependence of HIV prevalence on
HSV-2 therapy when only males are receiving treatment, i.,e. θf1 = θf2 = 0
and θm varies. It shows that in comparison with the case of c = 0.9 (see Fig-
ure 2.6), the effects of treating HSV-2 on HIV prevalence are reduced for the
measures presented in (a), (b), and (d), but increased for the measure presented
in (c). Moreover, the variations between different levels of treatment (θ) are
smaller in the case of c = 0.5 than c = 0.9.
is more effective to treat males, while the case of c = 0.9 shows the opposite. Another
difference between these two cases is HIV prevalence. In the case of equal preference
(c = 0.5), HIV prevalence does not change much when θi varies for i = m, f1, f2, whereas
in the case of higher preference for low-risk females (c = 0.9), HIV prevalence deceases
with increasing θi for i = m and f1. Furthermore, in Figure 2.9(d), we see a similar result
as in Figure 2.7(d), where an increase in θf2 has the largest impact on reducing cumulative
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Figure 2.9. Similar to Figure 2.7 except that c = 0.5. In terms of the com-
parisons of treating various sub-groups, most of the observations mentioned in
Figure 2.7 also apply in this figure, except that the effect of HSV-2 therapy on
HIV prevalence (see (c)) is similar among all three groups and does not change
much with increasing treatment rates (θi).
HIV infections per HSV-2 case treated. This indicates that focusing treatment efforts on
high-risk females, even when c = 0.5, is more effective in terms of RCP than focusing
therapy on males or low-risk females.
2.5.2 Sensitivity and Uncertainty Analysis
Figures 2.10 and 2.11 present our sensitivity and uncertainty analysis, the partial rank
correlation coefficients (PRCC) of the reproduction numbers using the Latin Hypercube
Sampling method [37, 76]. It shows how uncertainty in model parameters may influence
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the threshold quantities RH0 , RA0 , RHA and RAH . We observe in Figure 2.10 that RH0 and RA0
are very sensitive to the preference parameter c and the contact rate bm (note that bf1 and bf2
depend on bm and Ni), but not sensitive to the population size Nm (note that Nf1 and Nf2
vary with Nm). Among the various transmission probabilities (βi), that from female group
2 to male (βf2,m) is most influential for both RH0 and RA0 . For the treatment parameter (θi),
treating males is more effective in reducing RA0 .
Figure 2.10. Sensitivity analysis of the reproduction numbers RH0 and RA0 .
Based on the PRCC values, both RH0 and RA0 are very sensitive to the pref-
erence parameter c and contact rate bm, but insensitive to the population size
Nm. Among the various transmission probabilities (βi), that from female group
2 to males (βf2,m) is most influential for both RH0 and RA0 . For the treatment
parameter (θi), treating males is more effective in reducing RA0 .
Figure 2.11 illustrates that the preferential parameter c and contact rate bm are most
influential for the invasion reproduction numbersRHA andRAH . Moreover, the HIV invasion
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reproduction number RHA is more sensitive to the transmission rates between males and
high-risk females (βf2,m and βm,f2) than between males and low-risk females (βf1,m and
βm,f1), and much less sensitive to treatment θi. However, the HSV-2 invasion reproduction
number RAH is more sensitive to treatment θi. This indicates that, as we would expect,
treating individuals with HSV-2 decreases the ability of HSV-2 to invade a population.
However, because θi has a negative effect on RHA , even though the effect is much smaller,
treating individuals with HSV-2 may also decrease the possibility of HIV invasion.
Figure 2.11. Sensitivity analysis of the invasion reproduction numbers RHA
and RAH . We observe that both are very sensitive to c and bm, as in the case for
RH0 and RA0 . For RHA , the transmission rate βHf2,m is most influential among
all βHi , while for RAH , treating males (θm) is more effective than treating other
groups in reducing RAH .
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2.6 Summary and Concluding Remarks
In this chapter, we formulated a deterministic epidemic model to describe the trans-
mission dynamics and interactions between HIV and HSV-2. Our model includes hetero-
geneities in sexual activity, mixing between different activity groups and genders, with the
objectives of exploring the epidemiological synergy between HSV-2 and HIV and examin-
ing the potential population-level impact of HSV-2 therapy on HIV control.
We derived the reproduction numbers for the two pathogens when only one is present
in the population (i.e., RH0 for HIV and RA0 for HSV-2) and when one (HIV or HSV-2) is
already established and the other is trying to invade (i.e., RHA for the invasion of HIV and
RAH for the invasion of HSV-2). Given these basic and invasion reproduction numbers, we
performed a systematic qualitative analysis on the existence of steady states and their local
and global behaviors.
We conducted numerical simulations to confirm and extend the analytical results, as
well as to explore the apparent epidemiological synergy between HSV-2 and HIV. Our
numerical results show that the qualitative behavior of our model is determined by the re-
production numbersRH0 ,RA0 ,RHA andRAH . For example, ifRH0 > 1,RA0 > 1,RHA > 1 and
RAH > 1, then the prevalence of HIV and HSV-2 will converge to the co-infection endemic
equilibrium. Our theoretical and numerical results both showed that HSV-2 infections fa-
cilitate the invasion and spread of HIV. Hence, incorporating HSV-2 treatment that extends
the time spent latent (not infectious) versus acute (infectious) may effectively lower both
HSV-2 and HIV prevalence.
Our results in this study confirmed the hypothesis that HSV-2 has almost certainly fa-
cilitated HIV epidemics indirectly. The main contributions of this study include the results
that help understand the contribution of non-random mixing between males and females
due to different risk levels in the female population, which has not been considered in other
studies. This includes both the derivation of the reproduction numbers (RH0 , RA0 , RHA , RAH)
and the numerical results based on various measures for the synergy between HIV and
HSV-2 (PAF, PoV, RCP). For example, the effect of HSV-2 on HIV prevalence decreases
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as the treatment rate of the male and low-risk female groups increases, and HSV-2 therapy
of high-risk females is more effective than that of either low-risk females or males in terms
of reducing HIV prevalence per treated case (RCP). Most importantly, from the sensitivity
and uncertainty analysis of the reproduction numbers as well as numerical simulations, our
results suggest that the male preference for low-risk females (represented by the preference
parameter c) can dramatically alter the model outcomes. These insights can be very help-
ful for understanding the synergy between HIV and HSV-2, and cannot be obtained from
models without multiple risk groups.
The treatment considered in this chapter increases the amount of time an HSV-2 in-
fected individual spends in the latent rather than acute stage of the disease. As HSV-2
is incurable, this kind of treatment is beneficial in decreasing the time spent infectious.
However, it is important to recognize that the choice of an appropriate treatment strategy
depends on parameter values. For instance, it is crucial to understand the preference for
low versus high risk females in the given population as the change in this parameter (c)
drastically changes the model outcome (see Figure 2.5). When the preference for high risk
females is greater, we observed that HIV prevalence was higher while there was less in-
teraction between HIV and HSV-2. In this case, treatment of HSV-2 infected individuals
would have less impact on lowering HIV prevalence than when the preference for high risk
females was small. Moreover, no matter the preference for high versus low risk females, it
was most cost effective to treat the high risk female population as a means of reducing the
number of new HIV cases. Hence, considering risk levels and understanding the preference
for one over the other is critical when determining which treatment strategy is optimal.
In this chapter, we have considered only the case of two female groups and a single male
group, but, for simplicity, not heterogeneity in host ages. However, as the age-structure
of both female and male populations almost certainly play a key role in the dynamics of
sexually-transmitted diseases, it will be included in future models (see Chapter 3) to study
the joint transmission dynamics of HIV and HSV-2.
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3. AN AGE-STRUCTURED MODEL FOR THE COUPLED
DYNAMICS OF HIV AND HSV-2
This chapter presents a work in collaboration with Georgi Kapitanov and Katia Vogt-
Geisse, which is published in the Journal of Mathematical Biosciences and Engineering
[77]. This work extends the study presented in Chapter 2. My main contributions to this
work were in the formulation of the model, derivation and interpretation of the reproduction
numbers, and producing and interpreting the numerical simulations of the model.
3.1 Introduction
One of the key features of HSV-2 is that the disease has lifelong infection, but infected
individuals alternate between an acute stage, where they are infectious, and a latent stage,
where the disease remains dormant in the body. In Chapter 2, we presented an ODE model
with a parameter representing the disease’s progression to latency as well as a reactiva-
tion parameter, where the acute and latent stages of the disease were considered separate
classes. In this chapter, we incorporate time-since-infection with HSV-2. As we are inter-
ested in the effect of HSV-2 on HIV, we model HIV as a system of ordinary differential
equations. HSV-2 is modeled by partial differential equations with respect to chronologi-
cal time and time-since-infection. There are advantages to incorporating age-of-infection
dependent functions for several of our parameters. One is reduction of the number of pop-
ulation classes while still incorporating latency. Another advantage, not considered in this
chapter, would be incorporating both the reduction of shedding since the initial outbreak
and reduction of the frequency of outbreaks as the disease progresses. Asymptomatic shed-
ding can be included implicitly in the construction of the time-since-infection dependent
transmission function. The disadvantage, of course, is in the increased mathematical com-
plexity of the model. We have several goals. First, we aim to identify key aspects of
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the coupled dynamics of the two STDs and, more importantly, the parameters associated
with HSV-2 that drive HIV epidemics. Second, we divide our population into three groups:
males, general population females, and female sex workers (FSWs), as we did in Chapter 2.
Considering only heterosexual relationships, we want to explore the effect of FSWs on the
disease dynamics. Third, we wish to explain the contribution of the time-since-infection
variable on the reproduction numbers of these STDs.
The chapter is organized in the following manner: Section 3.2 introduces the model,
Section 3.3 presents the basic reproduction numbers for each pathogen. The invasion re-
production numbers for each pathogen and their biological interpretations are shown in
Section 3.4. Section 3.5 presents results from our numerical simulations and sensitivity
analysis, and Section 3.6 contains a discussion of our results. The calculation of the inva-
sion reproduction numbers is outlined in Appendices B.2 and B.3. Appendix B.4 contains
biological interpretations of the terms in the invasion reproduction numbers and Appendix
B.5 explains how we chose the parameters for our numerical simulations and sensitivity
analysis.
3.2 Model Formulation
In this section we present a model that describes the interaction and transmission dy-
namics of HSV-2 and HIV among members of a heterosexual population. We will consider
the implications of assuming a heterosexual transmission in Chapter 4. We consider three
basic population groups: males (denoted m), low-risk females (f1, members of the general
population), and high-risk females (f2, generally sex workers). We only consider trans-
mission due to sexual encounters. Because we focus on the influence of HSV-2 on HIV
prevalence, we use ordinary differential equations to describe the transmission dynamics
of HIV.
The population is compartmentalized at time t into the following: susceptible (Si(t)),
HIV-positive (Hi(t)), HSV-2-positive (Vi(t, a), time-since-infection dependent), and co-
infected (Pi(t, a), time-since-infection dependent), for i = m, f1, f2. Note that, for each
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population group i (i = m, f1, f2), the total population size of the group is







In our model there is a constant population recruitment rate Λi, which represents the




i (a), and μ
P
i (a)
represent a combination of mortality and sexual inactivity (due to age or acquisition of
AIDS). The forces-of-infection are λHi (t) and λ
V
i (t) for HIV and HSV-2 respectively. Their
expressions are in (3.2.3). The terms δHi and δ
V
i (a) refer to the greater susceptibility of peo-
ple with one STD to the other, i.e., individuals with HIV have an enhanced risk of acquiring
HSV-2 and individuals with HSV-2 have a greater risk of getting HIV. δVi (a) is dependent
on the time-since-infection because whether a person with HSV-2 is latent or shedding may
have an effect on their immune system and susceptibility to infection. The following de-
scribes the boundary conditions: susceptibles infected with HSV-2 become HSV-2-positive
with time-since-infection 0; and, HIV-positive individuals infected with HSV-2 become co-
infected with time-since-infection 0. We also assume some initial values/distributions at






i (a). System (3.2.1) presents the equations, Table
3.1 explains the variables and parameters of the model, and for a visual representation of





= Λi − (λVi (t) + λHi (t))Si(t)− μSi Si(t)
dHi
dt
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Description of variables and parameters used in the model.
Symbol Description
m, f1, f2 Male, low-risk female, high-risk female.
Ni(t) Total population of group i at time t.
Si(t) Number of susceptible individuals of group i at time t.
Hi(t) Number of HIV-positive individuals of group i at time t.
Vi(t, a) Number of individuals of group i who have been infected with HSV-2 for
a months, at chronological time t.
Pi(t, a) Number of individuals of group i who have both HIV and HSV-2 and have
been infected with HSV-2 for a months, at chronological time t.
μi Rate of exiting sexual activity for group i.
Λi Total recruitment rate of group i.
δVi (a) Enhanced susceptibility of individuals with HSV-2 to HIV.
δHi Enhanced susceptibility of individuals with HIV to HSV-2.
σPi (a) Enhanced infectivity of individuals with both STDs when transmitting
HSV-2.
δPi (a) Enhanced infectivity of individuals with both STDs when transmitting
HIV.
bm Rate of male sexual partnerships with females.
bfj Rate of sexual partnerships of group j females with males, j = 1, 2.
c1, c2 = 1− c1 Fraction of m partnerships with f1, f2.
βHm,fj Probability of HIV transmission by an HIV-positive male to an fj partner,
per partnership, j = 1, 2.
βHfj ,m Probability of HIV transmission by an HIV-positive female of group fj to
an m partner, per partnership, j = 1, 2.
βVm,fj(a) Probability of HSV-2 transmission by an HSV-2-positive male with time-
since-infection a to an fj partner, per partnership, j = 1, 2.
βVfj ,m(a) Probability of HSV-2 transmission by an HSV-2-positive female of group
fj with time-since-infection a to an m partner, per partnership, j = 1, 2.
λHm(t) Rate of infection of male individuals with HIV at time t.
λHfj(t) Rate of infection of fj individuals with HIV at time t, j = 1, 2.
λVm(t) Rate of infection of male individuals with HSV-2 at time t.
λVfj(t) Rate of infection of fj individuals with HSV-2 at time t, j = 1, 2.
In this table, i = m, f1, f2. The time unit is months.
Let bi be the number of partnerships an individual of group i has per unit time. Also,
let c1 and c2 be the fractions of those partnerships that a male has with a low-risk and a



















Figure 3.1. Model dynamics in a diagram form.
of partnerships with low-risk females as low-risk females have with males. The same holds
true for males and high-risk females. Therefore, the following balance conditions hold:
bmc1Nm = bf1Nf1
bmc2Nm = bf2Nf2 .
(3.2.2)
The force of infection functions appearing in (3.2.1) are defined in the following way, by









































, j = 1, 2.
(3.2.3)
We assume that all of our parameters are non-negative, with the following assumptions also
applied:
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• S0i , H
0
i ≥ 0 and V 0i (.), P 0i (.) ∈ L1([0,∞),R+0 ), i = m, f1, f2;




i (.) ∈ L∞([0,∞));




i (.) ≥ 1, ∀a ≥ 0 and δHi ≥ 1;
• μVi (.), μ
P
i (.) ∈ L∞([0,∞)), i = m, f1, f2;




(.) ∈ L∞([0,∞)), j = 1, 2.
Positivity of solutions and well-posedness of the problem can be shown.
Using the method of characteristics, we have the following solutions for Vi(t, a) and
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i (τ)dτδi(x− t+ a)λHi (x)Vi(x, x− t+ a)dx, a > t
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i (x+ t− a)Vi(x+ t− a, x)dx, t > a,
(3.2.5)
where LPi (a) := e
− ∫ a0 μPi (τ)dτ is the probability that an individual in class Pi will survive
until time-since-HSV-2-infection a. Note that it can be shown that the first parts of (3.2.4)
and (3.2.5) decay to 0 in L1 norm with respect to a as time goes to infinity. As we will be
examining the behavior of the system at equilibria, we will only consider the second parts
of (3.2.4) and (3.2.5), namely the cases when t > a.
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3.3 The Basic Reproduction Numbers
In the following sections, we aim to find the basic reproduction number of each pathogen,
i.e., RH0 for HIV and R
V
0 for HSV-2 when each disease is introduced in a population that is
at the disease-free equilibrium (DFE). The DFE is (S0i := Λi/μ
S
i , 0, 0, 0), i = m, f1, f2. In
our analysis, we want to consider constant population sizes for each group i = m, f1, f2;




i (a) = μ
P
i (a). We will keep this notation with
superscripts in each class to facilitate interpretation.
3.3.1 Basic Reproduction Number for HIV (RH0 )
First, we derive the basic reproduction number for HIV. Suppose that the number of
people with HSV-2 infection is and remains at the disease-free equilibrium where
Vi(t, a) = 0 and Pi(t, a) = 0. Then the force of infection terms reduce to:















, j = 1, 2;





= Λi − λHi (t)Si(t)− μSi Si(t)
dHi
dt
= λHi (t)Si(t)− μHi Hi(t)
Si(0) = S
0





System (3.3.1) has three infected variables with HIV, namely Hi, i = m, f1, f2. Us-
ing the next generation matrix approach [71] (see Appendix B.1.1 for details), the basic

















For j = 1, 2, bmcjβHm,fj is the rate with which HIV-positive males infect fj females,






the total number of fj females that one HIV-positive male individual will infect within his





is the number of males that an HIV-positive fj
female will infect in her lifetime of sexual activity. Therefore, (3.3.2) is the average number
of secondary male infections produced by one HIV-positive male through partnerships with
fj females.
3.3.2 Basic Reproduction Number for HSV-2 (RV0 )
Assume that HIV is and remains at the disease-free equilibrium, i.eH0i = 0, P
0
i (a) = 0.
The forces of infection are then as follows:















, j = 1, 2.
(3.3.3)











= −μVi Vi(t, a)
Si(0) = S
0
i ;Vi(0, a) = V
0
i (a);Vi(t, 0) = λ
V
i (t)Si(t), i = m, f1, f2.
(3.3.4)
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For simplification of notation, we will define LVi (a) := e
− ∫ a0 μVi (τ)dτ , which represents the
probability that an individual remains sexually active at time-since-HSV-2-infection a.




























(a)da, j = 1, 2.
(3.3.6)





(a)LVm(a)da represents the number of fj females infected by one HSV-2 pos-







tions with HSV-2 during her entire period of infection. Thus, the product of these two
factors represents the average number of secondary male infections produced by one in-
fected male via females of group j, j = 1, 2.
3.4 Invasion Reproduction Numbers
In this section, we describe and explain the invasion reproduction number for the pathogens
causing each STD, i.e., the reproduction number of one of the pathogens when the other is




i (a) = μ
P
i (a), i = m, f1, f2. We will keep
this notation to facilitate interpretation of the results.
3.4.1 Invasion HIV Reproduction Number (RHV )
In this section, we will present a biological interpretation of the invasion reproduction
number for HIV, RHV , when invading an HSV-2 endemic population (with HSV-2 endemic
equilibrium (S0i , 0, V
0





where the expression for GHV (0) can be found in Appendix B.2(equation (B.2.11)).
The invasion reproduction number (RHV ) is a measure of how many secondary male in-
fections one HIV infectious male will produce, on average, during his entire infectious pe-
riod, when introduced into an HIV susceptible but HSV-2 endemic population, and through
interaction with females of either risk group. To better interpret RHV biologically, we will
consider in which class the initial HIV infected male is present (i.e., whether this initial
male is susceptible to or already infected with HSV-2). As our model considers enhanced
susceptibility of HSV-2 infected individuals to HIV, measured by the parameters δVm(a) and
δVfj(a) (j = 1, 2, 0 < a < ∞), one has to be cautious when introducing the initial HIV
infectious male. This individual may be infected with HSV-2 before acquiring HIV, and
thus could have a higher susceptibility to acquiring HIV in the first place.







m(a)da represent the weighted HIV susceptible popu-
lation. Then, this first HIV infected male can be chosen either from the susceptible male
population, S0m, with probability
S0m
W 0,Vm
, which makes this individual part of the Hm class,







, which makes this individual part of the Pm class (entering the
co-infection class at time-since-HSV-2-infection x).
Now, expression (3.4.1) can be rewritten in the following form:
(RHV )
2 = (RHV (m, f1,m))



















































































and, for ease of presentation, we present the following notation:
THi := 1/E
H
i (0) is the average time an individual spends in class Hi (i = m, f1, f2),
where the definition of EHi (0), i = m, f1, f2 can be found in Appendix B.2(equation
(B.2.12)). Further, the rate at which an HIV male (Hm) infects susceptible females (Sfj ,












is the rate at which a co-infected male, with time-since-
HSV-2-infection a (Pm(a)), infects a female with HIV, where δPm(a) is the enhanced HIV
infectivity of a male with co-infection and time-since-HSV-2-infection a.
In an analogous way, the rates of HIV infection from female to male are given by









j = 1, 2.
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The probability that an HIV infected female (Hfj , j = 1, 2) becomes co-infected (Pfj ,





THfj , j = 1, 2.
Finally, the probability that an HIV infected male (Hm) becomes co-infected (Pm) via







THm , j = 1, 2.
Table 3.2 summarizes the other symbols appearing in (3.4.3). Each term on the right
hand side of (3.4.2) represents the infection cycle from male (m) to female (f1, f2) back
to male. The remainder of this section describes biologically the terms in equation (3.4.3),
each of which corresponds to one path in Figure 3.2.
The first six terms in (3.4.3) correspond to secondary HIV infections due to the initial
HIV infection being a male in the Hm class and the last three terms in (3.4.3) correspond
to secondary HIV infections traced back to an initial co-infected Pm individual. Each of
the expressions listed in Table 3.2 is of the form X Z(U)(Y ) or Pm(U) for X = Hfj ,Pfj ;
Z = Hm,Pm, Pm; U = Hm, V 0m; Y = S0fj , V 0fj (j = 1, 2). X represents the number of
people in theX class forX = Hfj , Pfj , and Pm(U) represents the probability that a person
in class U moves to class Pm. Also, X Z(U)(Y ) describes the following disease dynamics: a
person in class U moves to class Z and infects people in class Y , who, due to that infection,
end up in class X .





corresponds to the following disease dynamics pictured in Figure 3.2,
Sm





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































fj HIV susceptible individuals to be infected Sfj Vfj
 






New generation of HIV infected males Nm
Infects with HIV 
Result of HIV infection 
Result of HSV-2 infection 
Figure 3.2. Transmission dynamics of HIV between classes m and fj .
and can be interpreted as follows: HHmfj (S0fj) represents the number of completely suscep-
tible females that were infected with HIV by an infected male during his sexual lifetime
(see Table 3.2). Note that the initial HIV infected male is in the Hm class with probability
S0m
W 0,Vm
. This male infects susceptible females (HHmfj (S0fj)), who then, as Hfj females, infect




) at a rate πHfj ,m, throughout
their time in the HIV class (THfj ).
The remaining terms are explained in detail in Appendix B.4. Here, we will only
present the arrows in Figure 3.2 that correspond to the dynamics of those terms, in the
order presented in equation (3.4.3):
Sm
initial−−−→ Hm becomes−−−−→ Pm infects−−−−→ Sfj become−−−−→ Hfj infect−−−→ Nm,
Sm
initial−−−→ Hm infects−−−−→ Sfj become−−−−→ Hfj become−−−−→ Pfj infect−−−→ Nm,
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Sm
initial−−−→ Hm becomes−−−−→ Pm infects−−−−→ Sfj become−−−−→ Hfj become−−−−→ Pfj infect−−−→ Nm,
Sm
initial−−−→ Hm infects−−−−→ Vfj become−−−−→ Pfj infect−−−→ Nm,
Sm
initial−−−→ Hm becomes−−−−→ Pm infects−−−−→ Vfj become−−−−→ Pfj infect−−−→ Nm,
Vm
initial−−−→ Pm infects−−−−→ Sfj become−−−−→ Hfj infect−−−→ Nm,
Vm
initial−−−→ Pm infects−−−−→ Sfj become−−−−→ Hfj become−−−−→ Pfj infect−−−→ Nm, and
Vm
initial−−−→ Pm infects−−−−→ Vfj become−−−−→ Pfj infect−−−→ Nm.
3.4.2 Invasion HSV-2 Reproduction Number (RVH)
In this section, we will present a biological interpretation for the invasion reproduction
number for HSV-2, RVH , invading a susceptible and HIV endemic population. The equi-
librium reached by the population is given by (S0i , H
0
i , 0, 0). The full calculation of this
invasion reproduction number can be found in Appendix B.3.
The invasion reproduction number for HSV-2 (RVH) measures, on average, the sec-
ondary male HSV-2 infections traced back to one HSV-2 infected male introduced into
a susceptible and HIV endemic population, throughout his HSV-2 infectious period and
through sexual interaction with females. Similarly to RHV , we must consider whether the
initial male is susceptible to both diseases or is already infected with HIV. Let






m represent the weighted HSV-2 susceptible population. Then, this





, which makes this individual a part of the Vm class, or from the HIV





, which makes this individual a part
of the Pm class.
We obtain from Appendix B.3 the expression RVH :=
√
GVH(0) for the HSV-2 invasion














Each term on the right hand side of equation (3.4.4) represents the infection cycle from
one infected male individual, to one of the female classes (fj, j = 1, 2) and back to males.

































































































where, for j = 1, 2,
LVi (a) := e
− ∫ a0 μVi (τ)dτ , i = m, f1, f2,
pVm(a) := e
− ∫ a0 FVm(τ)dτ
(












− ∫ a0 FVfj (τ)dτ
(





−p˙Vfj(x) = FVfj (x)pVfj(x).
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Here, LVi (a) := e
− ∫ a0 μVi (x)dx is the probability that an individual in the Vi, i = m, f1, f2,
class is still sexually active at time-since-infection a; pVi (a) represents the probability that
an individual in the Vi, i = m, f1, f2, class remains in the HSV-2 only class when time-
since-infection a has been reached without acquiring HIV; and the quantity −p˙Vi (x) repre-






(a), j = 1, 2,
to be the rate at which an HSV-2-only infected male with time-since-infection a infects







the rates at which an HSV-2-only infected male infects an HIV female with enhanced sus-
ceptibility to HSV-2 (δHfj ) and a co-infected male with time-since-HSV-2-infection a and





πVm,fj(a) is the rate
at which a co-infected male with time-since-HSV-2-infection a infects an HIV infected fe-
male.
We define analogously the rates of female to male infection in the respective cases as
above by
πVfj ,m(a) := bfjβ
V
fj ,m














Table 3.3 gives the expressions and the biological interpretations of the remaining ab-
breviated terms in (3.4.5). Each has the form X Z(Y ) or [Pm(Vm)](a). The latter is de-
scribed in the table and X = Vfj ,Pfj ; Z = Vm, Pm,Pm(Vm), Y = Sf1 , Hf1 . The disease
dynamics described by X Z(Y ) follows the path Z infects−−−−→ Y becomes−−−−→ X , where X repre-
















































































































































































































































































































































































































































































































































































































































































































































































































































































































fj HSV-2 susceptible individuals to be infected Sfj Hfj
 






New generation of HSV-2 infected males Nm
Infects with HSV-2 
Result of HSV-2 infection 
Result of HIV infection 
Figure 3.3. Transmission dynamics of HSV-2 between classes m and fj .
The biological meanings of the terms in equation (3.4.5) can be explained in a similar
manner as shown for the HIV invasion reproduction number in the previous section. The
first six terms in equation (3.4.5) are traced back to infections by an initial HSV-2-only male
and the last three to infections by an initial co-infected male. Finally, each term corresponds
to one of the following paths, each being one of the nine paths shown in Figure 3.3.
Sm
initial−−−→ Vm infects−−−−→ Sfj become−−−−→ Vfj infect−−−→ Nm,
Sm
initial−−−→ Vm infects−−−−→ Sfj become−−−−→ Vfj become−−−−→ Pfj infect−−−→ Nm,
Sm
initial−−−→ Vm becomes−−−−→ Pm infects−−−−→ Sfj become−−−−→ Vfj infect−−−→ Nm,
Sm
initial−−−→ Vm becomes−−−−→ Pm infects−−−−→ Sfj become−−−−→ Vfj become−−−−→ Pfj infect−−−→ Nm,
Sm
initial−−−→ Vm infects−−−−→ Hfj become−−−−→ Pfj infect−−−→ Nm,
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Sm
initial−−−→ Vm becomes−−−−→ Pm infects−−−−→ Hfj become−−−−→ Pfj infect−−−→ Nm,
Hm
initial−−−→ Pm infects−−−−→ Sfj become−−−−→ Vfj infect−−−→ Nm,
Hm
initial−−−→ Pm infects−−−−→ Sfj become−−−−→ Vfj become−−−−→ Pfj infect−−−→ Nm, and
Hm
initial−−−→ Pm infects−−−−→ Hfj become−−−−→ Pfj infect−−−→ Nm.
3.5 Numerical Simulations
The current section presents our numerical results associated with the given model – a
representation of the total population dynamics using parameter values taken from literature
(consult Appendix B.5) and sensitivity analysis on the reproduction numbers. Because of
the complexity of the full model, numerical simulations of the model with age-dependent
parameters have been omitted in this chapter. For the total population dynamics we used an
ODE model, constructed by integrating the population classes over the time-since-infection
variable and assuming that all parameters dependent on time-since-infection are constants.
We plan to publish our numerical results for the more general case in the future.
3.5.1 Total Population Dynamics - ODE Model
We performed a numerical simulation of the simplified ODE model to determine the
prevalence of HIV and HSV-2 alone, as well as the co-infection obtained from our model
parameters (see Table 3.4). We then used these baseline values in conducting sensitivity
analyses of the basic and invasion reproduction numbers of the PDE system. The analysis
can be found in section 3.5.2. Note that we did not assume any difference in the transmis-
sion probabilities from males to either female group. Therefore, the infection probabilities
per partner satisfy: βVm,f1 = β
V
m,f2
and βHm,f1 = β
H
m,f2
. This assumption is made for both the
ODE plots and sensitivity analyses. Four of the parameters in Table 3.4 have not appeared
in the chapter thus far: r, ρH , ρVm, and ρ
V
f . They are auxiliary parameters and are only used
in the calculations of other parameters, as evident from the same table. These parameters




Parameter Value Unit Parameter Value Unit



























































,j = 1, 2 probpart












Abbreviations: mo = month, yr = year, ind = individual, act = sex act,
part = partnership, untls = unitless
In Figures 3.4 and 3.5, 35.8% of the male population, 34.3% of the general female
population, and 46.6% of the FSW population will eventually have HIV (including co-
infection). As this model does not include treatment or prevention, these numbers are
consistent with HIV prevalence in the Republic of South Africa, which is a country that
only recently started implementing policies to limit the spread of HIV [78]. The HSV-
2 prevalence levels (including co-infection) are, respectively, 33.9%, 42.5%, and 55.2%,
consistent with findings [79, 80]. We observe an overall higher prevalence of HSV-2 than
HIV, with co-infection largely in the FSW population. This high risk female class also
contracts both diseases at a much faster rate than the male or general female populations,
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as evident from Figures 3.4 and 3.5. This may be due to the high number of partnerships


















(a)   Males (m)














(b)   Low − Risk Females (f1)














(c)   High − Risk Females (f2)









Figure 3.4. Prevalence of HIV, HSV-2, and co-infection among the three
population groups, based on the total population dynamics, where Vˆ (t) =∫∞
0
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(b)   Low − Risk Females (f1)














(c)   High − Risk Females (f2)
0 100 200 300 400 500
HIV (total) HSV−2 (total)
Figure 3.5. Total HIV and HSV-2 (including co-infection) prevalence among
the three population groups, based on the total population dynamics.
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The male and general female populations exhibit very similar HIV prevalence, ac-
counting for co-infection with HSV-2. The general female population, however, has a
higher HSV-2 prevalence than the male population, which is also consistent with observa-
tions [80]. The shape of the curves in Figure 3.4 is due to the appearance of a co-infected
population with enhanced infectivity for HIV. That is, the enhancement of co-infected
individuals increases HIV-only prevalence with more new HIV-only infections than co-
infections. This enhancement also decreases HSV-2-only prevalence by making it more
likely for HSV-2 infected individuals to become co-infected with HIV.
Figure 3.6 gives a numerical verification for the properties of the HIV-invasion repro-
duction number, RHV . If R
H
0 < 1 and HSV-2 is not present in the population, HIV cannot
persist. However, if HSV-2 is endemic and RHV > 1, an HIV epidemic is apparent, even
though RH0 is still less than one. The values used are: R
H
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HIV infected cases 
 in the model 
 with HSV−2
HIV infected cases 
 in the model 
 without HSV−2
Figure 3.6. Total number of HIV cases among all population groups when
RH0 < 1. When HSV-2 is not present, HIV cannot persist. When HSV-2
is present and RHV > 1, an HIV epidemic occurs. For this figure, R
H
0 =
0.86, RHV = 1.62.
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3.5.2 Sensitivity Analysis of the PDE System
To explore the sensitivity of the basic and invasion reproduction numbers to the chosen
model parameters, we performed an analysis using a method based on Latin Hypercube
Sampling [37, 76] and calculated partial rank correlation coefficients (PRCC) [19, 81]. To
use this method, it is necessary to obtain a range of values for each parameter (see Table
3.5), as well as to determine a probability density function (pdf) for each parameter. It
is important to note that the infection transmission enhancement parameters δVi , δ
H
i , and
σPi were set at 1, i = m, f1, f2. For the purposes of this sensitivity analysis, we only
varied the infectivity enhancement of co-infected individuals when transmitting HIV, δPi ,
and made it equal for i = m, f1, f2, hence only including δPm in the sensitivity analysis
(see Appendix B.5 for more details). Furthermore, for simplicity, we chose the HSV-2
infectivity probabilities βVi,k(a), i, k = m, f1, f2, i = k to be step functions (Appendix B.5
contains more information on the function itself). βVi,k in Figures 3.7 and 3.8 refers to
the height of the step function. All other time-since-infection variables were chosen to be
constant. In the Latin Hypercube Sampling, we chose either a uniform (U) or triangular
(T) pdf with peak at the fixed ODE parameter value (see Tables 3.1 and 3.5). The Latin
Hypercube is then created by sampling equally probable regions exactly once for each
simulation [19, 37, 81]. A total of 3,000 simulations, and hence 3,000 sets of parameter
values, were obtained and consistently produced the results.
Using these sets of parameter values, we calculated PRCC indices by a method that
determines the effect of varying each parameter individually on the reproduction numbers
[19, 37, 81]. The PRCC indices that are obtained have a value between -1 and 1, with
a positive (negative) PRCC value signifying that the relationship between the parameter
and reproduction number is positive (negative). PRCC indices may also indicate which
parameters have the most influence on the reproduction numbers, with indices of magnitude
closer to 1 having the most influence and closer to 0 having almost no influence [19, 37].
Figure 3.7 gives the PRCC indices for the basic reproduction numbers, RH0 and R
V
0 .
The corresponding values for the indices can be found in Table 3.6. RH0 seems signifi-
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Table 3.5.
Parameter ranges used in sensitivity analysis.
Parameter Lower Bound Upper Bound Distribution
c .7 1 U
μm 1/480 1/240 T
μf1 1/480 1/240 T
μf2 1/120 1/36 T
bm 5 · μm 12 · μm T
bf2 5 · bf1 10 · bf1 U
Nm .5 · 105 1.5 · 105 T
ρH .001 .002 T
r 1 3 U
ρVf .03 .12 T
ρVm .07 .24 T
δPm 1.0 1.3 T
T indicates a triangular distribution, with peak at the fixed value from Table 3.1.
U indicates a uniform distribution.
Table 3.6.
PRCC Values.








c 0.22301403 0.10190679 0.2602452853 0.098150824
bm 0.28370741 0.10612063 0.2680427498 0.085017149
bf1 0.10567752 0.02932268 0.0995221633 0.004226425
bf2 0.08588136 0.12217032 0.0889434116 0.121739335
μm -0.72321671 -0.32687223 -0.7110994875 -0.316704407
μf1 -0.80320335 -0.39569917 -0.8073834092 -0.401428781
μf2 -0.01708556 -0.04316572 -0.0248582479 -0.036844353
βHm,f1 0.31556204 NA 0.2625038294 0.012115165
βHf1,m 0.09022262 NA 0.1110768711 -0.017815740
βHf2,m 0.16093696 NA 0.1513616342 -0.012076605
βVm,f1 NA 0.66185297 0.2436370753 0.660516281
βVf1,m NA 0.13333530 -0.0000301969 0.135995528
βVf2,m NA 0.11782067 0.0719251663 0.117135153
δPm NA NA 0.3808355572 0.004695554
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cantly dependent on several factors: the length of the sexual activity period of males and
the females of the general population (inverse proportion of μm and μf1), males’ sexual
partnerships per month (bm), the transmission probability between a male and a general




length of sexual activity reflects that once an individual is infected, the longer they are sex-
ually active, the more individuals they will infect. It is interesting to note that the majority
of the influential parameters for the HIV basic reproduction number are related to the male
population, with the probability of men infecting women with HIV being more important
than the probabilities of women infecting men. c1, the preference of men for women from
the general population, also is an important factor in the value of RH0 , which may be corre-
lated to the length of the f1 versus f2 periods of sexual activity. Beyond the sexually active














































(b)   R0V
Figure 3.7. Effect of model parameters on the basic reproduction numbers,
based on PRCC.
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significant factor: βVm,f1 , the probability of men infecting women with HSV-2. This is not
surprising, considering men are almost twice as infectious.
As evident from Figure 3.8, the same parameters are most influential for the invasion
reproduction numbers with one notable addition: δPm, the enhanced infectivity for HIV of
co-infected individuals, has a strong effect on RHV . This signifies the importance of HSV-2,
and specifically the effect of co-infection, on the HIV endemic. In Figure 3.8 it can also be
observed that, in general, the HSV-2 transmission probabilities, βV s, influence RHV but, on
the contrary, the HIV transmission probabilities, βHs, do not have a significant effect on
RVH . Also, transmission from FSW to a male, β
V
f2,m
has a greater impact on RHV than the
transmission probability from general population female to male, βf1,m. The implications
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We present a model of co-infection with HIV and HSV-2, prompted by the reported in-
fluence that HSV-2 has on HIV epidemics, and without considering methods of prevention
or treatment. The model has several goals. One is to evaluate the effect of co-infection
with HSV-2 on HIV prevalence. The second is to explore the role of female sex workers on
the HIV epidemic. The third goal is the introduction of a time-since-infection variable that
allows for more flexibility in modeling the interchanging acute and latent stages of HSV-2
and more flexibility when considering treatment and control of the disease. We calculate
the basic and invasion reproduction numbers and perform a sensitivity analysis (Figures 3.7
and 3.8). Due to computational difficulty in conducting numerical simulations for the PDE
model, we also plot the total population dynamics based on a simplified version of our
model, reducing our original system of partial differential equations to a system of ordi-
nary differential equations by integrating over the time-since-infection variable a. (Figure
3.4). Note that this ODE model differs from the ODE model of Chapter 2 as it does not
make a distinction between acute and latent HSV-2 infected individuals. While this dis-
tinction is important in Chapter 2 when considering treatment that shortens outbreaks and
increases latency, the potential treatment considered in this chapter would primarily reduce
the risk of transmission. Hence, considering HSV-2 infected individuals as a whole, in this
case, is sufficient. It will be important in future work to incorporate treatment that shortens
the length of outbreaks by returning to the PDE model and examining the effect of using
different transmission functions.
Consider the reproduction numbers’ sensitivity analysis of the PDE model in Fig-
ures 3.7 and 3.8. The following observations and implications are based on the given pa-
rameter values and ranges. It is possible that different outcomes and hence different strate-
gies would be more effective under different assumptions. We observe that co-infection
may be very important in the disease dynamics. This can be seen by the effect of the
enhancement δP on the HIV invasion reproduction number, indicating that the increased
infectivity of co-infected individuals when transmitting HIV has a strong influence on RHV
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(see Figure 3.8). Thus, introducing a control measure on the HSV-2 populations, which
would also affect co-infected individuals, may reduce HIV prevalence. To support this hy-
pothesis, we see that the transmission of HSV-2 probability βV has a positive impact onRHV ,
while the transmission of HIV probaility βH has almost no influence on RVH . This suggests
that treating individuals with HSV-2 could be effective in lowering HIV prevalence.




more influential than those of the other two groups, suggests that treatment and control
should be focused on the male population. This would prompt us to investigate the effect
of condoms, circumcision, and viral treatment for HSV-2, among other strategies.
Parameters that inversely influence the reproduction numbers are the mortality rates,
μ. Therefore, the length of the period of sexual activity seems to have a strong positive
correlation with the spread of either disease. This parameter is only important for the gen-
eral populations, m and f1, while the high turnover of FSWs seems to have little influence.
Hence, education and early detection of STDs in the general population may be useful
strategies for reducing the spread of both HIV and HSV-2.
The effect of female sex workers on the reproduction numbers is smaller than expected
or often believed. There may be several reasons for this: high turnover (reflected in high
μf2), the tendency for men to choose women from the general population as sexual partners
(reflected in high c1 to c2 ratio), the low infectious probability per partnership (because of
the relatively infrequent encounters with the same partner), and the fact that the model does
not consider what happens to these sex workers after they leave the class. Improvements
of the model to permit us to consider the effect of these aspects will be explored in the
future. However, this does not suggest that looking at FSWs as a separate population is not
useful. Based on the sensitivity analysis, there are different modes through which the two
female groups influence the reproduction numbers. The HSV-2 transmission probability
from FSW to male per partnership, βVf2,m, is more influential on R
H
V than the transmission
probability from general population female to male, βVf1,m. This suggests that strategies for
reducing HSV-2 in the FSWs may be an effective control measure against the spread of
HIV. On the other hand, because the general population female exit rate, μf1 , has so much
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more influence than the FSW exit rate, μf2 , early detection would be a more appropriate
tactic when considering non-sex workers. These different strategies should be explored.
There are several shortcomings of the model that should be discussed. The exclusion of
homosexual encounters may be a factor in its generality. This will be explored in Chapter 4.
Further, the model does not include other modes of transmitting HIV, for example, vertical
transmission and drug use. Also, we do not track the fate of women who leave the FSW
group. These remain topics for future work.
Our model can be used to consider several more realistic characteristics of the two dis-
eases. First, in this study, the transmission probabilities for HSV-2 are only modeled using
a step function. In future work, several functions that can model transition between latent
and acute stages will be explored. These functions would include more aspects of the dis-
ease progression: different acute and latent periods, different levels of infectivity depending
on the time since infection, and the effect of symptomatic versus asymptomatic breakouts
on an individual’s infectiousness and prevention strategy. Second, sensitivity analysis re-
sults could be used to study how implementing different control strategies, perturbing in
our model parameters representing control measures, may affect disease prevalence. And
third, including time-since-infection dependent enhancement parameters may give insight
into the importance of infectivity and/or susceptibility enhancement as a topic of future
biological research. Currently, the direct influence of these enhancements is uncertain.
However, the model does provide insights about the synergy between HIV and HSV-
2 as it estimates trends in disease progression in the absence of treatment. Furthermore,
it gives an expression and biological interpretation of the basic and invasion reproduction
numbers, adding an interesting aspect – the importance of the class from which the ini-
tial infectious person arises. Therefore, where the disease originates within the population
and which group of people is more susceptible to this disease affect the reproduction num-
bers.Finally, the inclusion of a time-since-HSV-2-infection variable adds another layer of
information that may be crucial when deciding on a treatment strategy and determining the
best timing for implementation.
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4. A MODEL FOR THE COUPLED DISEASE DYNAMICS OF HIV
AND HSV-2 WITH MIXING AMONG AND BETWEEN GENDERS
This chapter presents a work which will appear in Mathematical Biosciences. This work
continues the investigation of synergy between HIV and HSV-2 presented in Chapters 2
and 3 by incorporating both heterosexual and homosexual interactions.
4.1 Introduction
Most disease models incorporate either the heterosexual population alone [20,34,43] or
the homosexual population alone [16,29,39]. However, with the growing number of same-
sex couples in the United States and other countries, which may be due to the growing
acceptance of homosexuality, it is important to consider these types of interactions [82]. In
Malunguza et al. [42], an HIV model is presented that separates the male population into
heterosexual and homosexual, with the possibility of interaction to create a bisexual class.
The female population is considered to be completely heterosexual and the model only con-
siders HIV transmission. Including the possibility of homosexual relations was beneficial
in that Malunguza et al. were able to consider various treatment scenarios corresponding
to the different types of interactions. To our knowledge, a model that incorporates hetero-
sexual and homosexual encounters among both male and female populations and includes
the role of co-infection has not yet been considered.
Our model is based on the model of Feng et al., in which an ODE model is introduced
that describes the transmission dynamics of HIV and HSV-2 to examine the role of co-
infection and investigate possible treatment strategies [43]. The population is divided by
gender and includes risk groups among the female population, with transmission occurring
only through heterosexual contact [43]. In contrast, this chapter takes into account trans-
mission through either heterosexual or homosexual behavior and investigates the impact of
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these sexual encounters on the coupled dynamics of HIV and HSV-2. To focus on the com-
plexity of these new interactions between genders, we first consider a model that ignores
risk groups. The main goals of this work include determining the effect of sexual prefer-
ence on the reproduction numbers and disease prevalences and investigating the effect of
co-infection of HIV and HSV-2 on efforts to reduce the HIV epidemic.
We organize the chapter as follows: In Section 4.2, we present the model. We derive
and explain the basic reproduction numbers for HIV and HSV-2 in Section 4.3. Section 4.4
presents the invasion reproduction numbers for both diseases. Results from numerical sim-
ulations of the model are illustrated in Section 4.5. A sensitivity analysis is included in
Section 4.5. Finally, in Section 4.6, we discuss the results of our model.
4.2 Model Formulation
Here we present a model that describes the transmission dynamics of HIV and HSV-
2 in a population with both heterosexual and homosexual encounters. We consider two
population groups based on gender, males (denoted by a subscriptm) and females (f ), with
transmission occurring only due to sexual contacts. We incorporate sexual partnerships
between as well as partnerships within genders. As gender mixing complicates the model,
we ignore the heterogeneity in age-of-infection and use ordinary differential equations to
describe the transmission dynamics of both HIV and HSV-2.
The population is divided into six classes per gender at time t: susceptible (Si(t)), HIV-
positive (Hi(t)), individuals in the acute stage of HSV-2 (Ai(t)), individuals in the latent
stage of HSV-2 (Li(t)), co-infected individuals in the acute stage of HSV-2 (Pi(t)), and
co-infected individuals in the latent stage of HSV-2 (Qi(t)), i = m, f . Denote the total
population of group i as Ni = Si +Hi + Ai + Li + Pi +Qi at each time t,
i = m, f . It is important to note that the population under consideration is the sexually
active population. Hence, entry into the system (Λi) represents an individual becoming








i , and μ
Q
i ) represents cessation
of sexual activity, which may or may not be due to death. Moreover, we do not consider
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AIDS in our model, assuming that those individuals with AIDS refrain from sexual activity.
Thus, acquisition of AIDS is another means of exiting our system. The strength of HIV and
HSV-2 infections are represented by λHi,j and λ
V
i,j , i = m, f , j = m, f , respectively (see
(4.2.3)). As we would like to consider both heterosexual and homosexual relations, we
define qi to be the fraction of partnerships that an i individual has with another i individual,
i = m, f . We also consider enhancement terms δHi , δ
A
i , and δ
L
i , which account for the
greater susceptibility of individuals with one disease to the other. For instance, we may
assume that individuals with acute HSV-2 are more likely to obtain HIV (δAi ). We allow for
the possibility of co-infection increasing the infectivity of a disease with the terms σHi and
σVi . For example, if an individual has both diseases, he may be more infectious with HIV
than an individual who only has HIV (σHi ). In addition, we include progression from the
acute stage of HSV-2 to the latent stage (ωAi , ω
P
i ), and reactivation from the latent stage to
the acute stage (γLi , γ
Q
i ). The system is presented in (4.2.1) with an explanation of variables
and parameters in Table 4.1 and a visual representation of the model in Figure 4.1.
⎧⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎨
⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎪⎩










j,i)Si − δAi (λHi,i + λHj,i)Ai + γLi Li − (μAi + ωAi )Ai
L˙i = ω
A
























i Pi − (μQi + γQi )Qi
i = m, f, j = m, f, j = i.
(4.2.1)
Let bi be the number of contacts that an individual of group i has per unit time. Let
qm be the fraction of contacts that a male individual has with another male individual.




















































Figure 4.1. The compartmentalized model illustrating disease dynamics.
female. Note that males have the same number of contacts with females as females have
with males. Thus we have the following balance equation:
(1− qm)bmNm = (1− qf )bfNf . (4.2.2)

























, i = m, f, j = m, f, j = i.
(4.2.3)
Note that only individuals infected with acute HSV-2 may infect others with HSV-2, while
co-infected individuals with acute or latent HSV-2 may infect others with HIV. Using the
balance equation (4.2.2), we may write:














Description of Model Parameters
Symbol Description
m, f male, female
Ni(t) Total population of group i at time t
Si(t) Number of susceptible individuals of group i at time t
Hi(t) Number of HIV-positive individuals of group i at time t
Ai(t) Number of individuals in the acute stage of HSV-2 of group i at time t
Li(t) Number of individuals in the latent stage of HSV-2 of group i at time t
Pi(t) Number of co-infected individuals in the acute stage of HSV-2 of group i at time t
Qi(t) Number of co-infected individuals in the latent stage of HSV-2 of group i at time t
μi Rate of exiting sexual activity for group i
Λi Total recruitment rate of group i
qi Fraction of partnerships an individual of group i has with another individual of
group i
δAi Enhanced susceptibility of individuals with acute HSV-2 to HIV
δLi Enhanced susceptibility of individuals with latent HSV-2 to HIV
δHi Enhanced susceptibility of individuals with HIV to HSV-2
σVi Enhanced infectivity of individuals with both STDs when transmitting HSV-2
σHi Enhanced infectivity of individuals with both STDs when transmitting HIV
ωAi ,ω
P
i Rate of acute HSV-2 becoming latent
γLi ,γ
Q
i Reactivation rate of latent HSV-2
bi Rate of sexual contacts of individuals of group i
βHi,i Probability per partner of HIV transmission by an HIV-positive individual of group
i to a partner of the same group
βHi,j Probability per partner of HIV transmission by an HIV-positive individual of group
i to a partner of group j
βVi,i Probability per partner of HSV-2 transmission by an HSV-2-positive individual of
group i to a partner of the same group
βVi,j Probability per partner of HSV-2 transmission by an HSV-2-positive individual of
group i to a partner of group j
λHi,i(t) Rate of infection of individuals of group i by individuals of the same group with
HIV at time t
λHj,i(t) Rate of infection of individuals of group i by individuals of group j with HIV at
time t
λVi,i(t) Rate of infection of individuals of group i by individuals of the same group with
HSV-2 at time t
λVj,i(t) Rate of infection of individuals of group i by individuals of group j with HSV-2 at
time t
For this table, i = m, f, j = m, f j = i. Time unit is months.
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4.3 The Basic Reproduction Numbers
Our first aim is to find the basic reproduction number of each disease, i.e., RH0 and R
V
0 ,
around the disease-free equilibrium (DFE). The DFE is (S0i :=
Λi
μSi
, 0, 0, 0, 0, 0), i = m, f .
Note that the basic reproduction number is the average number of secondary infections
caused by one infected individual in a population that is completely susceptible to that
pathogen and without the other. If this value is greater than one, infection will spread in
the population; if this value is less than one, the infection will die out (i.e., the value one is
a threshold).
4.3.1 Basic Reproduction number for HIV (RH0 )
We first derive the basic reproduction number for HIV. In doing so, suppose the HSV-2
and co-infected classes remain at the disease-free equilibrium, so that Ai, Li, Pi, Qi = 0.
In this case, system (4.2.1) reduces to:
⎧⎪⎨
⎪⎩





j,i)Si − μHi Hi,






λHj,i = (1− qj)bjβHj,i
Hj
Ni
, i = m, f, j = m, f, j = i.
We find the basic reproduction number using the next-generation matrix approach [71].
Note that, to use this method, five conditions need to be verified (see Appendix C.1.1). We
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construct matrix F , which describes new infections to the system, and matrix V , which
describes all other transitions within the system.
F =
⎛






Hf + (1− qm)bmβHm,f SfNfHm
⎞






Note that at the DFE, S0i = N
0




⎝ qmbmβHm,m (1− qf )bfβHf,m
(1− qm)bmβHm,f qfbfβHf,f
⎞












































, i = m, f, j = m, f, j = i.
In the literature, reproduction numbers can be defined in different ways. One way
makes use of the next-generation matrix [71], as we did here, and has a square root in
the expression for R0. In this case, the square root appears due to the distinct female and
male populations, and the reproduction number is defined based on the disease spreading
from a single population to the same population (i.e female to female or male to male).
Another way is to derive the reproduction number biologically, which does not include a
square root in the expression. Note that in either case, the value 1 is still a threshold, so
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that both ways of defining reproduction numbers produce similar results. In this chapter,
we have chosen to interpret each of the terms in our R0 equation separately so that we
may understand biologically the importance of each term. However, we have chosen to
define R0 as the average number of secondary female infections by one female (through
contact with males) in the next generation setting (i.e., the expression with the square root).
Furthermore, note that (4.3.1) is composed of two parts. The first component accounts
for homosexual interactions within the female and male populations, and hence, does not
have a square root as these are single populations with no interaction between them. The
second component, however, includes a square root as this part accounts for the interaction
between genders (i.e., heterosexual interaction only or both homosexual and heterosexual
interactions).
Case 1: Only heterosexual interactions.





















is the number of females that an HIV-positive male will infect in his sexual
lifetime. Thus (4.3.2) is the average number of secondary infections caused by one HIV-
positive person through heterosexual contact.
Case 2: Only homosexual interactions.
Next, consider the case where qm, qf = 1, i.e., only homosexual relations. In this case,








. Note that RHf,f is
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the reproduction number for the system excluding the male population and RHm,m is the








The first term represents the total number of females that one HIV-positive female will
infect within her sexual lifetime via only homosexual encounters. Similarly, the second
term represents the total number of males one HIV-positive male individual will infect
within his sexual lifetime via homosexual relationships.
4.3.2 Basic Reproduction number for HSV-2 (RV0 )
Next we will derive the basic reproduction number for HSV-2. Suppose that the HIV
and co-infected classes remain at the disease-free equilibrium, so that Hi, Pi, Qi = 0. Then
we reduce (4.2.1) to the system:
⎧⎪⎪⎪⎪⎪⎨
⎪⎪⎪⎪⎪⎩







i Li − (μAi + ωAi )Ai
L˙i = ω
A
i Ai − (μLi + γLi )Li,






λVj,i = (1− qj)bjβVj,i
Aj
Ni
, i = m, f, j = m, f, j = i.
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f )Lf − ωAf Af
⎞
⎟⎟⎟⎟⎟⎟⎠ .
Note that at the DFE, S0i = N
0







m,m (1− qf )bfβVf,m 0 0
(1− qm)bmβVm,f qfbfβVf,f 0 0
0 0 0 0








m 0 −γLm 0
0 μAf + ω
A
f 0 −γLf
−ωAm 0 μLm + γLm 0
0 −ωAf 0 μLf + γLf
⎞
⎟⎟⎟⎟⎟⎟⎠ ,

































i )− ωAi γLi
, i = m, f, j = m, f, j = i. (4.3.5)
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Note that TAi is the length of time that an HSV-2 infected individual spends in the acute





be the probability that
an HSV-2 infected individual progresses from the acute stage to the latent stage of HSV-





be the probability that an HSV-2
infected individual in the latent stage returns to the acute stage before exiting the system.
Then the expected number of times that an HSV-2 infected individual is in the acute, rather























i )− ωAi γLi
.
Note that E(Ai) ≥ 1 for any choice of non-negative parameters. Now, the average time
spent in the Ai class each time is 1μAi +ωAi































i )− ωAi γLi
.
Case 1: Only heterosexual interactions.







Note that bfβVf,m is the rate at which HSV-2 positive females infect males, while T
A
f is the
amount of time that a female stays in the Af class. Note that, in this case, the Af class is





f is the total number of males that one HSV-2 positive female individual




m is the number of
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females that an HSV-2 positive male will infect in his sexual lifetime. Thus, (4.3.6) is
the average number of secondary female infections caused by one HSV-2 positive female
through heterosexual contact with males.
Case 2: Only homosexual interactions.
Next, consider the case where qm, qf = 1, i.e., only homosexual relations. In this case,
we have eigenvalues of FV −1: RVf,f and R
V
m,m. Note that R
V
f,f is the reproduction number
for the system excluding the male population and RVm,m is the reproduction number for the








The first term represents the total number of females that one HSV-2 positive female will
infect within her sexual lifetime via homosexual encounters. Similarly, the second term
represents the total number of males one HSV-2 positive male individual will infect within
his sexual lifetime via homosexual relationships.
4.4 Invasion Reproduction Numbers
Because the basic reproduction numbers only provide information in a population that is
without the other pathogen, it is important to consider another threshold value, the invasion
reproduction number. Note that the invasion reproduction number is the average number of
secondary infections caused by one infected individual in a population that is completely
susceptible to one pathogen, but already has the other. In this section, we find the invasion
reproduction number for each disease, i.e., the reproduction number for HIV when HSV-2
is endemic, and conversely, the reproduction number for HSV-2 when HIV is endemic.
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4.4.1 Invasion HIV Reproduction Number (RHV )
In this section, we will derive and explain the invasion reproduction numberRHV around




i , 0, 0).
Similar to the basic reproduction numbers, we will find the invasion reproduction num-
ber RHV using the next-generation approach [71]. For verification of condition A5 in [71],











































































Hf − γQf Qf + (μPf + ωPf )Pf
−ωPmPm + (μQm + γQm)Qm















































⎝1 0 σHm 0 σHm 0












m 0 0 0 0 0
0 Cf + μ
H
f 0 0 0 0
−Cm 0 μPm + ωPm 0 −γQm 0
0 −Cf 0 μPf + ωPf 0 −γQf
0 0 −ωPm 0 μQm + γQm 0


















For transparency, we will consider in which class individuals are infected with HIV,
whether they are susceptible to both diseases or are already infected with acute or latent
HSV-2, and how long individuals spend in each stage. While classifying individuals in this
way leads to more terms in the expression forRHV , it provides a way to more easily interpret
the expression biologically.
Case 1: Only heterosexual interactions.

















































































































































































































































































































































































































i )− ωPi γQi
.
(4.4.6)
First note thatWf is the size of the population susceptible to HIV, weighted by enhance-
ment. Also, pH→Pi is the probability that an individual will become infected with HSV-2
while in the Hi class, while THi is the length of time that an individual spends in the Hi
class. T (P )i is the amount of time that an individual spends co-infected if he or she acquires






be the probability that a co-infected individual progresses from the






be the probability that a co-infected individual in the latent stage of HSV-2
returns to the acute stage before exiting the system. Then the expected number of times
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that a co-infected individual, who acquired HIV while in the acute stage of HSV-2, remains























i )− ωPi γQi
.
Note that E(Pi) ≥ 1 for all non-negative parameters. The average time spent in the Pi class




. Hence, the overall time spent in the Pi class, if the individual was






























i )− ωPi γQi
.
(4.4.7)
Similarly, the expected number of times that a co-infected individual, who acquired
HIV while in the acute stage of HSV-2, progresses to the latent stage is:




















i )− ωPi γQi
,
where E(Pi → Qi) ≥ 0 for all non-negative parameters. The average time spent in the Qi




. Thus, the overall time spent in the Qi class, if the individual was


























i )− ωPi γQi
.
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Hence, as in (4.4.6), the length of time that an individual spends co-infected, if he or she



















i )− ωPi γQi
.
In a similar way, we can see that T (Q)i is the amount of time that an individual spends
co-infected if he or she acquires HIV while in the latent stage of HSV-2, and can be derived
as follows. With the same h1 and h2 as before, the expected number of times that a co-
























i )− ωPi γQi
.
Again, E(Qi) ≥ 1 for any non-negative parameter values. The average time spent in the
Qi class each time is 1μQi +γQi
. Hence, the overall time spent in the Qi class, if he or she was






























i )− ωPi γQi
.
Similarly, the expected number of times that a co-infected individual, who acquired
HIV while in the latent stage of HSV-2, progresses to the acute stage is:




















i )− ωPi γQi
,
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where E(Qi → Pi) ≥ 0. The average time spent in the Pi class each time is 1μPi +ωPi . Thus,



























i )− ωPi γQi
.
(4.4.8)
Hence, as in (4.4.6), the length of time that an individual spends co-infected, if he or she



















i )− ωPi γQi
.
Now note that the invasion reproduction number, RHV , has three main parts, correspond-
ing to the initial HIV-infected individual coming from the completely susceptible popula-
tion (4.4.3) or the populations that are already infected with either acute (4.4.4) or latent
(4.4.5) HSV-2. It is important to consider these cases separately because an individual may
acquire HIV at any stage of their HSV-2 infection.































is the weighted fraction of females who are susceptible to HIV and
do not yet have HSV-2; bfβHf,m is the rate at which HIV-positive females infect males; and
THf is the amount of time that a female stays in the Hf class, without exiting due to HSV-










is the total number of Sm males
that one HIV-positive female individual will infect within her sexual lifetime, provided that





is the number of females that an












indicates that the HIV-positive male may infect either
a completely susceptible female (to both diseases) or a female who already has HSV-2
(either acute or latent) with enhanced susceptibility to HIV (δAf , δ
L
f ). Hence, the first term
of (4.4.3) describes an initial Sf female who is infected with HIV only and infects an Sm
male; he does not contract HSV-2 and infects another female with HIV.
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Table 4.2.



















The initial Sf female who acquires HIV-only in-
fects an Sm male with HIV; the male does not





















The initial Sf female who acquires HIV-only
infects an Sm male, who then contracts HSV-2




















The initial Sf female acquires HIV, contracts
HSV-2, and infects an Sm male. The male does























The initial Sf female acquires HIV, contracts
HSV-2, and infects an Sm male. The male con-





















The initial female with HIV-only infects an Am
male with HIV; he is now co-infected and in-






















The initial female with HIV contracts HSV-2
and then infects an Am male with HIV. The





















A female with HIV-only infects an Lm male
with HIV. He is now co-infected and infects an-






















The initial female with HIV contracts HSV-2
and then infects anLm male with HIV. The male
now has both diseases and infects another fe-
male with HIV.

























m . Note that pH→Pm T
(P )
m is the amount of time that a male who initially
has only HIV spends co-infected after contracting acute HSV-2, and σHm is the enhanced
infectivity of this now co-infected male. Therefore, the second term of (4.4.3) describes
the situation where an initial Sf female who acquires HIV only infects an Sm male, who
then contracts HSV-2 and infects another female with HIV.
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Table 4.3.





















A co-infected female beginning in the acute
stage of HSV-2 infects an Sm male with HIV.
The male now has HIV, does not acquire HSV-






















A co-infected female in the acute HSV-2 stage
infects an Sm male with HIV. He then contracts






















A co-infected female in the acute stage of HSV-
2 infects an Am male with HIV; the male is now























A co-infected female in the acute stage of HSV-
2 infects an Lm male with HIV. The male is





















A co-infected female in the latent stage of HSV-
2 infects an Sm male with HIV. The male now






















A co-infected female in the latent stage of HSV-
2 infects an Sm male with HIV. The HIV-
infected male contracts HSV-2 before infecting






















A co-infected female in the latent stage of HSV-
2 infects a male, who has acute HSV-2, with
HIV. The male now has both diseases and in-






















A co-infected female in the latent stage of HSV-
2 infects an Lm male with HIV. The male in-
dividual is now co-infected and infects another
female with HIV.
The third and fourth terms of (4.4.3) have similar biological meanings. The third term
describes the scenario in which an initial Sf female, who acquires HIV, contracts HSV-2,
and infects an Sm male. The male does not contract HSV-2 and infects another female with
HIV. The fourth term only differs in that the male would also contract HSV-2 after his HIV
infection and before infecting another female with HIV.
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. Note that the female











indicates that the female infects a male who already has acute HSV-2 with HIV. The δAm
parameter is the enhanced susceptibility of this HSV-2 infected male to acquiring HIV.







describes the co-infected male infecting a female,
as bmβHm,f is the rate at which HIV-positive males infect females, T
(P )
m is the amount of
time that a male is co-infected when first experiencing the acute stage of HSV-2, σHm is the
enhanced infectivity of this co-infected male, and Wf
Nf
is the weighted population of females
that the male may infect. Hence the fifth term of (4.4.3) describes the situation where an
initial female with HIV only infects an Am male with HIV; the male is now co-infected and
infects another female with HIV.
The remaining 11 terms of (4.4.2) have similar interpretations and are explained in
Tables 4.2 and 4.3. Hence, taking the sum of these 16 possible scenarios and taking the
square root to account for the interaction between females and males, we have the average
number of secondary female HIV infections generated by a typical HIV-infected female in
a population that is completely susceptible to HIV (in a population where the dynamics for
HSV-2 are stable).
Case 2: Only homosexual interactions.
Next, consider the case where qm, qf = 1, i.e., only homosexual relations. Then, if we











































































































For interpretation, we will consider the invasion reproduction number for the female
population. In this case, RHV has four terms. The first term of (4.4.9) describes the situ-
ation where an HIV-positive female, who does not acquire HSV-2, infects another female
with HIV. The second term represents an HIV-positive female acquiring acute HSV-2 and
then infecting another female with HIV. The third term describes a co-infected female in
the acute stage of HSV-2 infecting another female with HIV. The final term indicates a
co-infected female in the latent stage of HSV-2 infecting another female with HIV. The
interpretation of (4.4.10) is analogous with males instead of females.
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4.4.2 Invasion HSV-2 Reproduction Number (RVH)
Next, we will derive the invasion reproduction number RVH around the HIV endemic
equilibrium (S∗i , H
∗
i , 0, 0, 0, 0). Using the next-generation matrix approach (see




































































































































0 0 0 0 0 0 0 0
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m 0 −γLm 0





−ωAm 0 dm + μLm + γLm 0






−cm 0 0 0
0 −cf 0 0
0 0 −dm 0







m 0 −γQm 0
0 μPf + ω
P
f 0 −γQf
−ωPm 0 μQm + γQm 0
0 −ωPf 0 μQf + γQf
⎞
⎟⎟⎟⎟⎟⎟⎠,
























Case 1: Only heterosexual interactions







































































































































































































































































































































































EAi = δAi qibiβHi,i
H∗i
Ni
+ δAi (1− qj)bjβHj,i
H∗j
Ni
+ μAi + ω
A
i ,
ELi = δLi qibiβHi,i
H∗i
Ni
+ δLi (1− qj)bjβHj,i
H∗j
Ni





























E(Ai) = E(Li) =
EAi ELi




EAi ELi − ωAi γLi
(4.4.15)
T P→Pi and T
Q→P
i are as in the previous section (see (4.4.7) and (4.4.8)) and Wf is the
size of the population susceptible to HSV-2, weighted by enhancement. Note that EAi is the
rate of exit from the Ai class, while ELi is the exit rate from the Li class. Then pA→Li is the
probability that an individual will progress to the latent stage of HSV-2 before acquiring
HIV or exiting the sexually active population, pA→Pi is the probability that an individual in
the acute stage of HSV-2 will acquire HIV, and pL→Qi is the probability that an individual
in the latent stage of HSV-2 will acquire HIV. E(Ai) is the expected number of times an
individual will be in the Ai class. Similarly, E(Li) is the expected number of times an
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individual will be in the Li class. Finally, TA→Ai is the overall length of time that an
individual spends in the Ai class, taking into account the progression of HSV-2 from acute




be the probability that an individual with HSV-2-only progresses from the
acute stage to the latent stage of HSV-2 before acquiring HIV or exiting the system. Simi-
larly, let h2 =
γLi
ELi
be the probability that an individual with HSV-2-only in the latent stage
returns to the acute stage before acquiring HIV or exiting the system. Then the expected
number of times that an HSV-2 infected individual in the acute stage of the disease, who











EAi ELi − ωAi γLi
.
Similarly, the expected number of times that an HSV-2 infected individual in the latent











EAi ELi − ωAi γLi
.
Hence, as in (4.4.15), E(Ai) = E(Li) =
EAi ELi
EAi ELi −ωAi γLi
.
Now, the average time spent in the Ai class each time is 1EAi
. Hence, as in (4.4.15), the





EAi ELi − ωAi γLi
=
ELi
EAi ELi − ωAi γLi
.
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Note that this case is similar to the invasion reproduction number for HIV, but the
interpretations differ as only individuals in the acute stage may infect others with HSV-2.
Also,RVH has two main parts corresponding to the cases in which the initial HSV-2-infected
individual comes from the completely susceptible (4.4.13) or population that is already
infected with HIV (4.4.14).




















is the weighted fraction of females who are susceptible to HSV-2 and do not yet have HIV;
bfβ
V
f,m is the rate at which HSV-2-infected females infect males; and T
A→A
f is the amount











is the total number of Sm males that one HSV-2-
infected female individual will infect within her lifetime of sexual activity, provided that





is the number of females that an









indicates that this HSV-2-infected male may infect either a completely
susceptible female (to both diseases) or a female who already has HIV with an enhanced
susceptibility to HSV-2 (δHf ). Hence, the first term of (4.4.13) describes an Sf female who
acquires HSV-2-only and infects an Sm male with HSV-2; the male does not contract HIV
and infects another female with HSV-2.




















has the same initial female-to-male infection as the first term. The remaining part differs




m . Note that E(Am) is the expected number of times that
an individual will remain in the Am class, pA→Pm is the probability that this Am individual
will be infected with HIV, T P→Pm is the amount of time that a male who initially only has
HSV-2 spends co-infected and in the acute stage of HSV-2 after contracting HIV, and σVm
is the enhanced infectivity of this now co-infected male. Therefore, the second term of
(4.4.13) describes the situation where an Sf female who acquires HSV-2-only infects an
Sm male, who then contracts HIV while in the acute stage of HSV-2 and infects another
female with HSV-2.
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m . This describes the scenario in which an Sf female acquires HSV-
2-only and infects an Sm male. The male goes from the acute stage of the disease to the
latent stage, acquires HIV while in the latent stage of HSV-2, and must become acute again
before infecting another female with HSV-2.



















. Note that the









. This indicates that the female infects a male who already has HIV with HSV-2. The








, describes the co-infected male infecting a female, as
bmβ
V
m,f is the rate at which HSV-2-infected males infect females, T
P→P
m is the amount of
time that a male is co-infected and in the acute stage of HSV-2 when first experiencing the




the weighted population of females that this male may infect. Hence the fourth term of
(4.4.13) describes the situation where a female with HSV-2-only infects an Hm male with
HSV-2; the male is now co-infected and infects another female with HSV-2.
The remaining 12 terms of (4.4.12) have similar interpretations and are explained in
Tables 4.4, 4.5, and 4.6. Thus, taking the sum of these 16 possible scenarios and taking the
square root, we have the average number of secondary female HSV-2 infections generated
by a typical HSV-2-infected female in a population that is completely susceptible to HSV-2



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Case 2: Only homosexual interactions.
Next, consider the case where qm, qf = 1, i.e., only homosexual relations. Then, if we










































































































For interpretation, we will consider the invasion reproduction number for the female
population. In this case,RVH has four terms. The first term of (4.4.16) describes the situation
where an HSV-2-positive female, who does not acquire HIV, infects another female with
HSV-2 (an individual must be in the acute stage of HSV-2 to infect). The second term
represents an HSV-2-positive female acquiring HIV while in the acute stage of HSV-2
and then infecting another female with HSV-2. The third term indicates an HSV-2 positive
female acquiring HIV while in the latent stage of HSV-2. This female now has both diseases
and must become acute again before infecting another female with HSV-2. The final term
describes a co-infected female infecting another female with HSV-2. The interpretation of
(4.4.17) is analogous with males instead of females.
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4.5 Numerical Simulations
This section gives numerical results of the total population dynamics for our model, as
well as a sensitivity analysis of the basic and invasion reproduction numbers and prevalence
of both diseases.
4.5.1 Population Dynamics
We performed numerical simulations to determine the prevalence of HIV, acute HSV-
2, latent HSV-2, and (acute and latent) co-infection using our model parameters (see Ta-
ble 4.7). We then used these values as a baseline in conducting a sensitivity analysis for the
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in the model with HSV-2
HIV infected cases
in the model without HSV-2
Figure 4.2. The HIV infected cases in the models with or without HSV-2. In
the left plot, RH0 = 0.87, R
H




H = 1.21. In the right plot,
RH0 = 0.96, R
H





First, it is important to recognize how the reproduction numbers may affect the dis-
ease dynamics (see Figures 4.2 and 4.3). In these figures, based on the chosen parameter
values, we allowed the simulations to run until they stabilized at the equilibrium level. In
Figure 4.2, we observe that, when both the basic and invasion reproduction numbers for
HIV are less than one, HIV cannot survive in the population. However, when the basic
reproduction number is less than one, but the invasion reproduction number is greater than
one, we see that the survival of HIV depends on whether or not HSV-2 is already present
in the population. In this case, when HSV-2 is present, HIV can invade the population; but
when HSV-2 is absent, then HIV dies out. The same results hold for the other disease, as
seen in Figure 4.3.
We will consider four main scenarios relating to the differences in sexual preference;
i.e., all heterosexual individuals, all homosexual individuals, all bisexual individuals, and a
final, more realistic setting, changing qm and qf accordingly. For these simulations, we will
assume that the exit rates for all classes (μ) are equal, but we may relax this assumption to
achieve similar results (see Section 4.5.3).
In Figure 4.4, we see the extreme scenarios in which either the entire population is





































































in the model with HIV
HSV-2 infected cases
in the model without HIV
Figure 4.3. The HSV-2 infected cases in the models with or without HIV. In
the left plot, RV0 = 0.78, R
V




V = 1.14. In the right plot,
RV0 = 0.93, R
V





are the situations that are most often considered, but give very different results. When
qm = qf = 0, we see a higher prevalence of latent HSV-2 than acute HSV-2 or HIV. We
may notice that, in this case, the female population has more disease overall than the male
population, which is consistent with the literature [17, 85]. Furthermore, we see an overall
prevalence for HSV-2 of about 15% and an overall prevalence for HIV of around 4%, values
currently observed in the United States [3, 17].
When qm = qf = 1, we see a much different scenario. In this case, primarily the
men are infected and we see the highest prevalence among men in the co-infected latent
population. This higher co-infected population causes a higher prevalence for both diseases
than when all individuals are heterosexual. We also observe that, in these two extreme
cases, the equilibrium is obtained in a much different time period. For qm = qf = 0, the
case when all individuals are heterosexual, we see that equilibrium is attained after about
300 years. But, when all individuals are homosexual (qm = qf = 1), equilibrium is reached
after only about 100 years. We should take this under consideration when implementing a
control policy, as there would be less time to develop a treatment strategy in the presence
of a homosexual population.
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Figure 4.4. The fraction of the population infected with HIV-only, acute HSV-
2-only, latent HSV-2-only, co-infected (acute or latent) corresponding to the
two scenarios where either all individuals are heterosexual (qm = qf = 0) or
all individuals are homosexual (qm = qf = 1). For qm = qf = 0, we have
RH0 = 1.05, R
V
0 = 1.15, R
H
V = 1.15, and R
V
H = 1.20. For qm = qf = 1, we
have RH0 = 3.33, R
V
0 = 2.35, R
H
V = 4.27, and R
V
H = 2.35.
Because the extreme cases with all heterosexuals or all homosexuals give drastically
different results, we want to use parameters that allow us to have both types of individuals
in our model. In Figure 4.5, we may first look at the case where all individuals are bisexual
(qm = qf = 0.5). This scenario shows an average of the previous extreme cases, but is not
very realistic, as the latent co-infected population causes a significant amount of disease.
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Figure 4.5. The fraction of the population infected with HIV-only, acute HSV-
2-only, latent HSV-2-only, co-infected (acute or latent) corresponding to the
two scenarios where either all individuals are bisexual (qm = qf = 0.5) or a
more realistic scenario in which qm = 0.2 and qf = 0.15. For qm = qf = 0.5,
we have RH0 = 1.85, R
V
0 = 1.50, R
H
V = 2.22, and R
V
H = 1.93. For qm = 0.2,
qf = 0.15, we have RH0 = 1.27, R
V
0 = 1.24, R
H
V = 1.44, and R
V
H = 1.44.
Observations suggest that, in certain cities such as San Francisco, we may see levels closer
to qm = 0.2 and qf = 0.15 [82,83]. It is important to note that qm = 0.2 does not mean that
20% of the male population is homosexual. It merely means that 20% of the time, a male
may choose to have relations with a member of the same sex, while this individual may or
may not identify as a homosexual [86]. This case shows a higher percentage of individuals
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with latent co-infection and HIV-only infection than in the case where qm = qf = 0,
while maintaining a similar level of HSV-2-only latent infection, even though homosexual
relations are infrequent. Moreover, we no longer see, as when qm = qf = 0, that women
have more disease than men. In this more realistic setting, we see that men have more HIV
and hence also have more latent co-infection than women, while women continue to have
higher levels of HSV-2-only infection.
In this more realistic case, there is much more latent infection among individuals with
HSV-2 only rather than co-infected individuals. When comparing this prevalence to the
prevalence when all individuals are heterosexual, we see a much different result. Even
though the preference for homosexual contact is small, we observe an almost double HSV-
2 prevalence and a much higher HIV prevalence. Hence, it is important to know where
data are obtained for the prevalence of each disease and to include the interaction between
and among genders to achieve a realistic result. Using a model that only incorporates
heterosexual contact may significantly underestimate disease prevalences, which could lead
to insufficient control efforts.
4.5.2 Sensitivity Analysis
In this section, we perform a sensitivity analysis to investigate the sensitivity of the basic
and invasion reproduction numbers to our choice of model parameters. We chose a range of
values and a probability density function (pdf) for each parameter and then used a method
based on Latin Hypercube Sampling [37, 76] to generate the model parameters. In this
case, we chose either a uniform (U) or a triangular (T) pdf for each parameter as indicated
in Table 4.8. By sampling equally probable regions, we obtain the Latin Hypercube [19,37,
81]. We generated 3,000 sets of parameters to consistently produce the following results.
In Figure 4.6, we see the densities of the basic and invasion reproduction numbers that
were obtained from our parameter ranges, with their mean identified by the point on the




Parameter Lower Bound Upper Bound Distribution
qm, qf 0 0.5 U
μm = μf 1/480 1/240 T
bm 1/12 1/8 U
Nm 10
5 106 U
βHm,m 0.05 0.2 T
βHm,f 0.03 0.15 T
βHf,m 0.02 0.1 T
βHf,f 0.005 0.05 T
βVm,m 0.3 0.5 T
βVm,f 0.1 0.4 T
βVf,m 0.1 0.3 T
βVf,f 0.05 0.3 T
ωAm 2.38 2.98 T
ωAf 1.78 2.38 T
ωPm 1.67 2.08 T
ωPf 1.25 1.67 T
γLm 0.39 0.48 T
γLf 0.29 0.39 T
γQm 0.42 0.52 T
γQf 0.31 0.42 T
δH , δA, δL 1 1.1 U
σH , σV 1 1.1 U
T indicates a triangular distribution, with peak at the fixed value from Table 4.7.
U indicates a uniform distribution.
calculating the invasion reproduction numbers, we numerically calculated the equilibrium
values to be used in the simulations.
Using the sets of parameter values obtained from the Latin Hypercube Sampling
method, we calculated partial rank correlation coefficients (PRCC) [19, 81]. These are
computed using a method that determines the effect of varying each parameter on the re-
production numbers, while accounting for the possible interactions between the remaining
parameters [19, 37, 81]. The results are PRCC indices that range between -1 and 1. A pos-
itive (negative) PRCC value indicates the relationship between the parameter and repro-


















































Figure 4.6. Densities of the basic and invasion reproduction numbers for HIV
and HSV-2 obtained from Latin Hypercube parameter ranges. The point indi-
cates the mean of the distribution.
parameters are most influential in their effect on the reproduction numbers, with indices of
magnitude closer to 1 having the most impact [19, 37].
In Figures 4.7 and 4.12, we show the PRCC indices for the basic and invasion re-
production numbers. We have eliminated any parameters that have minimal effect on the
reproduction numbers from the figures. First we may consider the basic reproduction num-
bers, RH0 and R
V
0 (see Figure 4.7). We first notice the effect of qm and qf on R
H
0 . We see
that as qm and qf increase, which increase homosexual relations in the system, we have
a higher HIV basic reproduction number. We observe this result in Figures 4.8 and 4.9.
As qm increases in Figure 4.8, the prevalence of HIV increases, primarily among the male
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Figure 4.7. Partial rank correlation coefficients (PRCC) calculated using pa-
rameter ranges from Latin Hypercube Sampling with respect to the basic re-
production numbers for HIV and HSV-2. Positive (negative) values indicate
a positive (negative) relationship of the parameter with the basic reproduction
number. Values in magnitude closer to 1 signify parameters having the most
effect on changing the reproduction number.




contact rate bm, and the transmission probabilities for male homosexual activity and all
heterosexual activity. We see that as μH increases (and hence the time spent sexually ac-
tive decreases), the basic reproduction number of HIV decreases as well, which is what we
would expect: with less time spent sexually active, an individual will infect fewer other
individuals. The contact rate bm has the opposite effect, whereby an increase in an individ-
ual’s number of partnerships results in a higher HIV basic reproduction number. As for the
transmission rates, transmission from woman-to-woman has a much lower impact than all
other transmissions, with heterosexual transmission having more influence than homosex-
ual transmission overall. This is likely due to observations which indicate that homosexual
contact occurs no more than 50% of the time.
For the HSV-2 basic reproduction number (see Figure 4.7), we see similar results for
μV , bm, and the transmission rates. However, we see that qf has a positive effect on RV0 ,
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Figure 4.8. The fraction of the population infected with HIV-only, correspond-
ing to different scenarios to show the effects of changing qm on the disease
dynamics.





























































































Figure 4.9. The fraction of the population infected with HIV-only, correspond-
ing to different scenarios to show the effects of changing qf on the disease
dynamics.
while qm has a minimal effect onRV0 . Comparing this result with Figures 4.10 and 4.11, we
see that this in fact holds. As qm increases (see Figure 4.10), we see relatively little change
in the prevalence of HSV-2-only infection as the male population obtains more HSV-2
overall, while the female population contracts less HSV-2. For qf (see Figure 4.11), we
observe that as qf increases, we obtain higher prevalence in both HSV-2 infected classes.
This may be due to qf determining the contact rate bf , whereas an increase in qf leads to
an increase in bf .
For the basic HSV-2 reproduction number, we also include the parameters ωA, which is
the rate at which individuals progress to the latent stage of the disease, and γL, which is the
reactivation rate. As expected, a higher rate of progression to the latent stage causes a lower
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Figure 4.10. The fraction of the population infected with acute HSV-2 only
and latent HSV-2 only corresponding to different scenarios to show the effects
of changing qm on the disease dynamics.































































































Figure 4.11. The fraction of the population infected with acute HSV-2 only
and latent HSV-2 only corresponding to different scenarios to show the effects
of changing qf on the disease dynamics.
RV0 as only acute individuals are infectious. Similarly, a higher reactivation rate, which
introduces infectious individuals to the acute stage faster causes the basic reproduction
number to increase as well.
In Figure 4.12, we give the PRCC indices for the invasion reproduction numbers, RHV
and RVH . The results are similar to the basic reproduction numbers, except for the added
HSV-2 transmission for RHV and the added HIV transmission for R
V
H . For R
H
V , we see
that all HSV-2 transmissions have a positive effect on the invasion reproduction number.
Hence, if we can implement a control measure on HSV-2, which would potentially lower
the HSV-2 transmission probabilities, we would also see a reduction in RHV . However, for
RVH , we see that all HIV transmissions have very minimal effect on the possibility for HSV-
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2 invasion. We also notice that forRVH , the progression from acute to latent and reactivation
has more impact from the singly-infected rather than co-infected population. This is likely
due to the choice of parameter values, in which (as in Figure 4.5) the co-infected population






































































Figure 4.12. Partial rank correlation coefficients (PRCC) calculated using pa-
rameter ranges from Latin Hypercube Sampling with respect to the invasion
reproduction numbers for HIV and HSV-2. Positive (negative) values indicate
a positive (negative) relationship of the parameter with the basic reproduction
number. Values in magnitude closer to 1 signify parameters having the most
effect on changing the reproduction number.
Moreover, we may consider the effects of enhancement parameters. For RHV , we see
that the only influential enhancement parameters are σH and δL. Recall that σH is the en-
hanced infectivity of co-infected individuals when transmitting HIV and δL is the enhanced
susceptibility of individuals with latent HSV-2 to HIV. The positive effect of both of these
parameters on RHV is expected as an increase in either kind of enhancement would allow
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individuals to infect or contract HIV with a higher probability, hence producing more dis-
ease in the population in a shorter period. In contrast, all of the enhancement parameters































































Figure 4.13. Partial rank correlation coefficients (PRCC) calculated using pa-
rameter ranges from Latin Hypercube Sampling with respect to the invasion
reproduction numbers for HIV and HSV-2. Positive (negative) values indicate
a positive (negative) relationship of the parameter with the invasion reproduc-
tion number. Values in magnitude closer to 1 signify parameters having the
most effect on changing the reproduction number.
While it is important to consider the effects of the parameters on the reproduction num-
bers, it is also helpful to observe their effects on disease prevalence. In Figure 4.13, we
give the PRCC indices for both HIV and HSV-2 prevalence. As expected, many of the
same parameters that affected the basic reproduction numbers for either disease also affect
disease prevalence. For HSV-2 prevalence, the only influential enhancement parameters
are σV and δH , which have an analogous meaning to the parameters in the PRCC for the
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invasion reproduction number for HIV in Figure 4.12. We see that all transmission param-
eters (β) affect both disease prevalences positively. This indicates that treating individuals
with HSV-2 will be beneficial throughout the course of both epidemics as all βV parame-
ters have a positive impact on both invasion reproduction numbers and both disease preva-
lences. Hence, not only will treating individuals with HSV-2 lower the disease prevalence
for both HIV and HSV-2, but it will also inhibit HIV from invading the population from
the beginning, whereas treating individuals with HIV has little effect in the case of HSV-2
invasion.
4.5.3 Case with Unequal Exit Rates
As our simulations are for the case when the exit rates from all classes are equal, we
would like to consider the effect of having a higher exit rate for the HIV-infected classes.
Individuals who have HIV progress to AIDS after about ten years [90], which is a much
smaller amount of time than the assumed sexually active period. We conducted numerical
simulations when a higher exit rate is considered for HIV-infected individuals. We observe
the same underestimation in disease prevalence (primarily for HSV-2) when homosexuality
is not included. We see less co-infection overall as HIV infected and co-infected individu-
als exit the system at a faster rate. However, the results are all similar to the case when we
assume that the exit rates are all equal. Also, the sensitivity analysis shows similar relation-
ships of the parameters with the basic reproduction numbers and the invasion reproduction
numbers as in Figures 4.7 and 4.12. The key difference in this case with different exit
rates is in the sensitivity of HSV-2 prevalence. When observing the role of these same
parameter values on HSV-2 prevalence (see Figure 4.14), we observe a negative effect of
the HIV transmission rates. This is likely due to the fact that decreasing βH increases the
susceptible population to HSV-2, as individuals with HIV exit the system at a faster rate
than completely susceptible individuals. Having more individuals susceptible to HSV-2
increases the prevalence, as we would expect.
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Figure 4.14. Partial rank correlation coefficients (PRCC) calculated using pa-
rameter ranges from Latin Hypercube Sampling with respect to the invasion
reproduction number for HSV-2 when HIV-infected classes have a higher exit
rate than non-HIV-infected classes. Positive (negative) values indicate a pos-
itive (negative) relationship of the parameter with the invasion reproduction
number. Values in magnitude closer to 1 signify parameters having the most
effect on changing the reproduction number.
4.6 Discussion
We aim to describe the coupled dynamics of HIV and HSV-2 and investigate the impact
of treating patients infected with HSV-2 on the HIV epidemic. Further, we introduce a
population with both heterosexual and homosexual encounters, a feature rarely considered
in mathematical models. One of the main goals of our model is to investigate how the
incorporation of both heterosexual and homosexual activity influences disease dynamics,
either through the reproduction numbers or disease prevalences. Another goal is to deter-
mine the role of co-infection on HIV prevalence. We first calculate and interpret the basic
and invasion reproduction numbers for HIV and HSV-2. We then perform numerical simu-
lations to examine the population dynamics under various scenarios to determine the effect
of having a mixed heterosexual and homosexual population. Finally, we analyze the repro-
duction numbers and disease prevalences to investigate the sensitivity of these numbers to
uncertainty in the parameter values.
In looking at the population dynamics (see Figures 4.4 and 4.5), we observe a sub-
stantial difference in the models with all heterosexual and all homosexual activity. Even
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including a small level of homosexual activity (see Figure 4.5) drastically changes results
from the case where all contacts are heterosexual. In this case, we see that including ho-
mosexual contacts causes the prevalence of both HIV and HSV-2 to be higher than if all
individuals were heterosexual. This is primarily seen in the higher prevalence of HIV-only
and latent co-infection, but all disease classes are more prevalent when qm = 0.2, qf = 0.15
than when qm = qf = 0. This is not surprising as many of the individuals with HIV (and
hence also co-infection) are members of the homosexual population [3, 16]. Thus, even
though the frequency of homosexual activity may be low, ignoring this kind of interaction
causes a significant underestimation of disease prevalence. When deciding on a treatment
regime, this underestimation may affect which treatment strategy is optimal for any given
population. Hence, it is very important to determine the frequency of homosexual activity
in the population under consideration.
For the sensitivity analysis, we wish to determine which parameter values influence the
reproduction numbers most (see Figures 4.7 and 4.12). We see that a higher preference
for homosexual rather than heterosexual encounters increases both basic and invasion re-
production numbers, which we confirm by observing this same relationship with respect
to the disease prevalences in Figures 4.13. One reason may be the effect of qm and qf in
determining the contact rate bf =
(1−qm)bmNm
(1−qf )Nf . Another may be that the transmission rate
for homosexual men is always greater than the rate among heterosexuals. In any case, it is
very important to accurately estimate sexual preferences for a given population to correctly
calculate the reproduction numbers.
Another key result of this model is the relationship between the transmission parameters
(β) and the reproduction numbers and disease prevalences. In Figure 4.12, we see that all
transmission parameters increase RHV , indicating that treating either disease would inhibit
HIV invasion. We may also observe the effects of these potential treatments on the disease
prevalence (see Figure 4.13). We observe that treating either disease will be beneficial to
lowering both disease prevalences. This relationship allows us to analyze various treatment
strategies, whether we treat HSV-2 alone or in conjunction with HIV. Treating individuals
with HSV-2 will always be helpful in controlling both HSV-2 and HIV epidemics. Particu-
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larly, treating HSV-2 cases will lower HIV and HSV-2 prevalence, while also providing an
HIV-free population protection against HIV invasion.
To further explore the effects of co-infection, we may investigate the impact of enhance-
ment on the reproduction numbers. We see that the enhanced infectivity of co-infected in-
dividuals when transmitting HIV (σH) and the enhanced susceptibility of individuals with
latent HSV-2 to HIV (δL) both increase RHV and HIV prevalence. Similarly, the enhanced
infectivity of co-infected individuals when transmitting HSV-2 (σV ) and the enhanced sus-
ceptibility of individuals with HIV to HSV-2 (δH) both increase HSV-2 prevalence. This
signifies that HSV-2 facilitates the spread of HIV. Moreover, co-infection plays an impor-
tant role in the spread of both diseases as the enhanced infectivity of co-infected individuals
positively affects both disease prevalences (see Figure 4.13). The only kind of enhancement
that has no impact on either disease is δA, the increased susceptibility of individuals with
acute HSV-2 to HIV. This may be due to the overall shorter time that is spent in the acute
versus latent stage of HSV-2.
Due to the complexity of the current model, we modeled the choice of heterosexual
versus homosexual contact as preference (i.e., there is a probability that an interaction will
be either heterosexual or homosexual in nature). Furthermore, there is little data available
to indicate the appropriate sizes of the heterosexual and homosexual populations in many
places, as until recently, homosexuality was illegal and/or highly looked down upon in
many countries. Nevertheless, it will be important in future work to explore the effect of
having a separated class for a true homosexual population, with a smaller interaction be-
tween the heterosexual and homosexual groups. Also, while implications regarding treat-
ment strategies have been discussed, it will be interesting to compare specific treatment
scenarios and their influence on the disease dynamics. This will be explored in future
works.
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5. IMPACT OF AGE-DEPENDENT RELAPSE AND IMMUNITY
ON MALARIA DYNAMICS
This chapter presents a work that has been been published in Journal of Biological Sys-
tems in collaboration with Katia Vogt-Geisse [91]. My main contributions were in biolog-
ically interpreting the reproduction numbers, performing numerical simulations, including
a time-dependent sensitivity and uncertainty analysis, and interpreting the results in terms
of potential control measures. While this work presents a model for the transmission dy-
namics of malaria, it provides a similar modeling approach as the models in Chapters 2,
3, and 4. Moreover, the mathematical complexities that arise from the interaction between
host and vector are similar to those of mixing between males and females seen in Chap-
ter 2. Furthermore, studies suggest a relationship between malaria and HIV in areas in
which malaria is endemic. It would be interesting to analyze this synergy in the future.
5.1 Introduction
Across Sub-Saharan Africa, humans develop immunity against the
malaria parasite. In regions where people are almost continuously exposed to the para-
site, different types of immunity have been observed: anti-disease immunity (i.e., gives
protection against clinical disease), anti-parasite immunity (i.e., gives protection against
mainly the asexual stage of the parasite in the body, which controls parasite density) and
transmission-reducing immunity (i.e., reduces the transmission from human to mosquito)
[92, 93]. In regions where malaria is endemic, infected adults rarely experience clini-
cal symptoms, even though they test positive and often carry enough malaria parasites in
their blood to kill a malaria-naive person [58, 92]. On the other hand, children, especially
young children, experience clinical symptoms most of the time when infected with P. fal-
ciparum [94, 95]. The general belief is that age-dependent anti-parasite and anti-disease
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immunity develop in populations exposed almost continuously to the parasite [92]. Studies
have shown that this age-dependent immunity is either due to repeated exposure or immune
responses that depend on host development and maturation, or a combination [96,97]. Be-
cause of the human host’s ability to acquire clinical immunity against the infection, it is im-
portant to determine how and to what extent asymptomatic parasite carriers may influence
malaria transmission. The methods used to measure parasite presence in the body are often
not sensitive enough to detect low parasitemia [98]. This suggests that individuals with low
parasitemia represent a reservoir for the subsequent transmission season that could have
been underestimated. In most malaria regions in Africa, the endemicity is stable, which
is probably because infectiousness is very insensitive to anti-malarial interventions [99].
Therefore, human infectiousness to mosquitoes, especially of asymptomatic carriers, is an
important aspect to consider when modeling malaria transmission.
An infected human host is able to infect mosquitoes only when the parasites within
the human body have developed to the sexual stage, i.e., when gametocytes are present in
the bloodstream. Thus, to determine the infectiousness of a human host, it is important
to consider the duration of gametocytemia and the effect of transmission-reducing immu-
nity, which prevents the parasite from developing inside the mosquito mid-gut and stops
the cycle [93]. However, it can be difficult to determine, for asymptomatic carriers, how
long gametocytes are present in their bloodstream. Nevertheless, it has been observed
that the duration of asymptomatic gametocyte carriage decreases with age [100]. It has
also been argued that transmission-reducing immunity should be higher in children. The
anti-parasite immunity prevents adults from developing high gametocytemia, whereas kids
develop enough gametocytemia to acquire transmission-reducing immunity [93]. The fac-
tors that stimulate gamecytogenesis are not very clearly understood [92, 100]. Therefore,
insight into how different hypotheses on creation of gametocytes may affect malaria trans-
mission is important. It has been suggested that environmental factors may be associated
with gametocyte production [101,102]. Seasons in the tropics are based on rainfall and are
therefore linked to mosquito bionomics. Mosquitoes can be found throughout the year; and
thus, seasonal mosquito activity refers to an increased number of mosquitoes in the rainy
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season [102]. During the dry season, it is expected that parasitemia in asymptomatic car-
riers would be reduced to a minimum amount, but not disappear completely, leaving them
with a chronic infection insufficient to infect mosquitoes. Evidence supports that mosquito
saliva has an impact on the parasite during the chronically asymptomatic stage of infec-
tion [103]. It has been hypothesized that in tropical regions, where the seasons are defined
by mosquito bionomics, the parasite has evolved to respond to the mosquitoes, specifically
to the mosquito bites [101, 102]. This hypothesis leads to the belief that reappearance of
gametocytemia, and so reappearance of infectious asymptomatic carriers, may be triggered
by susceptible, not yet infectious, mosquito bites [102] on asymptomatic chronically in-
fected individuals. A similar phenomenon has been demonstrated for other vector-borne
parasites [101]. This, together with the assumption that partially immune children develop
a better transmission-reducing immunity than adults, as well as the knowledge that most
adults do not show clinical symptoms, suggests that it is important to study a model that in-
corporates several aspects: age dependent immunity, factors responsible for stimulating ga-
metocytogenesis, and the separation of the asymptomatic population into an asymptomatic
infectious class (gametocyte carriers) and an asymptomatic chronically infected class (in-
dividuals with low parasitemia).
We developed a malaria transmission model that considers age-structure of the human
host, factors representing various age-dependent immune responses as well as environ-
mental factors that stimulate parasite development and human infectiousness. The model
is formulated in a way that allows us to capture several important malaria features includ-
ing age-dependent anti-disease, anti-parasite and transmission-reducing immunity, asymp-
tomatic infectious and chronically infected individuals, age-dependent infectivity and sus-
ceptibility of humans to mosquitoes, as well as seasonal relapse of asymptomatic chronic
infections triggered when bitten by (even only susceptible) mosquitoes. One of the main
objectives of this study is to determine how age-dependent host immunity, asymptomatic
chronic infections and parasite adaptation to seasonally-variable mosquito bites may impact
malaria dynamics, which to the best of our knowledge has not previously been simultane-
ously studied using mathematical models.
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The formulation of our model will also allow us to identify the targeted age group(s)
for vaccination and treatment/diagnosis strategies. Currently, there are several malaria vac-
cines under development. One approach is based on targeting one stage of parasite devel-
opment in the human body. Those vaccines would either aim to prevent clinical symptoms
or reduce human infections. Another approach is based on reducing the disease transmis-
sion of the parasites to the mosquito, resembling transmission-reducing immunity [104].
Because different vaccines generate different immunity involved in the malaria transmis-
sion process, it is helpful to study models that can examine how distinct immunity aspects,
as well as other factors, contribute to the malaria burden. Our model can also be used to
identify the most effective disease control strategies. We demonstrate this by examining
the effects of these vaccines and treatment on reducing either the reproduction number R0
and/or disease prevalence.
In Section 5.2, we present the age-dependent model, which consists of partial differ-
ential equations. Section 5.3 includes the derivation of the basic reproduction number R0
with a biological interpretation of its components. This section also includes a stability
analysis of the infection-free steady-state, which is shown to be determined by R0. In Sec-
tion 5.4, we derived from the PDE model a system of ordinary differential equations with
multiple age groups of the human host under the assumption that the model parameters
are constant within each age group. The basic reproduction number for this ODE model
is also obtained using the next generation matrix approach [71]. Section 5.5 is devoted to
numerical simulations of the ODE system, which illustrate the effect of various biological
factors on the disease prevalence and R0 . A sensitivity and uncertainty analysis is also
presented in this section. Finally, section 5.7 collects the conclusions and discussions.
5.2 The PDE Model
To incorporate age-dependent immunity, susceptibility, and infectivity, we consider the
age density of individuals in each epidemiological class. Specifically, let s(t, a), i(t, a),
iA(t, a), and jA(t, a) denote the densities of susceptible, symptomatic infectious, asymp-
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tomatic infectious, and asymptomatic chronically infected (non-infectious, parasite carriers
with low parasitemia) individuals, respectively, at time t of age a. Let Iv(t) and Sv(t) de-
note the numbers of infectious and susceptible mosquitoes, respectively, at time t. When
modeling malaria transmission dynamics, different functional forms have been used for
the transmission rates between humans and mosquitoes. A detailed discussion of various
forms and the corresponding assumptions are given in [57]. This discussion stresses the
importance of relating the model parameters to observations. The specific forms of trans-
mission rates used in our model are adopted from those in [57]. The force of infection from
infectious mosquitoes to susceptible humans, which is denoted by λ1(t, a), is




Here, β is the number of bites per mosquito per day, d(a) is the probability of host infection




n(t, a)da with n(t, a) = s(t, a) + i(t, a) + iA(t, a) + jA(t, a). (5.2.2)
Given a successful bite by an infectious mosquito of a susceptible human host, assume
that the probability that it leads to symptomatic infection is k. Let γ(a) denote the rate of
recovery of a symptomatic infectious individual of age a. An asymptomatic infectious in-
dividual of age a (iA(a)) is assumed to become asymptomatic chronically infected (jA(a))
at the rate γA(a). Assume that asymptomatic infectious and chronically infected individu-
als do not die from the disease. There is a possibility for non-infectious jA individuals to
relapse and become asymptomatic infectious (iA), triggered by susceptible mosquito bites.
We assume that this happens during a fraction p of a year when the mosquito number rises
due to rainfall. We model this rate of relapse by λ2(t, a) with the following form





where dA(a) is the probability of relapse per bite. The transmission rate from infectious













where c(a) and cA(a) are the probabilities that a susceptible mosquito becomes infectious
per bite from infectious symptomatic and asymptomatic humans, respectively. All variables
and parameters are listed in Table 5.2.
Table 5.1.
Description of variables and parameters used in the PDE model.
Variable Description Units
s(t, a) age density of susceptible humans humans
i(t, a) age density of symptomatic infectious humans humans
iA(t, a) age density of asymptomatic infectious humans humans
jA(t, a) age density of asymptomatic chronically infected humans humans
Nh(t) total number of humans humans
Sv(t) number of susceptible mosquitoes mosquitoes
Iv(t) number of infectious mosquitoes mosquitoes
Nv(t) total mosquito population mosquitoes
Parameter Description Units
β number of bites one mosquito can give per day bitesmosquito·day
d(a) percentage of susceptible humans infected per bite human/bite
dA(a) percentage of human relapses per bite human/bite
c(a) percentage of mosquitoes infected per bite on humans in i(t, a) mosquito/bite
cA(a) percentage of mosquitoes infected per bite on humans in iA(t, a) mosquito/bite
f(a) per capita birth rate of humans of age a day−1
μ(a) per capita natural mortality rate of humans of age a day−1
δ(a) per capita disease induced death rate of individuals in i(t, a) day−1
γ(a) recovery rate of symptomatic humans of age a day−1
γA(a) recovery rate of asymptomatic humans of age a day−1
bv per capita mosquito birth rate mosquito/day
μv per capita mosquito death rate day−1
p percentage of a year with high mosquito density dimensionless
k percentage of new infections being symptomatic dimensionless
λ1(t, a) human infection (see (5.2.1)) day−1
λ2(t, a) human relapse (see (5.2.3)) day−1













(μ(a) + δ(a)) i(t, a)
iA(t, a)






Figure 5.1. A diagram for the transitions between epidemiological classes of
the human population.
The transitions of humans between the epidemiological classes are depicted in Fig-

























= −pλ2(t, a)jA(t, a) + γA(a)iA(t, a)− μ(a)jA(t, a) (5.2.5)




f(a)n(t, a)da, i(t, 0) = 0, iA(t, 0) = 0, jA(t, 0) = 0 (5.2.6)
and initial conditions (IC)
s(0, a) = s0(a), i(0, a) = i0(a), iA(0, a) = iA0(a), jA(0, a) = jA0(a). (5.2.7)
The functionsX0(a) (X = s, i, iA, jA) are non-negative integrable functions with i0(a) > 0
for some a > 0. The forces of infection λ1, λ2 and λv are given in (5.2.1), (5.2.3) and
(5.2.4), respectively. The equations for mosquitoes are
dSv
dt
= bv − λv(t)Sv(t)− μvSv(t)
dIv
dt
= λv(t)Sv(t)− μvIv(t) (5.2.8)
with initial conditions Sv(0) = Sv0 ≥ 0, Iv(0) = Iv0 ≥ 0. The continuous age-structured
model is given by the system of equations in (5.2.5)–(5.2.8). It can be shown that the
system has a unique non-negative solution for non-negative initial conditions and that the
model is well-posed. Furthermore, we assume:
• μ(a), f(a), γ(a), γA(a), and δ(a) are non-negative, piecewise continuous functions
on [0,∞);
• d(a), dA(a), c(a), and cA(a) are non-negative, piecewise continuous, bounded func-
tions on [0,∞);
• the birth rate f(a) > 0 on some interval (a1, a2) and f(a) = 0 for a /∈ (a1, a2); and
• ∃μ0, a∗ > 0 such that the mortality rate μ(a) > μ0 for all ages a > a∗.
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5.3 Computation of R0 and Stability of the Disease-free State for the PDE Model
As in most mathematical models for the spread of infectious diseases, one of the most
useful threshold quantities is the basic reproduction number R0, which usually determines
whether the pathogen can invade the population (whenR0 > 1) or dies out (whenR0 < 1).
The basic reproduction number is defined, in general, as the average number of secondary
infections produced by one infectious individual during the entire infectious period when
introduced into a completely susceptible population. In this section, we derive an expres-
sion for R0 by first analyzing the linearized system of (5.2.5) and (5.2.8) at the disease-free
steady state, which provides a threshold quantity for the stability condition. By examining
the biological interpretation of the threshold quantity, we can confirm that it is indeed the
R0 for the age-structured model.
5.3.1 Stable Age Distribution of the Human Population in the Absence of Disease
Various methods can be used to compute the reproduction numberR0 for age-structured
models. We follow the approach of Hadeler and Mu¨ller [105, 106]. We restrict our atten-
tion to the case in which the human population has reached the stable age distribution in the
absence of disease. This distribution can be obtained from (5.2.5) by considering the fol-







= −μ(a)n(t, a) (5.3.1)




f(a)n(t, a)da := B(t), n(0, a) = n0(a). (5.3.2)






a−t μ(σ)dσ, if a ≥ t
B(t− a)e−
∫ a
0 μ(σ)dσ, if t > a.
(5.3.3)
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a−t μ(σ)dσda → 0 as t → ∞. Note that F0(t) represents
the population of newborns at time t generated by individuals of age a, with a > t (i.e.,
by individuals who were already in the population at time t = 0). Hence, F0(t) → 0 as
t → ∞ is also biologically relevant. It can be shown [107] that
B(t) = Λepˆt(1 + Ω(t)) (5.3.5)
where Λ is a non-negative constant, Ω(t) is a function with the property lim
t→∞
Ω(t) = 0, and
pˆ measures the population growth, satisfying the equation
∫ ∞
0
f(a)P (a)e−pˆada = 1, (5.3.6)
where
P (a) = e−
∫ a
0 μ(σ)dσ. (5.3.7)
Note that P (a) represents the probability that an individual escaped natural death from birth
to age a. Substituting (5.3.5) into (5.3.3) for large t, we obtain the exponential solution with
constant population structure:
n(t, a) = n˜(a)epˆt (5.3.8)
where
n˜(a) = Λe−pˆaP (a) (5.3.9)
is the stable age distribution. It is easy to see from (5.3.8) that if pˆ > 0 (< 0) then the
human population will grow (decay) exponentially. Hence, pˆ determines the asymptotic
behavior of the population n(t, a).
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5.3.2 R0 and Stability of the Disease-Free Equilibrium
We determine R0 by analyzing the stability of the disease-free equilibrium, for which
we assume that the human population has achieved the stable age distribution with constant
population size, i.e., pˆ = 0 (see (5.3.8) and (5.3.9)), and
n(t, a) = ΛP (a), (5.3.10)
where P (a) is given in (5.3.7). In this case, the constraint (5.3.6) becomes
∫ ∞
0
f(a)P (a)da = 1. (5.3.11)







By applying the theory of asymptotically autonomous systems [108], we assume that the
vector population has already reached the equilibrium N¯v in the absence of disease.
For the remaining analysis in this section, we will consider the limiting system of (5.2.5)
and (5.2.8) under the conditions
n(t, a) = ΛP (a), Nh(t) = Λ
∫ ∞
0




In this case, the disease-free equilibrium E∗ is given by






v ) = (ΛP (a), 0, 0, 0, N¯v, 0). (5.3.14)
To linearize the system, let
x(t, a) = s(t, a)− ΛP (a), Xv(t) = Sv(t)− N¯v. (5.3.15)
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, λ¯2(a) = βdA(a)
N¯v
N¯h





















































cA(a)iA(t, a) + c(a)i(t, a)
]
da− μvIv(t), (5.3.17)
where λ¯1(a), λ¯2(a) and λ¯v are given in (5.3.16).
The function Θ(ω) defined in (D.1.9) (see Appendix D.1 for details) can be used to
define the basic reproduction number R0:










where the functions F and G are defined in (D.1.4) and (D.1.8), respectively. A biological
interpretation of the expression for R0 defined by (5.3.18) will be provided at the end of
this section. The following result shows that R0 = 1 provides a threshold condition of the
local stability of the disease-free equilibrium E∗.
Theorem 5.3.1. The disease-free steady state E∗ is locally asymptotically stable ifR0 < 1
and unstable if R0 > 1.
The proof of Theorem 5.3.1 can be found in Appendix D.2.
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5.3.3 Interpretation of R0
For vector-borne diseases such as malaria, the reproduction number in general includes
two components. One is related to human-to-mosquito transmission, which we denote
by Rhm and the other is related to mosquito-to-human transmission, which we denote by
Rmh. As a consequence, the overall reproduction number is (usually) a geometric mean
√RhmRmh. Thus, the expression for R0 defined in (5.3.18) is actually RhmRmh. How-
ever, this does not change the threshold condition R0 = 1 for whether the disease will
die out or persist in the population. For notational convenience, we will use the expres-
sion of R0 in (5.3.18) to describe its biological interpretation, and show that it gives the
average number of new infected mosquitoes that one infected mosquito can produce when
introduced into a completely susceptible vector population during its entire infectious pe-
riod. The square root in
√RhmRmh, then, accounts for the mosquito to human and human
to mosquito interaction, which is similar to the form seen in Chapter 2 with the male to
female interactions.



























































PA(a, σ, 0) = e
− ∫ aσ (γA(τ)+μ(τ)+pλ¯2(τ))dτ . (5.3.20)
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is the number of individuals infected at age σ with symptomatic infection by one mosquito










σ (γ(τ)+μ(τ)+δ(τ))dτdσ =: I(a) (5.3.22)
gives the density of symptomatic infectious humans of age a who got infected at age σ < a











N¯vda, the first term in (5.3.19).
Similarly, the second (third) term in (5.3.19) represents the contribution from asymp-
tomatic infectious individuals who have not (have) passed through the asymptomatic chron-
ically infected stage. As individuals cannot directly infect mosquitoes from the jA class and










σ (γA(τ)+μ(τ)+pλ¯2(τ))dτdσ =: IA1(a) (5.3.24)
gives the density of asymptomatic infectious humans of age a who were infected at age
σ < a but have not passed through the asymptomatic chronic stage, and have not re-
covered or died at age a. Thus, the number of mosquitoes infected by asymptomatic in-





N¯vda, the second term in (5.3.19).
For the third term in (5.3.19), JA(σ) is the density of asymptomatic infected humans
who were infected at age ξ < σ and still alive and in the asymptomatic infectious/chronically
140














σ (γA(τ)+μ(τ)+pλ¯2(τ))dτdσ =: IA2(a) (5.3.26)
gives the density of asymptomatic infectious humans who have been through the asymp-
tomatic chronic stage, relapsed at age σ < a, and have not recovered or died at age a.
Thus, the number of mosquitoes infected by asymptomatic infectious humans of all ages







third term in (5.3.19).
Observe that the third term in (5.3.19) would not be present in the expression for
R0 if the relapse occurred only due to infected mosquitoes (Iv(t)) instead of susceptible
mosquitoes (Sv(t)). This is because the term λ2(t, a)jA(t, a) in (5.2.5) would vanish when
linearizing system (5.2.5) around the disease-free equilibrium.
The R0 formula (5.3.19) for the continuous age-structured model can be very helpful,
for example, in evaluating age-dependent vaccination strategies (see, e.g., [105, 106, 109,
110]). For ease of numerical computations, we will derive a system of ordinary differential
equations from the PDE system by assuming that the human population can be divided into
several age groups such that the model parameters within each age group are constant. We
will use the ODE system to carry out numerical simulations to examine the influence of
various factors on both the reproduction number and the disease prevalence.
5.4 Reduction of the PDE Model to an ODE System for Discrete Age Groups
Due to the difficulty of analyzing the dependence of disease prevalence on model pa-
rameters from the PDE model in Section 5.2, we follow the approach of Hethcote [68]
to convert the PDE system to an ODE system. This can be done by dividing the human
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population into n age groups defined by the n disjoint age intervals, [a0, a1), [a1, a2), . . . ,
[an−1, an = ∞) and assuming that the model parameters in (5.2.5) are constant in each
interval. These age intervals need not have equal length. It is important to point out that
the ODE system obtained using this approach will include a transition term from one age
group to the next due to aging. Although an ODE model that includes these aging terms
may increase the difficulty of model analysis more dramatically than multiple age-group
models ignoring these terms (which most do), it is necessary to consider the aging factor
for the ODE system to be comparable to the PDE system.
5.4.1 Derivation of the ODE Model
We focus again on the limiting system of the PDE model with stable age distribution
for humans n(t, a) = n(a) = ΛP (a), and the constant population sizes N¯h and N¯v of
humans and mosquitoes, respectively. Let the constant parameter values in the age interval
a ∈ [ak−1, ak), k = 1, . . . , n, be denoted by f(a) = fk, d(a) = dk, dA(a) = dAk ,





denote the number of humans in age group k (i.e., ages in [ak−1, ak)) at time t. Then the
total number of humans is N¯h =
n∑
k=1
Nk(t). Similarly, let Ik(t), IAk(t), JAk(t) and Sk(t)















































, for k = 1, ..., n− 1, (5.4.5)
and αn = 0. This rate, αk, for each age group is the same for all epidemiological classes
(i.e., s, i, iA, jA), and is a constant, independent of the state variables.
We reduce the PDE system in Section 5.2 to the following system of ordinary differen-
tial equations (see Appendix D.3 for details):
S ′1(t) = Λ− (α1 + λ11(t) + μ1)S1(t) + γ1I1(t)
I ′1(t) = kλ11(t)S1(t)− (γ1 + μ1 + δ1 + α1)I1(t)
I ′A1(t) = (1− k)λ11(t)S1(t) + pλ21(t)JA1(t)− (γA1 + μ1 + α1)IA1(t)
J ′A1(t) = −(pλ21(t) + μ1 + α1)JA1(t) + γA1IA1(t)
S ′k(t) = −(αk + λ1k(t) + μk)Sk(t) + γkIk(t) + αk−1Sk−1(t)
I ′k(t) = kλ1k(t)Sk(t)− (γk + μk + δk + αk)Ik(t) + αk−1Ik−1(t)
I ′Ak(t) = (1− k)λ1k(t)Sk(t) + pλ2k(t)JAk(t)− (γAk + μk + αk)IAk(t)
+αk−1IAk−1(t)
J ′Ak(t) = −(pλ2k(t) + μk + αk)JAk(t) + γAkIAk(t) + αk−1JAk−1(t)
S ′v(t) = bv − λ˜v(t)Sv(t)− μvSv(t)
I ′v(t) = λ˜v(t)Sv(t)− μvIv(t), (5.4.6)
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for k = 2, . . . , n with αn = 0.















for k = 1, ..., n.
5.4.2 The Basic Reproduction Number R0 for the ODE Model (5.4.6)
Although the formula for R0 given in (5.3.19) for continuous age is more convenient
to apply in some cases (e.g., age-dependent optimal vaccination problems considered in
[105, 106, 109, 110]), the formula for R0 derived from the ODE system could be much
easier to apply in other cases, particularly for numerical computations. We derive a formula
of R0 for discrete age using the next generation matrix approach [71]. The disease-free






















, 0, ..., 0, N¯v, 0
⎞
⎟⎟⎟⎟⎟⎠ . (5.4.8)










, k = 1, 2, · · · , n (αn = 0). (5.4.9)
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For ease of notation, let














for k = 1, 2, · · · , nwith αn = 0. Note that Tk represents the death and aging adjusted mean
duration in the Ik class, TAk represents the death and aging adjusted mean period of an
asymptomatic infected individual during each sojourn in the IAk class in age group k, and
Tv is the mean infectious period of mosquitoes. The fraction θk represents the proportion
of symptomatic infectious humans in age group k that survived and aged to group k + 1.
The system (5.4.6) has 3n+ 1 infected variables, which will be ordered as
(I1, IA1 , JA1 , ..., In, IAn , JAn , Iv). Using the next generation matrix approach [71] (see Ap-









where E2(FV −1) is the sum of the principal minors of order two of the matrix FV −1.
The case of n = 1 age group
To facilitate the biological interpretation of R0 given by (5.4.11), we first examine the
case of one age group, i.e., n = 1. A more detailed description of the matrices F and V
can be found in Appendix D.4.






















kh1Tvv1T1 + (1− k)h1TvvA1Th1P IA1IA1 . (5.4.12)
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The biological meaning of the quantities of which (5.4.12) is composed are:
• Tv and T1 are as in (5.4.10);
• h1 := β d1N¯h
Λ
μ1
is the number of humans infected by one mosquito per unit of time in
a completely susceptible human population;
• v1 := βc1 N¯vN¯h is the number of mosquitoes (in a susceptible mosquito population) that
one symptomatic infectious human can infect per unit of time;
• vA1 := βcA1
N¯v
N¯h
is the number of mosquitoes (in a susceptible mosquito population)
that one asymptomatic infectious human can infect per unit of time;




is the probability that an individual, who entered the IA1  JA1 loop through











A more detailed explanation for P
IA1
IA1
is given in Appendix D.4.
The case of n = 2 age groups


























Here, the notation (e.g., hk, vk,P
IA1
IA1
) have similar meanings as in the case of n = 1 except
the difference due to aging (α1 > 0, α2 = 0):
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• h1 = β d1N¯h N¯1 and h2 = β
d2
N¯h
N¯2 are the numbers of humans infected by one mosquito
per unit of time in the completely susceptible human populations in group one and
group two, respectively;
• vk = βck N¯vN¯h is the number of mosquitoes (in a susceptible mosquito population) that
one symptomatic infectious human can infect per unit of time (k = 1, 2);
• vAk = βcAk
N¯v
N¯h
is the number of mosquitoes (in a susceptible mosquito population)
that one asymptomatic infectious human can infect per unit of time (k = 1, 2);
• Th1 = 1α1+μ1 and Th2 =
1
μ2
are the average stage durations of individuals in age group




represents the disease independent probability that an individual of
age group one ages to age group two;




represents the probability that an individual, who entered the IAk  JAk loop





ρk + μk + αk
γ¯Ak + ρk
, where ρk = pβdAk
N¯v
N¯h




represents the probability that an individual that entered the IA1  JA1 loop












represents the probability that an individual, who entered the IA2  JA2 loop









A more detailed explanation on the derivation of these quantities can be found in Ap-
pendix D.4.
Therefore, (5.4.14) represents the number of infected mosquitoes generated by an in-
fectious mosquito via humans in different age groups and different stages. Specifically,
the first term corresponds to the contribution from symptomatic infectious individuals who
were initially infected in age group one (a fraction θ1 aged to group two). The second term
in (5.4.14) corresponds to the contribution from symptomatic infectious individuals who
were initially infected in age group two; and the third term corresponds to the contribution
from asymptomatic individuals who were initially infected in age group two.
Finally, the fourth term corresponds to the contribution from asymptomatic individuals
who were initially infected in age group one. These individuals enter the IA1  JA1 loop
through IA1 and then they undergo one of the following three scenarios at a given time
depending on the class into which aging occurs: i) they have not aged and are currently in
IA1 where they can infect mosquitoes (see the term vA1Th1P
IA1
IA1
in (5.4.14)); ii) they aged







Th2 in (5.4.14)); and iii) they aged while in JA1 (so they entered








Notice that, as we have already mentioned for the PDE R0, various terms that involve
looping in the expression forR0, (5.4.14), would not have appeared without the assumption
of relapse triggered by susceptible mosquito bites and instead by infectious mosquito bites.
We will discuss the implications of this assumption in Section 5.6.
It is possible to rewrite the expression for R0 in (5.4.14) as a linear combination of
reproduction numbers of a child population only and an adult population only, in the fol-
lowing way:
R20 = R201 +R202 +
h1θ1
h2







for k = 1, and






















for k > 1,
where
R201 = kh1Tvv1T1︸ ︷︷ ︸
=:R201S




R202 = kh2Tvv2T2︸ ︷︷ ︸
=:R202S
+(1− k)h2TvvA2Th2P IA2IA2︸ ︷︷ ︸
=:R202A
(5.4.21)
are the reproduction numbers for a child only and adult only population (no aging involved),
respectively, with their symptomatic (R201S , R202S) and asymptomatic (R201A, R202A) contri-
butions. For example, in the case k = 1 (in which our model reduces to an SIS model),
the term h1θ1
h2
in (5.4.18) represents the ratio of newly infected children that age and newly
infected adults. This demonstrates that when aging from one group to another is involved,
the basic reproduction number is not solely a sum of contributions of each age group, but
also has extra terms that arise from aging.
5.5 Numerical Simulations and Results
To illustrate how the disease dynamics in different groups may be influenced by var-
ious factors represented by the model parameters, we carried out numerical simulations
of the ODE system in the case of two age groups. Because the simulation results depend
on the choice of parameter values, we performed uncertainty and sensitivity analyses us-
ing the Latin Hypercube Sampling approach. These analyses are conducted for both the
reproduction number R0 and the disease prevalence.
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5.5.1 Parameter Values and Calibration of the Model
We developed a computer code using the R computer Language and Environment [111]
for the ODE system (5.4.6) for two age groups: children from 0 to 15 years and adults from
16 years on. Although we do not have an analytic result for the existence and stability of
endemic equilibrium points, our simulations of the system suggest that when R0 > 1 there
is a unique stable endemic equilibrium. We run the simulations until the endemic equi-
librium has been reached (25 years for the parameter values that we used). We calibrated
the demographics such that the mosquito population and human population size and age
distribution in the absence of disease remain the same. Based on the demographic data
reported in [112], the initial population age distribution is chosen to be 45% children and
55% adults, thus N¯1/N¯h = 0.45 and N¯2/N¯h = 0.55, respectively. For a given population in
Sub-Saharan Africa, assume that the total population N¯h is known. Notice that, when using
the DFE N¯1 = Λ/(μ1 + α1), fixing μ1 = 0.0002 (day−1), and assuming the aging rate in
group one to be α1 = 1/(15∗365) per day, we obtain the value of Λ from Λ = N¯1(μ1+α1).
Using N¯2 = Λμ2
α1
α1+μ1
= 0.55N¯h we get an estimate for μ2 = α1 N¯1N¯2 ≈ 0.00015.
Some parameters have been commonly used in previous modeling studies on malaria
and can be adopted for our model. For the remaining parameters, particularly ones that
are specific to our model, values are determined so that the simulation results are con-
sistent with observed malaria prevalence. For example, disease-induced mortality is on
average 0.25% [47, 94], which our model predicts. We define symptomatic (asymptomatic
infectious) prevalence in age group k (k = 1, 2) as the fraction of symptomatic (asymp-
tomatic) infectious individuals at equilibrium, i.e., Ik/N¯h (IAk/N¯h). Our results show
a symptomatic prevalence of children of approximately 3.2% (see Figure 5.2(a) in Sec-
tion 5.5.2). This is concordant with observations in countries of Sub-Saharan Africa like
Tanzania, where seasons may be characterized by mosquito bionomics [113, 114], chil-
dren’s prevalence ranges from 2.5% to 15% [113, 115]. Out of the symptomatic cases, the
majority correspond to children [116], as can also be seen in Figure 5.2(a) of Section 5.5.2.
150
The parameter k represents the proportion of susceptible individuals who become symp-
tomatic upon infection, and depends on innate resistance of individuals. For example,
genetically determined traits are selected over generations and contribute to the innate pro-
tection against the risk of clinical illness [117–120]. In this study, we assume k to be a
constant, although it would be of interest for future work to consider k to be age dependent
if significant evidence can be found in the literature, but of which we do not presently have
sufficient knowledge.
In a stable perennial transmission region, the mosquito population starts to grow with
the onset of the rainy season and relapse of asymptomatic chronically infected individuals
gets triggered by non-infectious mosquito bites [102]. The value 0.4 given to p represents
a rainy season of at least 4.8 months.
For the parameters representing human susceptibility of becoming infectious, we as-
sume that d2 < d1 due to anti-parasite immunity acquired by adults [92], even after a few
malaria attacks [58]. Because of the higher anti-parasite immunity of adults, we also as-
sume dA2 < dA1 . It can be argued that asymptomatic adults have fewer asexual parasites
in their blood compared to asymptomatic children, and are therefore less likely to create
gametocytes.
For the parameters representing human infectiousness, we assume that c2 < c1 due
to a fast gain of transmission-reducing immunity for susceptible humans, as observed for
malaria-naive individuals, and in general a higher gametocyte density observed in chil-
dren [93, 121]. Also, a higher anti-parasite immunity in asymptomatic adults produces a
lower gametocyte prevalence for these individuals compared to children. As gametocytes
must be present in the blood for acquisition of transmission-reducing immunity, this could
imply a lower transmission-reducing immunity in adults than children [93]. This is why we
made the assumption cA1 < cA2 , as other studies also suggest [122]. We chose c2 < cA2 as it
has been observed that clinical symptoms stimulate gametocytogenesis [123] and therefore
symptomatic adults could develop a better transmission-reducing immunity than asymp-
tomatic individuals. Also, investigators have observed that infectiousness of asymptomatic
carriers is higher than symptomatic, once gametocytes are present in the blood [124]. Un-
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like adults, we assume for children that cA1 < c1, as children are longer exposed to gameto-
cytes because of the assumed higher probability of relapse (dA2 < dA1) and the observation
that they can show a high density parasitemia without symptoms [123, 125, 126]. There-
fore, higher gametocyte densities in children induce higher levels of transmission-reducing
activity [122], which we assume asymptomatic children continue to develop, unlike adults
that we assume lose such immunity due to increasing anti-asexual parasite immunity [121].
Complications due to malaria are worse in children, and they recover at a lower rate
than adults, which is why we chose δ2 < δ1 and γ1 < γ2. We assume a lower duration
in the asymptomatic infectious stage for both age groups compared with the time spent in
the symptomatic class, as well as a decreasing amount of time spent in the asymptomatic
infectious class with age (γA1 < γA2) [125, 126].
The aging rate from one group to another is represented by the parameter α1 and chosen
to be (1/15)/365 assuming that each age is evenly distributed in the children’s age group,
such that a fraction of 1/15 individuals move each year from age group one to age group
two.
We used the parameters that satisfy our assumptions as baseline values for our simu-
lations. Because of uncertainty about some of the assumptions (due to the difficulties in
field studies) in Section 5.5.2, we chose a reasonable range for each parameter to check
robustness of our results. More details on the parameter values and their references can be
found in Table 5.5.1.
152
Table 5.2.
Parameter values and ranges used in the numerical simulations as well as in
















Age-Dependent Age Group 1 Age Group 2
μk 0.0002 α1N¯1/N¯2 112
αk 1/15/365 0 112
δk
0.00002 0.000002
T (0.000001,0.0001) T (0,0.0003) 129
dk
0.03 0.015
T (0.01,0.08) T (0.005,0.08) 129
dAk
0.02 0.009
T (0.005,0.06) T (0.006,0.015) 102
ck
0.3 0.24
T (0.05,0.4) T (0.12,0.4) 129
cAk
0.12 0.4
T (0.005,0.15) T (0.01,0.8) 122,129
γk
1/100 1/80
T (1/105,1/80) T (1/90,1/70) 129
γAk
1/65 1/50
T (1/100,1/30) T (1/80,1/30) 100,125
T indicates a triangular distribution, with peak at the fixed value.
U indicates a uniform distribution.
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5.5.2 Simulations Results and Interpretations
We conducted numerical simulations under two scenarios. In the first, we used a fixed
set of parameter values, and in the second scenario, parameters are allowed to take on
values from regions with fixed distributions such that previously fixed values would be most
probable. In the case of variable parameter values, 1, 000 simulations were run with values
chosen randomly in their respective ranges. These simulations can be used to demonstrate
the sensitivity of model outcomes to uncertainty in parameter choices.
Simulations and results with fixed parameter values
For the case of fixed parameter values, the choice of parameters leads to the reproduc-
tion numberR0 = 3.4. We are mostly interested in the fraction of symptomatic (I), asymp-
tomatic infectious (IA), and asymptomatic chronically infected (JA) individuals, as well as
the fractions of individuals for each age group (group 1 for children and group 2 for adults)
of these classes and their relative densities. Figures 5.2 (a)-(c) illustrate the fractions of hu-
man populations in each of the infected classes within each age group. We observe that, for
this set of parameter values, the endemic equilibrium has been reached after 25 years. Fig-
ures 5.2 (a) and (b) show that the asymptomatic infectious individuals contribute 2-3 times
more than symptomatic infectious individuals. In particular, the fraction of asymptomatic
infectious individuals (gametocyte carriers), which are the asymptomatic individuals with
parasites in their blood capable of infecting mosquitoes, can be observed in Figure 5.2(b).
There, we can see a combined age group prevalence of 16% and a decrease in prevalence
with age, which has also been observed in previous studies [100]. Detection of low P. falci-
parum parasitemia is a great challenge. Methods like the classic thick blood smear or rapid
diagnostic tests (RDTs) often show decreased sensitivity at lower parasitemia. An overall
asymptomatic adult prevalence of 52% can be detected by more sensitive tests [98], a re-
sult that our model confirms (see Figure 5.3(d)) for R0 > 2. Studies have also estimated
that, in some malaria endemic settings, 90% of the exposed individuals are likely infected
with asymptomatic malaria [130]. Our model estimates approximately 80% (Figures 5.3
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(c) and (d)) when combining overall asymptomatic children and adult populations. This
value is close to what can be found in the literature and represents individuals with sexual
and asexual parasites in their blood. Figsures 5.3 (c) and (d) also show that the proportion
of overall asymptomatic infection is higher among adults than among children, as can be
expected in malaria endemic areas [58, 92]. Because of the difficulty of detection, it is im-
portant to develop mathematical models that can give information about individuals with
low parasitemia. In our model, these asymptomatic chronic parasite carriers (JA) serve as
a reservoir for malaria parasites before they develop into gametocytes.
Our simulations show that the majority of symptomatic infectious (I) and asymptomatic
infectious (IA) individuals are children (see Figures 5.2(a) and (b)), consistent with ob-
served patterns of malaria prevalence and the higher expected gametocyte densities in chil-
dren [93, 116, 121]. Nevertheless, it is of great importance to notice that over 60% of the
population is asymptomatic chronically infected, with twice as many adults as children (see
Figure 5.2(c))). Adults in this class could be responsible for the persistence of malaria in
many regions of Sub-Saharan Africa and need to be taken into consideration. They possi-
bly undergo a relapse and contribute to the infectious pool of mosquitoes. This indicates
that the number of infected cases might be underestimated in field studies due to commonly
undetectable parasite loads.
The fractions of infectious and susceptible mosquitoes are plotted in Figure 5.2(d). For
ease of comparison, Figures 5.2 (e) and (f) show the plots of relative magnitudes of different
infected classes within each age group and between age groups. In these plots, we observe a
similar trend among age groups for all infected classes. Nevertheless, a significantly higher
fraction of asymptomatic chronically infected individuals (JA) is observed for age group 2
compared to age group 1 relative to their fractions in I and IA, reinforcing the importance
of asymptomatic chronically infected adults.
In Figures 5.2 (a), (b), and (c), the curve for the total fractions (two age groups com-
bined) for each of the infected classes and the curves in Figure 5.3 will also be useful later
in comparison with simulations with variable parameter values.
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Figure 5.2. Numerical simulations of the ODE model with two age groups
using fixed parameter values given in Table 5.5.1. These parameter values
produce an R0 of 3.4. Plots in (a)-(c) show the fractions of symptomatic in-
fectious individuals, asymptomatic infectious individuals, and asymptomatic
chronically infected individuals, respectively, for the two age groups. The plot
in (d) is for the mosquito population. Plots in (e) and (f) show all four epidemi-
ological classes for groups 1 and 2, respectively.
Figure 5.3 also shows how differentR0 values affect prevalence at equilibrium, an indi-
cator of what happens at the endemic state. For R0 = .83, the disease dies out as expected.
For values of R0 = 2, 3, 4, 5, we reach after 25 years a non-trivial equilibrium. The preva-
lence of symptomatic children (Figure 5.3(a)), asymptomatic children (Figure 5.3(c)) and
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Figure 5.3. Numerical simulations of the ODE model with two age groups for
different R0 values, obtained from varying β. For the other parameters the
values in Table 5.5.1 were used. Plots (a) and (b) show the fractions of symp-
tomatic infectious individuals for age group 1 and 2, respectively, while (c)
and (d) illustrate overall asymptomatic (asymptomatic infectious and asymp-
tomatic chronically infected) individuals for the two age groups.
Figure 5.4. The plots illustrate R0 versus percent of age group 1 (plot (a)) and
age group 2 (plot (b)) of Symptomatic (black line) and Asymptomatic (grey
line) individuals, taken at equilibrium.
asymptomatic adults (Figure 5.3(d)) decrease when R0 decreases. This can also be ob-
served in Figure 5.4, which shows R0 vs symptomatic and asymptomatic prevalence of
age group 1 (plot (a)) and age group 2 (plot (b)). But it is interesting to note that, for the
symptomatic adult population, there is a slight increase in prevalence when lowering R0
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for R0 > 1 (see Figure 5.2(b) and Figure 5.4(b) black curve). This indicates that a policy
based solely on lowering R0 might cause symptomatic adult cases to appear.
Uncertainty analysis
Although we have chosen parameter values based on available information, it is impor-
tant to examine how the uncertainty associated with estimates of these parameter values
may influence model outcomes, such as disease prevalence and the reproduction number.
To do this, we consider a range of values for most of the parameters (as described in Ta-
ble 5.5.1). Using a method based on Latin Hypercube Sampling, we simultaneously varied
these parameters and performed uncertainty and sensitivity analyses. For the probability
density function (pdf) used in Latin Hypercube Sampling, we used either a triangular (T)
or uniform (U) distribution (see Table 5.5.1). For each pdf, we divided the parameter range
into equally probable regions (one for each simulation), and sampled each region exactly
once, creating a Latin Hypercube [37, 76]. This statistical sampling method allows us to
explore the dynamics of our model more efficiently and broadly than varying parameters
individually [37]. Our simulation results suggest that 1, 000 sets of parameter values are
enough to produce consistent results.
We conducted uncertainty analyses for the prevalence of malaria and the reproduction
number R0. To illustrate the variability in prevalence that results from uncertainty in the
parameter values, we present in Figures 5.5 and 5.6 the box plots of the fraction of indi-
viduals over time. Each plot divides the results of 1, 000 simulations into quartiles at each
moment in time, plotted every six months for 25 years. The median value is represented by
the thicker curve and the box around the median value represents the interquartile range.
The dotted lines extend to cover the 95% confidence interval for our outcome distributions.
It shows a very similar trend among the 1, 000 simulations, with the interquartile range
having the same shape and a small range of values concentrated around the median. We
can compare the median values from the uncertainty analysis in Figures 5.5 and 5.6 with
the simulation results presented in Figures 5.2 (a)-(d) and 5.3 respectively, where fixed pa-
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Figure 5.5. Time-dependent uncertainty analysis with 1, 000 simulations and
parameter values from distributions given in Table 5.5.1. Plots in (a)-(c) il-
lustrate time-dependent density distributions of the populations in the symp-
tomatic infectious (I), asymptomatic infectious (IA) and asymptomatic chron-
ically infected (JA) classes, respectively, and (d) shows the fraction of infec-
tious mosquitoes. Each graph consists of boxplots plotted every six months for
25 years. The thick black curve is the median value and the interquartile range
is the box around the median value. The dotted lines extend to cover the 95%
confidence interval for our outcome distributions.
rameter values were used. We observe that the medians in the plots for I , IA and JA in
Figures 5.5 (a)-(c) and for I1, I2, IA1 + JA1 , IA2 + JA2 in Figure 5.6 are very close to the
corresponding curves in Figures 5.2 (a)-(c) (see the thin curve) and the trend of the curves
seen in Figure 5.3 for R0 > 1. This indicates that the choice of parameter ranges is robust.
Figures 5.7 (a) and (b) are similar to Figures 5.5 and 5.6 except that they provide in-
formation for the frequency distributions of infections at the endemic equilibrium (preva-
lence). For example, Figure 5.7(a) shows the symptomatic prevalence in children relative
to the total symptomatic prevalence, I1/(I1+I2), and Figure 5.7(b) is for the asymptomatic
prevalence in adults relative to the total asymptomatic prevalence,
(IA2 +JA2)/(IA1 +JA1 +IA2 +JA2). The black triangle labels the mean of the 1, 000 simu-
lations, and the gray triangle indicates the value from the simulations with fixed parameter
values. The model predicts that, among the symptomatic infections (I), children contribute
the majority of cases (see Figure 5.7(a)), which is concordant with observations [116].
We observe from Figure 5.7(b) that adults form a majority of the asymptomatic infections
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Figure 5.6. Time-dependent uncertainty analysis with 1, 000 simulations and
parameter values from distributions given in Table 5.5.1. Plots (a) and (b) il-
lustrate the time-dependent density distributions of the symptomatic infectious
class for age group 1 and 2, respectively, while (c) and (d) show that of the
combined asymptomatic classes (asymptomatic infectious and asymptomatic
chronically infected) for age group 1 and 2, respectively. The thick black curve
is the median value and the interquartile range is the box around the median
value. The dotted lines extend to cover the 95% confidence interval for our
outcome distributions.
(IA + JA), which is also consistent with observations [131]. This again confirms that the
model is capable of producing reasonable outcomes in terms of malaria prevalence.
Figure 5.7(c) illustrates the distribution of values of the reproduction number R0 in
the 1, 000 simulations with the chosen parameter ranges. Let Rv0 denote the mean of the
distribution (v for variable parameter values) and let Rf0 denote the reproduction number
obtained when the fixed parameter values are used (f for fixed). The black triangle labels
Rv0 = 4.01 and the gray triangle indicates Rf0 = 3.4. The relatively low variability of
the distribution and the fact that Rv0 is very close to Rf0 indicate that the chosen parameter
ranges are robust. Notice in Figure 5.7 that, in all simulations, R0 > 1, indicating that
malaria is likely to persist, as observed in malaria endemic regions.
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Figure 5.7. Results of the uncertainty analysis from 1, 000 simulations with
variable parameter values for (a) the overall symptomatic prevalence in chil-
dren relative to symptomatic prevalence, (b) asymptomatic infectious and
asymptomatic chronic prevalence in adults relative to overall asymptomatic in-
fectious and asymptomatic chronic prevalence, and (c) the reproduction num-
ber R0. The black triangle represents the mean prevalence in these 1, 000
simulations with the median represented by a black dot, while the gray triangle
indicates the prevalence from the fixed parameter setting.
Sensitivity analysis
To examine the sensitivity of model outcomes (e.g., the reproduction number R0 and
the time-dependent disease prevalence) to parameters, we calculate partial rank correlation
coefficients (PRCC) using the same 1, 000 sets of parameter values. This statistical method
produces a sensitivity index, which describes the effect of varying one parameter on the
outcome while minimizing the effects of others [37, 76, 81]. These sensitivity indices have
a value between −1 and 1. A positive (negative) PRCC indicates a positive (negative) re-
lationship between the parameter and outcome. Furthermore, the absolute values of PRCC
indices can help determine which parameter value(s) may have the strongest influence on
the outcome variable, with a magnitude of 0 having almost no influence and 1 having the
most influence [19, 37, 76, 81].
Figure 5.8 shows the PRCC for (a) the reproduction number R0, (b) combined symp-
tomatic and asymptomatic infectious prevalence, (c) symptomatic prevalence alone, and
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(d) asymptomatic infectious prevalence alone. First, we remark that disease-induced death
(δ1, δ2) is not included in Figure 5.8 as it had a minimal impact on all of the epidemiological
outcomes. Next, we will give a brief description of the impact that parameter values have
on each of the epidemiological outcomes based on Figure 5.8 and how these are modified
by host age.
The parameters that have the most influence on R0 can be observed in Figure 5.8(a).
The biting rate β influences R0 most, followed by k (symptomatic fraction after a suscep-
tible individual becomes infected) and d2 (probability of infection per bite in susceptible
adults). It is important to notice that k affectsR0 negatively, which may be counterintuitive.
This is closely related to the fact that, in the model, chronically infected individuals may
relapse when bitten by even susceptible mosquitoes. The intensity of the relapse depends
Figure 5.8. Outcomes from the sensitivity analysis with parameter ranges de-
fined in Table 5.5.1. Partial rank correlation coefficients (PRCC) for each
parameter are plotted for four epidemiological outcomes: (a) R0, (b) over-
all infectious prevalence, (c) symptomatic prevalence, and (d) asymptomatic
infectious prevalence. A larger absolute value of the PRCC indicates a greater
impact on the epidemiological outcome, with positive (negative) values indi-
cating a positive (negative) relationship.
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heavily on the ratio of humans to mosquitoes in addition to other parameters as indicated in
the expression for R0 (see (5.4.14)). Such a negative relationship between R0 and k would
not be identified if the model did not consider relapse triggered by susceptible mosquitoes.
Notice that the PRCC of dA2 and γA2 are larger than that of dA1 and γA1 , respectively. This
indicates that R0 is more strongly influenced by relapse of the adult group. The figure
shows that, in general, infectiousness of individuals in the first age group (c1, cA1) does
not have as much influence on R0 as the infectiousness of those in the second age group
(c2, cA2). Lastly, we can observe that the difference in magnitude of d1 and d2 on R0 is not
significant.
Figures 5.8 (b), (c), and (d) show infectious prevalences of the disease. Parameters to
which malaria prevalence is sensitive may differ from those to which R0 was sensitive.
Figures 5.8 (b) and (d) suggest that, for the overall infectious prevalence and asymptomatic
infectious prevalence, respectively, the most influential parameters are p (proportion of the
year with high mosquito presence), dA1 (probability of relapse of age group 1), followed by
β. The parameter d1 is noticeably more influential than its equivalent for age group 2 (d2).
In the case of R0, the susceptibility d1 and d2 of the two groups are similar. In general,
it is interesting to note, in Figures 5.8 (b) and (d), that most of the influential parameters
correspond to age group 1. Moreover, the most influential parameters are those related to
relapse. Also, infectiousness of humans to mosquitoes (i.e., ci and cAi, i = 1, 2) as well as
recovery rates (γi, i = 1, 2) do not have a significant influence on the overall infectious or
asymptomatic infectious prevalence.
Finally, from Figure 5.8(c), we observe that symptomatic prevalence is most sensitive
to k, then β, followed closely by γ1 (recovery rate of symptomatic children). It is surpris-
ing that the recovery rates γ1 and γ2 have dramatically different influence on symptomatic
prevalence, with γ1 having a much stronger impact. However, for the symptomatic preva-
lence, d1 has a much stronger impact than d2, as we could also observe for asymptomatic
infectious and overall infectious prevalence, but not for R0. Thus, the use of R0 as a
measure for evaluating policy options may not be optimal. It can also be observed for
symptomatic prevalence that infectiousness of asymptomatic infectious adults (cA2) has a
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Figure 5.9. Outcomes from the time-dependent sensitivity analysis with pa-
rameter ranges defined in Table 5.5.1. Partial rank correlation coefficients
(PRCC) for each parameter are plotted over time for three outcomes: (a) over-
all prevalence, (b) symptomatic prevalence, and (c) asymptomatic prevalence.
stronger positive impact than the other infectiousness parameters (c1, c2, cA1), which have
very small impacts if any.
Figures 5.9 (a)-(c) are similar to Figures 5.8 (b)-(d), respectively, except that Figure 5.9
shows the PRCC of the solution as a function of time. The total infectious fraction (see Fig-
ure 5.9(a)) and the asymptomatic infectious fraction (see Figure 5.9(c)) show similar trends
and both are less variable, while the symptomatic infectious fraction (see Figure 5.9(b))
shows noticeable fluctuations during the first 15 years in several parameters including β,
γ1, d1 and d2. We observe from Fig. 5.9(b) that, at the beginning of the simulation, β has
a high positive impact (close to 1) on the symptomatic fraction. During the first 5 years,
the PRCC of β decreases and starts to increase until the equilibrium level is reached after
about 15 years. The two other influential parameters d1 and d2 behave similarly; that is, the
PRCC decreases during the initial 10 years of the simulation and then increases to reach the
equilibrium level. However, the impact of d1 on I is always positive, whereas the impact of
d2 is negative between years 4 and 18, with the equilibrium level close to zero. This sug-
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gests that implementing a control measure when fluctuations in the effects are minimal is
best. Notice that the constant effects of parameters on IA (see Figure 5.9(c)) dominate the
effects on overall prevalence I + IA (see Figure 5.9(a)), which again shows the importance
of asymptomatic individuals in malaria prevalence and control.
5.6 Evaluating the Relapse Assumption
We have previously made the assumption that chronically infected individuals relapse
and become asymptomatic infectious after being bitten by susceptible mosquitoes. We base
this assumption on the observation that, in malaria endemic areas, relapse occurs during
the time of year when only susceptible mosquitoes are present. As our model does not
include this seasonality, we may instead assume that relapse can occur from bites of either
susceptible or infectious mosquitoes. With this new assumption, our model has the same
form as (5.2.5)- (5.2.8), with the only difference being:




Notice that the basic reproduction number R0 does not change under this new assumption.
In fact, the expression associated with relapse (the third term in (5.3.19)), would not be
affected because the second term of






would vanish when linearizing system (5.2.5) around the disease-free equilibrium.
With this new assumption, we conducted numerical simulations corresponding to those
in Section 5.5. The two models produce very similar results. For example, in Figure 5.10,
we observe almost identical results for the 2 age groups when compared to Figure 5.2.
Other than Figure 5.8, all other figures in Section 5.5 have similar results with this new
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Figure 5.10. Numerical simulations of the ODE model with alternative as-
sumption (5.6.1). Two age groups are considered and fixed parameter values
in Table 5.5.1 are used. These parameter values produce an R0 of 3.4. Plots in
(a)-(c) show the fractions of symptomatic infectious individuals, asymptomatic
infectious individuals, and asymptomatic chronically infected individuals, re-
spectively, for the two age groups. The plot in (d) is for the mosquito popula-
tion. Plots in (e) and (f) show all four epidemiological classes for groups 1 and
2, respectively.
However, there is a slight difference between the results for the sensitivity analyses
in Figures 5.8 and 5.11. The parameter cA2 now has a positive impact on the prevalence
in both the overall infections (see Figure 5.11(b)) and the asymptomatic infections (see
Figure 5.11(d)), while it appears to be insignificant in Figures 5.8(b) and (d). The effect
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of cA2 on R0 and on symptomatic prevalence are the same as in Figure 5.8, and the same
is true for other parameters with respect to all epidemiological outcomes presented. Recall
that cA2 represents the infectivity of adults with asymptomatic infections and it can be
affected, for example, when implementing a vaccination campaign with a transmission-
blocking vaccine. Hence, targeting asymptomatic infectious adults with such a vaccine
would be more effective than targeting children. The same conclusion can be drawn from
the previous model when observing thatR0 is more strongly influenced by relapse of adults
(see Figure 5.8(a)). Moreover, under this alternative assumption (5.6.1), a transmission-
blocking vaccine would have an impact not only on reducing symptomatic infections and
R0, but also prevalence in asymptomatic as well as overall infections.
Figure 5.11. Outcomes from the sensitivity analysis under assumption (5.6.1)
with parameter ranges defined in Table 5.5.1. Partial rank correlation coef-
ficients (PRCC) for each parameter are plotted for four epidemiological out-
comes: (a) R0, (b) overall infectious prevalence, (c) symptomatic prevalence,
and (d) asymptomatic infectious prevalence. A larger absolute value of the
PRCC indicates a greater impact on the epidemiological outcome, with posi-
tive (negative) values indicating a positive (negative) relationship.
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5.7 Discussion
Eradication efforts in the past 30 years have failed to control malaria in many parts
of Sub-Saharan Africa. An important factor of this failure is due to a poor understanding
in the mechanisms of acquired immunity [92] as well as human behavior with respect to
control measures [132]. The lack of understanding of how different types of immunity
correlate and affect disease dynamics has been an obstacle to the development of a malaria
vaccine [104]. So far vector control measures have been successful but still seem insuffi-
cient. Vector control measures are part of the solution but must be applied in conjunction
with human control measures and better implementation approaches. Although there have
been mathematical models of malaria transmission dynamics focusing on various factors,
to the best of our knowledge, none of the existing models consider all relevant factors that
we have considered. Immunity of human host to malaria infection has been modeled either
as a separate epidemiological class or by considering loss of immunity for recovered indi-
viduals. Such models do not specify the type of immunity being referred to. We include
chronological age of the human host, multiple types of age-dependent immunity (each rep-
resented by a specific parameter), asymptomatic infectious and asymptomatic chronically
infected human hosts, and relapse of chronically infected individuals triggered by suscep-
tible mosquito bites as a reason for reappearance of gametocytemia, (i.e., reappearance of
human infectiousness).
The model presented in this chapter shows that asymptomatic infectious individuals
contribute 2-3 times more than symptomatic individuals to malaria transmission. This in-
dicates that control measures based on the information from reported clinical cases might
not be adequate. This is well known in the malaria literature, but what has not been suffi-
ciently studied yet is: where do so many asymptomatic infectious individuals come from?
Is there a reservoir of asymptomatic chronically infected humans waiting to become in-
fectious? These questions are difficult to answer in field studies but need to be addressed.
One hypothesis found in the literature is that reappearance of infectious asymptomatic in-
dividuals is triggered by even non-infectious mosquito bites. We modeled this hypothesis
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and realized that it plays a fundamental role. The R0 expression is considerably affected
by this assumption. This suggests that it is very important to further study the reasons for
reappearance of gametocytemia, especially as many public health decisions are based on
R0.
It is known that low parasitemia and therefore asymptomatic chronic infections are dif-
ficult to measure. Our model predicts that at least 60% of the population is asymptomatic
chronically infected (not yet infectious), with twice as many adults as children. This means
that this part of the population contributes to the infectious pool for mosquitoes, by even-
tually becoming asymptomatic infectious. This indicates, also, that the number of infected
cases might be underestimated in field studies.
The structure of the model facilitates investigating measures that target a specific factor
(represented by the parameters in our model). We observe some commonly expected re-
sults, e.g., that reducing the biting rate of mosquitoes (β) can most effectively reduce R0 as
well as symptomatic, asymptomatic infectious and overall infectious prevalence. In addi-
tion, our model can also help to determine the age group of humans to target for a specific
type of vaccination and/or treatment implementation strategy, to achieve the most effective
reduction in R0 and disease prevalence in the whole population. Most importantly, our
model can generate non-intuitive results.
For example, a pre-erythrocytic vaccine aims to generate antibodies responsible for
neutralizing sporozoites (stage of the parasite that enters the host when bitten by an infec-
tious mosquito) [104]. This leads to a reduction in the probability of transmission from
mosquitoes to susceptible humans and therefore the parameters that would be reduced by
implementing a vaccine of this type are d1 and d2. Our simulation results show that by bas-
ing a pre-erythrocytic vaccination strategy on R0, it would not be clear which age group to
target, as the parameters d1 and d2 contribute equally. If at all, d2 has a slightly more posi-
tive effect on R0 than d1. In fact, the best vaccination strategy would be to target children,
i.e., lowering d1, which has a significantly stronger positive effect on prevalence than d2
(see Figure 5.9). This example cautions that, in some cases, control measures determined
based on R0 alone may not be optimal.
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While vaccines targeting the pre-erythrocytic stages of the parasites would affect the in-
fectiousness of humans indirectly, transmission-blocking vaccines aim to reduce infectious-
ness directly. These vaccines are based on antigens expressed on the surface of the sexual
and mosquito mid-gut stages of malaria parasites. These antigens are the targets of anti-
bodies induced by vaccination of the host and ingested with the parasites when a mosquito
takes a blood meal. The antibodies act by inhibiting the parasite’s development within the
mosquito and thereby reduce human infectiousness directly [133]. The parameters in our
model related to transmission-blocking vaccines are c1, c2, cA1 and cA2 (probabilities of
mosquito infection). Our results suggest that age group 2 (adults) should be targeted when
implementing transmission-blocking vaccines, particularly asymptomatic infectious adults
(see Figures 5.8 (a) and (c)). To target asymptomatic infectious adults would effectively
lower R0 as well as symptomatic prevalence.
As important as considering optimal vaccination strategies and vector control is effec-
tive treatment and diagnosis of malaria. Improving case management through strength-
ening health services in many countries is needed. Malaria control strongly depends on
correct diagnosis, prescription, and availability of effective treatment [134]. Our results
emphasize this and the importance of symptomatic children for malaria transmission. Our
simulations show that the infectious period of symptomatic children (γ1) has a significantly
higher influence on the symptomatic prevalence than that of adults (γ2). This suggests
the importance of monitoring the effective diagnosis and treatment of children, to reduce
symptomatic malaria prevalence efficiently.
We point out that many of the conclusions mentioned above depend critically on the
rate of relapse triggered by mosquito bites on asymptomatic chronic individuals. A key
parameter that determines the level of relapse is p, which depends on the period when
mosquito density rises. Both R0 and disease prevalence are very sensitive to changes in p.
A decrease in p (e.g., by reducing mosquito breeding sites when rainy season starts) will
no doubt have a significant impact on malaria control as it will greatly reduce the influence
of asymptomatic chronic humans on the overall malaria prevalence.
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In summary, by incorporating several relevant factors such as relapse of asymptomatic
chronically infected individuals triggered by non-infectious mosquitoes and different age-
specific host immunity (anti-disease, anti-parasite and transmission-reducing immunity),
our model is capable of generating important insights into the dynamics of malaria that are
not possible to obtain from existing models for malaria transmission. The model can be
used to evaluate the effectiveness of various control measures including vaccination and
drug treatment for humans as well as vector control. The sensitivity and uncertainty anal-
yses help to identify the most influential factors for reducing the reproduction number R0
and disease prevalence. The age structure of the model makes it possible to determine spe-
cific age group(s) to target for vaccination or other control programs. We simulate two age
groups, as we found reasonable parameter values in the literature for 0− 15 year old indi-
viduals. However, the model can be applied to any finite number of age groups. Although
the model has already included many complexities associated with malaria transmission,
simplifying assumptions were made. For example, p is taken as constant but can be consid-
ered as a time-dependent function to allow for a seasonally-variable relapse rate. Another
extension would be to allow superinfection of asymptomatic chronically infected individu-




In this dissertation, we present four models that investigate synergy. Three of these
models focus on the coupled dynamics of two sexually transmitted diseases: HIV and
HSV-2. The remaining model examines the synergy between host and vector in a malaria
model. Despite the differences to be expected between an HIV/HSV-2 model and a malaria
model, they permit similar approaches to the study of disease. In the case of HIV and HSV-
2, we introduce complexities due to sexual relations within as well as between genders.
For malaria, the host/vector relationship is equivalent in that infection must pass from one
type of population to another, in this case, from humans to mosquitoes. For HSV-2, we
investigate the differences in acute and latent infection; for malaria, we investigate relapse
due to chronic infection. Each of the four models presented is similar and all provide insight
into the transmission dynamics. For each model, we derive and interpret reproduction
numbers and perform numerical simulations to illustrate how various control measures
may be used to effectively lower disease prevalence.
Chapter 2 begins our investigation into the synergy of HIV and HSV-2. We present a
deterministic model to describe the relationship between the two pathogens with the goal of
determining the impact of HSV-2 therapy on controlling HIV prevalence. In this model, we
consider the HSV-2 population as having two separate classes–acute and latent infection–
to focus on the complexities of gender and levels of sexual activity in the population. As
suggested by previous modeling studies, the reproduction numbers play a critical role in
determining the disease prevalence and control. Towards this purpose, we derive the basic
and invasion reproduction numbers for both pathogen systems, and perform an analysis on
the existence and stability of steady states. To confirm these analyses, we also conduct
numerical simulations, which demonstrate the ability of HSV-2 to facilitate the invasion of
HIV.
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One of the main findings of this chapter is due to the inclusion of risk levels among
the female population. We observe that risk levels indirectly affect HIV epidemics. First,
the preference of men for low versus high risk females can drastically change the model
outcome, a result that is confirmed by the sensitivity analysis. Secondly, as the preference
for the high risk females increases, we notice significantly higher HIV prevalence, but also
a smaller interaction between the infections. Hence, with increased preference for the high
risk female group, HSV-2 therapy will have a smaller effect on HIV dynamics, making it
more difficult to reduce the already greater HIV prevalence. Furthermore, we conclude
that treating the high risk female population would be most cost-effective in reducing HIV
prevalence per treated case. Thus, treating the high risk female group, perhaps in conjunc-
tion with the male or low risk female group, would be most effective overall in lowering
the HIV burden.
Chapter 3 continues the exploration of HIV and HSV-2. As HSV-2 infected individuals
alternate between an acute and latent stage, it is important to understand the nature of this
progression. Observations indicate that the longer an individual is infected with HSV-2,
the more time he will spend in the latent stage of the disease and the less infectious he
will be while in the acute stage. The model presented in this chapter introduces a time-
since-infection variable for HSV-2 to account for this time spent acute versus latent, while
including both stages in one HSV-2 infected compartment. In doing so, we eliminate the
“loop” structure observed in the previous model by incorporating it into time-dependent
parameters. This allows us to introduce time-dependent transmission functions which in-
volve those aspects of HSV-2 progression. As in the other models, we again derive the
reproduction numbers. Characteristics of the initially infected individual affect biological
interpretation of the reproduction numbers. We also conduct numerical simulations and a
sensitivity analysis for the simplified ODE model.
As in Chapter 2, co-infection is very important for this model and HSV-2 does facilitate
the invasion of HIV. The sensitivity analysis provides evidence that treating individuals
with HSV-2, which would lower their transmission rate, would be effective in lowering
HIV prevalence. Various treatment strategies must be considered. As this model also in-
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corporates gender and risk groups, we observe that transmission rates from male to female
have a stronger impact on both HIV and HSV-2 survival in a population without the other
disease and invasion in a population with the other disease. Focusing treatment on men, in
this instance, may be effective in lowering disease prevalence.
Finally, our investigation into the synergy between HIV and HSV-2 culminates in Chap-
ter 4. As both HIV and HSV-2 models discussed earlier concentrate on the heterosexual
population, and because most models focus on either the heterosexual or homosexual pop-
ulation alone, we analyze in this chapter a mixed heterosexual and homosexual disease
model. To focus on this new complexity, we simplify our model by ignoring risk levels
and time-since-infection. In this case, the HSV-2 disease is again separated into an acute
and latent class. An important goal of this model is to explore how the inclusion of both
heterosexual and homosexual interactions influences disease dynamics, especially as most
models consider either one or the other, but not both. With this goal in mind, we calculate
the reproduction numbers and provide biological interpretations under certain scenarios.
To extend these results, we perform numerical simulations and investigate the sensitivity of
the reproduction numbers to uncertainty in the parameter values.
Results show that ignoring the homosexual population, as many studies do, may cause
a significant underestimation in disease prevalence. This is particularly important when
implementing a control strategy. Furthermore, we observe that the reproduction numbers
are very sensitive to this sexual preference. Thus, it is very important to determine the
frequency of heterosexual versus homosexual encounters in a given population. We con-
clude that treating individuals with HSV-2 may be effective in lowering HIV prevalence.
Moreover, treating these individuals will also protect a population against HIV invasion.
In Chapter 5, we analyze a host/vector malaria model with chronological age of hu-
mans. This model presents similar mathematical complexities to the models in the other
chapters, particularly through the comparison in structure of the host/vector and
male/female dynamics. Another similarity is in the “loop” structure of the disease. In
endemic regions, it has been observed that individuals exhibit chronic malaria infections.
These individuals alternate between periods of asymptomatic infectiousness and chronic
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infection in which they have low parasite loads and cannot infect others. A similar struc-
ture is observed with HSV-2, where individuals alternate between acute and latent infection.
This structure complicates the reproduction numbers, but can shed some light on potential
treatment strategies. Moreover, the inclusion of chronological age in this model allows us
to consider the implications of age-dependent immunity.
The numerical simulations for this model are presented for two age groups: children and
adults. However, the model and the reproduction numbers are all formulated for n groups.
Our results demonstrate that inclusion of a chronically infected class is crucial. Over 60%
of the population is asymptomatic chronically infected, with the majority of these cases
among the adult population. As we also notice 2-3 times more asymptomatic infection
than symptomatic infection, this chronically infected population is of great concern. Field
studies may underestimate malaria prevalence because of this chronically infected group
and current malaria treatments would focus on the symptomatic population, leaving chroni-
cally infected individuals as a reservoir for future mosquito infection. When implementing
a vaccination program, we also conclude that it would be best to target children with a
pre-erythrocytic vaccine, but that adults should be targeted if the vaccine is a transmission-
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A. Supplementary Material for Chapter 2
A.1 Derivation of P ai in (2.3.3)












represent the probability that an individual moves from Li to Ai. Thus, the

























A.2 Derivation of RHA


































, i = m, f1, f2.
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It follows from [71] that the matrices FH and VH (corresponding to the new infection and














V Hm 0 0
0 V Hf1 0




























i ) 0 0
−δHi λA0i ωPi + θPi + μi + dPi −γQi (θPi )
0 −(ωPi + θPi ) γQi (θPi ) + μi + dQi
⎞
⎟⎟⎟⎟⎟⎟⎠ , (A.2.2)




























where the entries kij of KH are given in Appendix A.4.
Noting that Rank(KH) = 2 and the sum of the diagonal elements in matrix KH is
zero (i.e., Tr(KH) = 0), it follows from Vieta’s formulas that if the numbers of susceptible
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i , respectively, the
reproduction number for HIV infection is given by










where ρ(KH) represents the spectral radius of the matrix KH and E2(KH) is the sum of all
the 2× 2 principal minors of matrix KH (see Appendix A.4 for the definition of kij).

















, j = 1, 2.
The matrices FA and VA (corresponding to the new infection and remaining transfer terms,














V Am 0 0
0 V Af1 0






























1, 0, σPm, 0
)
, j = 1, 2,
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i −γLi 0 0
−(ωAi + θAi ) γLi + μi + δLi λH0i 0 0
−δAi λH0i 0 ωPi + θPi + μi + dPi −γQi
































where the entries k˜ij of the matrix KA are described in Appendix A.4.
Noting again that Rank(KA) = 2 and that the sum of the diagonal elements in matrix
KA is zero, it follows from Vieta’s formulas that, if the numbers of susceptible people and
ones with HIV in group i are S0i , H
0
i , respectively, the reproduction number for HSV-2
infection is given by










where ρ(KA) again represents the spectral radius of the matrix KA and E2(KA) is the sum
of all the 2× 2 principal minors of matrix KA (see Appendix A.4 for the definition of k˜ij).
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A.4 The elements of matrices KH and KA.
Recall that the formulas for the invasion reproduction numbers RHA (invasion of HIV
into a population where HSV-2 is endemic) and RAH (invasion of HSV-2 into a population
where HIV is endemic) are determined by the dominant eigenvalues of the matrices














In this appendix, we provide the formulas for the elements kij and k˜ij .












































































i ), i = m, f1, f2. Using (A.2.1)












































































































































































































































































































































































































































































































































k˜1,5 k˜1,6 k˜1,7 k˜1,8
0 0 0 0
k˜3,5 k˜3,6 k˜3,7 k˜3,8































































k˜1,9 k˜1,10 k˜1,11 k˜1,12
0 0 0 0
k˜3,9 k˜3,10 k˜3,11 k˜3,12

























































k˜5,1 k˜5,2 k˜5,3 k˜5,4
0 0 0 0
k˜7,1 k˜7,2 k˜7,3 k˜7,4


























































k˜9,1 k˜9,2 k˜9,3 k˜9,4
0 0 0 0
k˜11,1 k˜11,2 k˜11,3 k˜11,4





A.5 Proof of Lemma 2.4.2.




= dHf2 = 0, then notice from system (2.3.5) that
dNi
dt
= 0, i = m, f1, f2
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and that Ni(t) = N0i for all t ≥ 0. Recall that c1 = c and c2 = 1 − c. Then, using the











































− μfiHfi , i = 1, 2.
(A.5.1)































is non-negative, it follows from Perron-Frobenius theory of positive matrices that there
exists a positive eigenvector (vm, vf1 , vf2), where vi > 0, i = m, f1, f2, such that
(vm, vf1 , vf2)M = ρ(M)(vm, vf1 , vf2).






The derivative of L along solutions of system (A.5.1) is
dL
dt




















































= (vm, vf1 , vf2)(M − I)diag{μm, μf1 , μf2}(Hm, Hf1 , Hf2)T
= (ρ(M)− 1)(vm, vf1 , vf2)diag{μm, μf1 , μf2}(Hm, Hf1 , Hf2)T
≤ 0
if ρ(M) = RH0 ≤ 1. Therefore, all limit points are contained in the largest invariant subset
K of
G = {(Sm, Hm, Sf1 , Hf1 , Sf2 , Hf2)|L˙ = 0}.
We can easily see that L˙ = 0 if and only if Si = N0i and Hi = 0 for i = m, f1, f2.
Therefore, the only one compact invariant subset of the set where L˙ = 0 is the single-
ton {E˜0 = (N0m, 0, N0f1 , 0, N0f2 , 0)}. By the LaSalle Invariance Principle, E˜0 is globally
asymptotically stable if RH0 ≤ 1.
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Now consider the case RH0 > 1. In this case, we can easily prove that the limiting
































































, i = 1, 2.
(A.5.2)


























m, i, j = 1, 2, i = j.































































































































≥ 4, i = 1, 2















































for all (Sm, Hm, Sf1 , Hf1 , Sf2 , Hf2) ∈ BH∂ , and that
dV
dt
|(A.5.1) = 0 if and only if (A.5.4)













|(A.5.1) = 0 if and only if Si = S∂i , Hi = ξH∂i , i = m, f1, f2. Substituting
Si = S
∂
i , Hi = ξH
∂
i , i = m, f1, f2 into the first, third and fifth equations of system (A.5.1),




|(A.5.1) = 0 is the singleton {E˜}. By the LaSalle Invariance Principle, E˜ is globally
stable in BH∂ if RHE0 > 1.
Because system (2.2.1) can be reduced to the limiting system (A.5.1), if RH0 ≤ 1, the
DFE E˜0 of system (A.5.1) is globally asymptotically stable in Γ. By using Corollary 4.3
in paper [135], the DFE E0 of system (2.2.1) is also globally asymptotically stable in BH∂ .
Similarly, if RH0 > 1, system (2.2.1) has a unique positive equilibrium that is globally
asymptotically stable in BH∂ because the unique positive equilibrium E˜ of system (A.5.1)
is globally asymptotically stable if RH0 > 1. This completes the proof of Theorem 2.4.2.
A.6 Proof of Theorem 2.4.5.
We only provide the proof of (a). The proof of (b) is similar so we omit it here.
Denote the subspace for the subsystem (2.3.4) byH A∂ , i.e.,
H A∂ = {(M,F1, F2) : (M,F1, F2) ∈ Γ, Hi = Pi = Qi = 0, i = m, f1, f2}. (A.6.1)




∂ is invariant for the system (2.2.1),
it follows from Lemma 2.4.1 that EA∂ is globally stable inH
A
∂ \ {E0}. Thus,
H A∂ \ {E0} ⊂ W s(EA∂ ). Let
V1 = {(M,F1, F2) : Hi = Pi = Qi = 0, i = m, f1, f2},
V2 = {(M,F1, F2) : Si = Ai = Li = 0, i = m, f1, f2}.
It is easy to check that V1 and V2 are invariant subspaces of the linearization of system
(2.2.1) at the equilibrium EA∂ . The Center Manifold Theorem tells us that there exists
invariant manifolds, denoted by W1,W2, of the system (2.2.1) tangent to the subspaces
V1, V2, respectively, and dimWi = dimVi, i = 1, 2. We can easily see that
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H A∂ \ {E0} ⊂ V1. Now consider the linearization of system (2.2.1) on the subspace V2.
Straightforward computations yield the corresponding Jacobian matrix J2
J2 = FH − VH ,










i . Then from Theorem 2
in [71], we have
s(J2) < 0(= 0, > 0) ⇐⇒ RHA < 1(= 1, > 1),
where s(J2) denotes the maximum real part of all eigenvalues of the matrix J2. If RHA > 1,
i.e, s(J2) > 0, it follows from the Hartman-Grobman Theorem that the equilibrium EA∂ is
unstable. If RHA < 1, then all the real parts of the eigenvalues of the matrix J2 are negative,
and the subspace V2 is a stable subspace. Then it follows from the Hartman-Grobman
Theorem that the manifold W2 is also stable. Noting that
dimW s(EA∂ ) ≥ dimH A∂ + dimW2 = 18, it follows that dimW s(EA∂ ) = 18, i.e., the
equilibrium EA∂ is stable. This completes the proof of Theorem 2.4.5.
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B. Supplementary Material for Chapter 3
B.1 Derivation of the Basic Reproduction Numbers
B.1.1 Basic Reproduction Number for HIV (RH0 )
Using the notation from [71], we construct the matricesF , F and V , V . F is a vector of
rates of appearances of new infections in the infectious compartments (Hm, Hf1 , and Hf2),
while V is a vector of rates of transfer of individuals in the infectious compartments by any
other means. F and V are the Jacobian matrices of F and V , respectively, with respect to


































Evaluating at the DFE (noting that S0i = N
0





















































































B.1.2 Basic Reproduction Number for HSV-2 (RV0 )
For simplification, we define:







(a)LVm(a), j = 1, 2. (B.1.2)
Substituting the second part of (3.2.4), i.e.,
Vi(t, a) = λ
V
i (t− a)Si(t− a)LVi (a), t > a, (B.1.3)
into (3.3.3), integrating over a, and adding the classes in order to get an expression for






= Λi − λVi (t)Si(t)− μSi Si(t)
dNi
dt














, j = 1, 2,
(B.1.4)




i , i = m, f1, f2.
Analyzing the previous system is equivalent to analyzing system (3.3.4), as the number
of infectious individuals Vi can be obtained from Si(t), Ni(t), λVi (t), i = m, f1, f2.
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Next, we linearize system (B.1.4) around the DFE and, by assuming constant popula-
tion size, we reduce the system to only the disease-related variables λVi , i = m, f1, f2, in
















, j = 1, 2.
(B.1.5)
To find eigenvalues of the linear operator, we look for solutions of the form
λVi (t) = λ¯
V
i e
ωt, i = m, f1, f2, where λ¯i is positive for each i and ω is the eigenvalue. By




















, j = 1, 2.
(B.1.6)





























e−aωAVfj ,m(a)da, j = 1, 2.
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(ω) = 1. (B.1.8)
It is easy to see that for real ω, lim
ω→∞
G(ω) = 0, lim
ω→−∞
G(ω) = ∞, and that G(ω) is a
decreasing function. Also, by a similar approach as in the proof of Theorem 5.3.1 in the
previous chapter, it is easy to show that the real root of the equationG(ω) = 1 is the leading
root, i.e., if ω0 is the real root and ω is any complex root, then Re(ω) < ω0.


































(a)da, j = 1, 2.
(B.1.10)
B.2 Derivation of the Invasion HIV Reproduction Number (RHV )
In this section, the invasion reproduction number for HIV, RHV (see Section 3.4.1), will
be calculated. We assume the HIV disease invades an endemic HSV-2 population. We will
analyze system (3.2.1), where the variables Hi, Pi will be assumed to be disease variables
and Si, Vi non-disease variables. We then linearize system (3.2.1) around the HIV disease-
free and HSV-2 endemic equilibrium (S0i , 0, V
0
i (a), 0), look for eigenvalues for the linear
operator and derive a characteristic equation in order to define RHV .
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(a)Pfj(t, a)da, j = 1, 2.
(B.2.3)















































, j = 1, 2.
(B.2.5)
We will use (B.2.1) and (B.2.2) extensively in our calculations. Since we will linearize












m(a)da, for j = 1, 2.
When linearizing system (3.2.1) around the HIV disease-free equilibrium
(S0i , 0, V
0
i (a), 0) and considering only the equations for the disease variables Hi and Pi,
we obtain the following linear system equivalent to the linear system of equations with the

































































[Hfj(x+ t− a) + γfk(x+ t− a)]dx

















[Hm(x+ t− a) + γm(x+ t− a)]dx,
j = 1, 2.
In the next step we look for eigenvalues for the linear operator, i.e., for solutions of the





















(H¯m + γ¯m)− δHfjbmcj
φ0m,fj
N0fj








K2,fj ,m(ω)(H¯fj + γ¯fj),



















































































































































+ μHfj . (B.2.9)


















































We can then define the invasion HIV reproduction number as RHV :=
√
GHV (0). This

























































































































are the rates at which male m and female fj , j = 1, 2, individuals exit the Hm and Hfj
classes, respectively, either because of acquiring HSV-2 or due to ceasing sexual activity.
A detailed biological interpretation can be found in Section 3.4.1.
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B.3 Derivation of the Invasion HSV-2 Reproduction Number (RVH)
In this section, we will show the derivation of the HSV-2 invasion reproduction number
RVH (see Section 3.4.2). We will proceed in a similar way as we did in order to find the HIV
invasion reproduction number (see Appendix B.2). In this case we will consider that in
system (3.2.1), the HSV-2 variables Vi, Pi are disease variables and Si, Hi are non-disease
variables. We will then linearize system (3.2.1) around the HSV-2 disease-free but HIV
endemic equilibrium (S0i , H
0
i , 0, 0), and then derive a characteristic equation in order to
define RVH .







































































(− p˙Vfj(x))LPfj(a)LPfj(x)dx e−ωada, (B.3.4)
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where
LVi (a) := e
− ∫ a0 μVi (τ)dτ , i = m, f1, f2,
pVm(a) := e
− ∫ a0 FVm(τ)dτ
(












− ∫ a0 FVfj (τ)dτ
(





−p˙Vfj(x) = FVfj (x)pVfj(x), j = 1, 2.
In the following, consider λVi (t), i = m, f1, f2, ηm,fj(t), ηfj ,m(t), j = 1, 2, as defined in
(B.2.3).
After linearizing system (3.2.1) around the HSV-2 disease-free equilibrium
(S0i , H
0
i , 0, 0), i = m, f1, f2, reducing the system to only consider the HSV-2 disease vari-
ables, Vi and Pi, and substituting solutions of the form
λVi (t) = λ¯
V
i e
ωt, ηm,fj(t) = η¯m,fje
ωt, ηfj ,m(t) = η¯fj ,me
ωt
into the linear system in order to find the eigenvalues of the linear operator, the linearized






















η¯fj ,m = Fˆfj ,m(ω)λ¯
V
fj








Eˆm,fj(ω) := Dˆm,fj(ω) +
bmcj
N0fj
Fˆm,fj(ω), j = 1, 2.











m, j = 1, 2,
(B.3.6)








⎟⎟⎟⎠ = 0. (B.3.7)
Computing the determinant, (B.3.7) is equivalent to the following equation
GVH(ω) := Eˆf1,m(ω)Eˆm,f1(ω) + Eˆf2,m(ω)Eˆm,f2(ω) = 1. (B.3.8)
We then can define the HSV-2 invasion reproduction number as RVH :=
√
GVH(0). For a
biological interpretation refer to section 3.4.2.
B.4 Biological Interpretation of the Terms of RHV
This Appendix describes biologically the remaining terms in equation (3.4.3). The first
term was explained in Section 3.4.1.













where [Pm(Hm)](a) represents the number of co-infected males of time-since-HSV-2-
infection a that were HIV-only males before (see Table 3.2). This case represents the
path
Sm
initial−−−→ Hm becomes−−−−→ Pm infects−−−−→ Sfj become−−−−→ Hfj infect−−−→ Nm
in Figure 3.2. Here, the initial HIV infected male becomes co-infected and is still sexually
active at time-since-co-infection a, ([Pm(Hm)](a)). Then, at time-since-infection a, this
male infects susceptible females at a rate δPm(a)π
H
m,fj
, who then as Hfj , j = 1, 2, females




to consider all individuals in Pm, of all times-since-HSV-2-infection, that infected suscep-
tible females.












where HHmfj (S0fj) is as in the first term. The path
Sm
initial−−−→ Hm infects−−−−→ Sfj become−−−−→ Hfj become−−−−→ Pfj infect−−−→ Nm
in Figure 3.2 represents this scenario. This case is explained in the following way: the
initial HIV-positive male is in Hm, infects susceptible females, who, as Hfj females, ac-
quire HSV-2 with probability qVmHfj ,Pfj and are still sexually active at time-since-co-infection
a with probability LPfj(a). These co-infected females then infect males at time-since-
infection a, at a rate δPfj(a)π
H
fj ,m
. Finally, by integrating we consider infections due to
co-infected females with all possible times-since-HSV-2-infection.













where (HPm(Hm)fj (S0fj))(a) is the number of HIV females who initially were in the suscep-
tible class, acquired HIV by a co-infected male who was initially an Hm male (see Table
3.2). The path corresponding to this term is
Sm
initial−−−→ Hm becomes−−−−→ Pm infects−−−−→ Sfj become−−−−→ Hfj become−−−−→ Pfj infect−−−→ Nm
in Figure 3.2. The interpretation is as in the previous case, only that the initial HIV male
individual becomes co-infected before infecting susceptible females.
The fifth term is
∫ ∞
0




where [PHmfj (V 0fj)](a) represents the number of co-infected females (with time-since- in-
fection a) who acquired HIV while being in the HSV-2-only class, by the initial HIV male
(who is in Hm) (see Table 3.2). This case follows the path
Sm
initial−−−→ Hm infects−−−−→ Vfj become−−−−→ Pfj infect−−−→ Nm.
The situation is as follows: the first HIV male case infects V 0fj(x) females during his sexual
lifetime, who as Pfj females remain sexually active at time-since-infection a(
[PHmfj (V 0fj)](a)
)




. We integrate to consider infection by females with co-infection of all possible
times-since-infection.
The sixth term is
∫ ∞
0





where [PPm(Hm)fj (V 0fj)](a) is similar to [PHmfj (V 0fj)](a), with the only difference being that
the females got the infection from the initial HIV male after he was co-infected with HSV-2
(see Table 3.2). This case follows the path
Sm
initial−−−→ Hm becomes−−−−→ Pm infects−−−−→ Vfj become−−−−→ Pfj infect−−−→ Nm.
The interpretation is as in term five, only that, as stated above, the initial HIV male individ-
ual becomes co-infected before infecting HSV-2 only females with HIV.
The last three terms correspond to the case when the initial HIV male was already





where HPmfj (S0fj) corresponds to the number of HIV females that acquired HIV, while sus-
ceptible, by the initial co-infected HIV male (see Table 3.2). These females then infect
males at a rate πHfj ,m, throughout their permanence in the HIV class, T
H
fj
. Observe that this
term follows the path
Vm
initial−−−→ Pm infects−−−−→ Sfj become−−−−→ Hfj infect−−−→ Nm.












where HPmfj (S0fj) is as in the previous case. This case describes the path
Vm
initial−−−→ Pm infects−−−−→ Sfj become−−−−→ Hfj become−−−−→ Pfj infect−−−→ Nm
in Figure 3.2. The interpretation is similar to the previous case, only that the females
infected by the initial male, before infecting males, become co-infected with probability
qVmHfj ,Pfj
, and then infect males when their time-since-HSV-2-infection is a. We integrate to
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account for male infections from all times-since-infection of those co-infected females.
Finally, the last term reads
∫ ∞
0




where [PPmfj (V 0fj)](a) is as in the previous case, with the only difference being that now V 0fj
females, instead of completely susceptible females, are being infected by Pm males. The
path followed by this term is the following,
Vm
initial−−−→ Pm infects−−−−→ Vfj become−−−−→ Pfj infect−−−→ Nm.
B.5 Choosing Parameters
This section justifies our choices for mean values of the parameters. For a full list of
parameters, consult Table 3.1. In what follows, i = m, f1, f2.
B.5.1 μi
Recall that the analysis required a constant population size for each population group
(m, f1, f2). Therefore, we considered the same exiting parameter μi for each class (S, H ,
V , P ). This is not simply the mortality rate, it is the rate with which individuals cease
sexual activity. We assume that the average sexual lifespan for individuals from the general
population is 30 years. For high-risk women, class f2, we assumed 4 years. It is hard to
determine how long FSWs work on average – migration to different place of work, periods
of working in and out of the sex industry, and disparity within the type of partners (client,
relationship, etc.) make such a calculation unreliable. Furthermore, in our model we do not
consider movement between groups. Still, the length of working in the sexual industry can
be approximated to be around 4 years, considering the high turn over [136]. Therefore, our
mean value for μm and μf1 is 1/360 and for μf2 is 1/48 per month.
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B.5.2 bi, Ni
Several of these parameters were found in the literature, while others were calculated
using the balance equations (3.2.2).
Studies on African men agree that the average number of lifetime sexual partnerships
for men are 8-10 [137]. Therefore, we chose 9 as our mean. Then, bm is 9/360 partnerships
per month.
The number of lifetime sexual partnerships for the general female population is not that
concrete: [137] estimates this number to be around 2 for South Africa, while [138] esti-
mates them at 6.8. The reasons for the vast disparities between female numbers in different
areas and especially between male and female numbers that are often discussed are: overre-
porting in males, underreporting in females, low reliability of recollection, matters of how
the questions on the survey are worded, and sampling bias that leaves sex workers out of
the surveys [137–140]. The average number of sexual partners for FSWs also varies: [136]
estimates it at 22 per week, [140] gives a range of 13-22 per week, depending on how they
are reported, and according to [141], it varies between 60 and 160 partners per year.
Given the great disparity between the data, we calculated bf1 and bf2 from bm and our
assumptions for the ratio between bf2 and bf1 and the preference men give to f1 women
when choosing a sexual partner, c1. bf2/bf1 was estimated at 10. The ratio may seem small
considering the numbers above; however, beyond the unreliability of the data discussed
above, other cultural issues would have to be considered. In South Africa, for example,
it is common for individuals to enter casual relationships in exchange for money or gifts
[142–145]. We believe women with this behavior would have to be considered in the f2
category. If they are, this would add another level of uncertainty about the parameters.
Hence, our estimation is conservative.
The proportion of partners of males who are f1, c1, was chosen to be 0.9. Adding to
the discussion about difficulty in estimating parameters, [146] gives an overview of global
studies that calculate the percentage of men who paid for sexual services. The figures
differ greatly, depending on how the surveys were conducted. However, if “paying” for sex
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is considered exchanging money, gifts, or favors in return for sexual favors, then around
10% of men have engaged in such activity. Hence our assumption. We define c2 = 1 − c1
and Nm is chosen at 107. We further assumed that Nm = Nf1 + Nf2 . Therefore, given
bm, c1, Nm, and bf2/bf1 , we calculate bf1 , bf2 , c2, Nf1 , and Nf2 using the balance equation
(3.2.2).
B.5.3 βH
Note that the units of our values are probability of transmission per partnership. There-
fore, if an individual has a lot of partnerships, the average transmission is low for each
partnership. If a person has only a few partnerships, the average probability of transmission
is high because a lot of time is spent per partnership. We assume that there is no difference
between male and female transmissions per act. No significant difference has been found in
lower income countries, while the usual assumption that men are more infectious has been
shown for higher income countries [147]. The average infectivity is reported per coital act.
In Africa, the average probability per act varies greatly, depending on region, way of ap-
proximation, viral load, circumcision of males, and HIV stage [26,88,147–150]. The mean
values of probabilities of transmission per act range between 0.0007 and 0.0082 [148].
HIV-positive individuals spend most of their time in the latent stage, so we assumed a more
conservative 0.0017 per coital act. Therefore, in Table 3.4, ρH is the probability of HIV
transmission per act and is set at 0.0017. Average acts per month vary [151]. However, we
believe that 2.5 acts per month is within the average per lifetime [152]. For sex workers,
we assumed the number of acts per partnership per year to be 2 because of the relatively
high turnover of clients. Therefore, in Table 3.4, r is the number of sexual acts per partner-
ship per year for FSWs and is estimated at 2. βHm,f1 , β
H
m,f2







We decided to use a simple step function describing βVi,k, i = m, f1, f2, k = m, f1, f2,
i = k for this work. The step functions alternate periods of infectivity (nonzero value)
and latency (zero). Different studies find different rates of transmission. [153] gives a great
disparity between ethnicities for transmission rates. The average is 6.8% per year of male-
to-female transmission risk (5.8 for white women, 11.2 for black women) and 4.4% per
year risk for female-to-male contacts (2.6 for white, 8.1 for black males). The participants
were instructed in safe sexual practices, but the role of different sexual behaviors is not
mentioned in the results. In [154], male-to-female probability of transmission is 16.9%
(9.1% to 31%, depending on whether women had HSV-1 antibodies) and female-to-male
is 3.8% per 11 months. 9 of the infections were asymptomatic, 4 were in early symptoms,
which leads us to suspect that either the participants were instructed not to have sex during
outbreaks or were aware of the risks before entering the survey. Based on these data, we
assumed 8% male-to-female risk per year and 4% female-to-male. Therefore, in Table 3.4,
ρVm is the probability of HSV-2 transmission by a male per year, and is set at 0.08. ρ
V
f is the
probability of HSV-2 transmission by a female, and is set at 0.04.
For the reproduction numbers’ sensitivity analysis, using some available data about the
periods of latency, we constructed a step function for βVm,f1(a) by alternating periods of
infectiousness of length two weeks with periods of latency (no infectivity) of 2.5 months
[13, 155, 156]. The value of the step function at the non-zero intervals was constructed so
that the average of βVm,f1(a)matched the 8% male-to-female infectious probability per year,
converting it to probability per partnership. The other βV s were calculated similarly. The
parameter βVi,k, i = m, f1, f2, k = m, f1, f2, i = k used in the sensitivity analysis, figures
3.7 and 3.8, refers to the height of the step function.
B.5.5 δV and δP
In [30], the authors claim that the increased susceptibility of an individual with HSV-2
to HIV is 2-4 times higher than that of a healthy person. According to [21], the risk of
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acquisition of HIV if one already has HSV-2 is increased 3-fold. In [26], it was found that
the probability per act of someone with both HSV-2 and HIV to transmit HIV increases
4-fold in comparison with an individual who only has HIV. However, our parameters are
in probabilities per partnership. Therefore, an enhancement of 2 to 4 would make our
probabilities greater than 1, which is not realistic. Therefore, we were conservative in our
assumption that δP = 1.1 and δV = 1, regardless of gender.
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C. Supplementary Material for Chapter 4
C.1 Verification of Conditions for the Basic Reproduction Numbers
Note that conditions A1-A4 in [71] are satisfied for our system since all parameters
are positive and biologically relevant. Then it remains to verify condition A5: If F = 0,
then all eigenvalues of Df(x0) (the Jacobian of our system evaluated at the disease-free
equilibrium) have negative real parts [71].










Hf + (1− qm)bmβHm,f SfNfHm
⎞
⎠ = 0.














−μHm 0 0 0
0 −μHf 0 0
0 0 −μSm 0




Hence, the eigenvalues of Df(x0) are −μHm,−μHf ,−μSm,−μSf , which are all negative.
Thus, the conditions are satisfied.
C.1.2 Basic Reproduction Number for HSV-2 (RV0 )
























γLmLm − (μAm + ωAm)Am
γLf Lf − (μAf + ωAf )Af
ωAmAm − (μLm + γLm)Lm










−(μAm + ωAm) 0 γLm 0 0 0
0 −(μAf + ωAf ) 0 γLf 0 0
ωAm 0 −(μLm + γLm) 0 0 0
0 ωAf 0 −(μLf + γLf ) 0 0
0 0 0 0 −μSm 0





Note that we have eigenvalues −μSm and −μSf . In order to determine the remaining 4
eigenvalues, we may find the eigenvalues of the matrix found by rearranging the rows and
columns of the remaining 4× 4 matrix:
⎛
⎜⎜⎜⎜⎜⎜⎝
−(μAm + ωAm) γLm 0 0
ωAm −(μLm + γLm) 0 0
0 0 −(μAf + ωAf ) γLf
0 0 ωAf −(μLf + γLf )
⎞
⎟⎟⎟⎟⎟⎟⎠ .











































)2 − 4 (μAf μLf + μAf γLf + μLf ωAf ).























2 − 4 (μAi μLi + μAi γLi + μLi ωAi )
< 0.

















)2 − 4 (μAi μLi + μAi γLi + μLi ωAi ) < (μAi + ωAi + μLi + γLi )2
−4 (μAi μLi + μAi γLi + μLi ωAi ) < 0,
which is a true statement as all of our parameter values are positive. Hence, the eigenvalues
of Df(x0) are all negative, so the conditions are satisfied.
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C.2 Verification of Conditions for the Invasion Reproduction Numbers
C.2.1 Invasion Reproduction Number for HIV (RHV )









































Note that for the invasion reproduction number, we consider the HIV-free equilibrium in a
system which contains HSV-2.
























































f Lf − (μAf + ωAf )Af
ωAmAm − (μLm + γLm)Lm


























f Qf − (μPf + ωPf )Pf
ωPmPm − (μQm + γQm)Qm


























































−Cf − μHf 0 0
Cf −μPf − ωPf γQf
0 ωPf −μQf − γQf
⎞
⎟⎟⎟⎠ ,






−Cm − μHm 0 0
Cm −μPm − ωPm γQm



































































































































































































⎞ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎟ ⎠.
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det (M3). Notice that M
(2)
1 and M3
have the same form, replacing males with females. Also, the eigenvalues of M3 are
−Cf − μHf < 0 and the eigenvalues of
⎛
⎝−μPf − ωPf γQf








































Note that these eigenvalues are of the same form as those in Appendix C.1.2, with A and L




It remains to show that M (2)3 satisfies this same condition. We will verify this numeri-















Figure C.1. A boxplot of the real part of eigenvalues of M (2)3 obtained from
the parameter ranges in Table 4.8. The box covers the interquartile range with
the red line indicating the median value. The whiskers extend to cover the 95%
confidence interval.
In Figure C.1, we observe that the 95% confidence interval for the range of eigenvalues
of M (2)3 consists of eigenvalues with negative real part. Hence, for appropriate choice in
parameters, M (2)3 satisfies the condition that all eigenvalues have negative real part.
Thus, the condition is satisfied for M (2)1 , M
(2)
3 , and M3, so that Df(x0) has the desired
property.
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C.2.2 Invasion Reproduction Number for HSV-2 (RVH)































Note that for the invasion reproduction number, we consider the HSV-2-free equilibrium in
a system which contains HIV.


































































Lm − (μLm + γLm)Lm






















































































































































































































−cm − μAm − ωAm γLm 0 0
ωAm −dm − μLm − γLm 0 0
0 0 −cf − μAf − ωAf γLf








cm 0 0 0
0 dm 0 0
0 0 cf 0









−μPm − ωPm γQm 0 0
ωPm −μQm − γQm 0 0
0 0 −μPf − ωPf γQf
0 0 ωPf −μQf − γQf
⎞
⎟⎟⎟⎟⎟⎟⎠ ,
where ci and di are defined in Section 4.4.2.



















ζ2i − 4 [(ci + μAi ) (di + μLi + γLi ) + ωAi (di + μLi )]
for i = m, f , where ζi = ci + μAi + ω
A




i . Note that these eigenvalues are of
a similar form as those in Appendix C.1.2. Thus, all eigenvalues of N (2)1 have negative real
part.
Similarly, the eigenvalues of N (2)3 are the eigenvalues of
⎛
⎝−μPi − ωPi γQi
ωPi −μQi − γQi
⎞
⎠,
which we know has eigenvalues with negative real part from the analysis of matrix M3 in
Appendix C.2.1.
It remains to show that N1 satisfies this same condition. We will verify this numerically
for our parameter ranges (see Tables 4.7 and 4.8).
In Figure C.2, we see that the 95% confidence interval for the range of eigenvalues of N1
consists of eigenvalues with negative real part. Hence, for appropriate choice in parameters,
N1 satisfies the condition that all eigenvalues have negative real part.
Thus, the condition is satisfied for N1, N
(2)
1 , and N
(2)
3 , so that Df(x0) has the desired
property.
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Figure C.2. A boxplot of the real part of eigenvalues of N1 obtained from the
parameter ranges in Table 4.8. The box covers the interquartile range with the
red line indicating the median value. The whiskers extend to cover the 95%
confidence interval.
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D. Supplementary Material for Chapter 5
D.1 Derivation of R0
Consider exponential solutions of the form
x(t, a) = x(a)eωt, i(t, a) = i(a)eωt, iA(t, a) = iA(a)e
ωt, jA(t, a) = jA(a)e
ωt,
Xv(t) = X¯ve
ωt, Iv(t) = I¯ve
ωt, (D.1.1)
where ω is a constant. The stability of E∗ can be determined by the sign of ω. Substituting
these into equations in (5.3.17) and canceling eωt, we obtain the following equations (it
suffices in this case to consider only the i(a), iA(a), jA(a) and I¯v equations):
i′(a) = kλ¯1(a)I¯v − (γ(a) + μ(a) + δ(a) + ω)i(a)
i′A(a) = (1− k)λ¯1(a)I¯v + pλ¯2(a)jA(a)− (γA(a) + μ(a) + ω)iA(a)




[cA(a)iA(a) + c(a)i(a)]da− μv I¯v. (D.1.2)





− ∫ aσ (γ(τ)+μ(τ)+δ(τ)+ω)dτdσ = I¯vkF (a, ω), where (D.1.3)




− ∫ aσ (γ(τ)+μ(τ)+δ(τ)+ω)dτdσ. (D.1.4)





A(a) = (1− k)λ¯1(a)I¯v − (μ(a) + ω)(iA(a) + jA(a)).
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By solving for iA(a) + jA(a), we find






Solving for jA(a) from (D.1.5) and substituting it into the iA(a) equation in (D.1.2) we
obtain




− ∫ aσ (μ(τ)+ω)dτdσ
−(γA(a) + μ(a) + pλ¯2(a) + ω)iA(a), (D.1.6)
from which we have
iA(a) = (1− k)I¯vG(a, ω, p), (D.1.7)
where














and PA(a, σ, ω) = e−
∫ a
σ (γA(τ)+μ(τ)+pλ¯2(τ)+ω)dτ .
Finally, substituting i(a) and iA(a) into the I¯v equation in (D.1.2) and dividing by I¯v (= 0),












The function Θ(ω) defined in (D.1.9) can be used to define the basic reproduction num-
ber R0:










where the functions F and G are defined in (D.1.4) and (D.1.8), respectively.
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D.2 Proof of Theorem 5.3.1
In this appendix we give the proof of Theorem 5.3.1.
Theorem 5.3.1 The disease-free steady state E∗ is locally asymptotically stable if R0 < 1
and unstable if R0 > 1.
Proof. First consider the case when ω ∈ R. Notice that
∂
∂ω




























− ∫ σξ (μ(τ)+ω)dτdξ
]






























and Θ(ω) is a continuous decreasing function. Moreover, since F (a, ω) → 0 and
G(a, ω, p) → 0 as ω → ∞, it is easy to see that lim
ω→∞
Θ(ω) = 0. Similarly, it can also be
shown easily that lim
ω→−∞
Θ(ω) = ∞. Therefore, there exists a unique real root, denoted by
ω0, of the characteristic equation Θ(ω) = 1 such that Θ(ω) > 1 (< 1) for ω < ω0 (> ω0).
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Next we show that when ω0 < 0, all complex solutions of the equation Θ(ω) = 1 will
have a negative real part. Let z ∈ C and Θ(z) = 1. If Re{z} ≥ 0, then











Since Θ(ω) is a decreasing function, from the above inequality we have Re{z} ≤ ω0,
which is a contradiction. This implies that Re{z} < 0 whenever ω0 < 0.
Note that R0 := Θ(0). Thus, ω0 < 0 (> 0) if R0 < 1 (> 1). It follows that the
disease-free state E∗ is locally asymptotically stable if R0 < 1 and unstable if R0 > 1.
This completes the proof.
D.3 Reduction of the PDE Model to an ODE Model with Aging
To derive the ODE for the susceptible humans of age group k we integrate the s(t, a)
equation in the limiting PDE system over the age interval [ak−1, ak), which yields
S ′k(t) + s(t, ak)− s(t, ak−1) = −λ1k(t)Sk(t)− μkSk(t) + γkIk(t). (D.3.1)
From [68], s(t, ak) = αkSk(t) where αk is the aging rate out of age group k.

























fkNk(t) = Λ. (D.3.3)
Replacing s(t, a1) in (D.3.1) with k = 1 by α1S1(t) and using (D.3.3) for s(t, 0), we obtain
d
dt
S1(t) = Λ− α1S1(t)− λ11(t)S1(t)− μ1S1(t) + γ1I1(t). (D.3.4)
Similarly, replacing s(t, ak) in (D.3.1) by αkSk(t) for k ≥ 2, we have
S ′k(t) = −λ1k(t)Sk(t)− μkSk(t) + γkIk(t)− αkSk(t) + αk−1Sk−1(t). (D.3.5)
We can use the same approach for the other equations in system (5.2.5) and reduce the PDE
system in Section 5.2 to the following system of ordinary differential equations:
S ′1(t) = Λ− (α1 + λ11(t) + μ1)S1(t) + γ1I1(t)
I ′1(t) = kλ11(t)S1(t)− (γ1 + μ1 + δ1 + α1)I1(t)
I ′A1(t) = (1− k)λ11(t)S1(t) + pλ21(t)JA1(t)− (γA1 + μ1 + α1)IA1(t)
J ′A1(t) = −(pλ21(t) + μ1 + α1)JA1(t) + γA1IA1(t)
S ′k(t) = −(αk + λ1k(t) + μk)Sk(t) + γkIk(t) + αk−1Sk−1(t)
I ′k(t) = kλ1k(t)Sk(t)− (γk + μk + δk + αk)Ik(t) + αk−1Ik−1(t)
I ′Ak(t) = (1− k)λ1k(t)Sk(t) + pλ2k(t)JAk(t)− (γAk + μk + αk)IAk(t)
+αk−1IAk−1(t)
J ′Ak(t) = −(pλ2k(t) + μk + αk)JAk(t) + γAkIAk(t) + αk−1JAk−1(t)
S ′v(t) = bv − λ˜v(t)Sv(t)− μvSv(t)
I ′v(t) = λ˜v(t)Sv(t)− μvIv(t), (D.3.6)
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for k = 2, . . . , n with αn = 0.















for k = 1, ..., n.
D.4 Derivation of the Basic Reproduction Number for the ODE Model
We adopt the notation in [71] to organize the matrix F for new infections and the























(pλ21(t) + μ1 + α1)JA1(t)− γA1IA1(t)
...
γkIk(t)− αk−1Ik−1(t)
−pλ2k(t)JAk(t) + γAkIAk(t)− αk−1IAk−1(t)
(pλ2k(t) + μk + αk)JAk(t)− γAkIAk(t)− αk−1JAk−1(t)
...
γnIn(t)− αn−1In−1(t)
−pλ2n(t)JAn(t) + γAnIAn(t)− αn−1IAn−1(t)











0 0 · · · 0 0 · · · 0 0 kh1
0 0 · · · 0 0 · · · 0 0 (1− k)hA1
...
...
0 0 · · · 0 0 · · · 0 0 khk
0 0 · · · 0 0 · · · 0 0 (1− k)hAk
...
...
0 0 · · · 0 0 · · · 0 0 khn
0 0 · · · 0 0 · · · 0 0 (1− k)hAn







γ¯1 0 0 0 · · · 0 0 0 0 0
0 AA1 0 0 0 0 0 0 0
−α1 0 γ¯2 0 · · · 0 0 0 0 0
0 −C1 0 AA2 · · · 0 0 0 0 0
...
...
0 0 0 0 · · · γ¯n−1 0 0 0 0
0 0 0 0 · · · 0 AAn−1 0 0 0
0 0 0 0 · · · −αn−1 0 γ¯n 0 0
0 0 0 0 · · · 0 −Cn−1 0 AAn 0





























⎠ , AAk =
⎛
⎝ γ¯Ak −pβdAk N¯vN¯h
−γAk pβdAk N¯vN¯h + μk + αk
⎞
⎠ . (D.4.5)




T1 0 0 0 · · · 0 0 0
0 A−1A1 0 0 · · · 0 0 0




























αn−kA−1An−k · · · 0 A−1An 0










0 0 · · · 0 0 kh1Tv
0 0 · · · 0 0 (1− k)hA1Tv
...
...
0 0 · · · 0 0 khkTv
0 0 · · · 0 0 (1− k)hAkTv
...
...
0 0 · · · 0 0 khnTv
0 0 · · · 0 0 (1− k)hAnTv














Fn,j · V −1j,n−2 = vnTn, Fn,j · V −1j,n−1 = vAnA−1n . (D.4.10)
Notice that the matrix FV −1 is of rank two and that its trace tr(FV −1) = 0. Therefore,









where E2(FV −1) is the sum of the principal minors of order two of the matrix FV −1.
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D.4.1 The case of n = 1 age group




0 0 0 kβ d1
N¯h
N¯1
0 0 0 (1− k)β d1
N¯h
N¯1












γ¯1 0 0 0
0 γ¯A1 −pβdA1 N¯vN¯h 0
0 −γA1 pβdA1 N¯vN¯h + μ1 0














































Thus, FV −1 =
⎛
⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 kβd1
N¯h
N¯1Tv
0 0 0 (1−k)βd1
N¯h
N¯1Tv






























For the explanation of P
IA1
IA1
we let q1 = γA1/(γA1 + μ1) = γA1/γ¯A1 denote the proba-
bility that a person in IA1 moves to JA1 , let q2 = ρ1/(ρ1 + μ1) denote the probability that
a person in JA1 moves back to IA1 , where ρ1 = pβdA1N¯v/N¯h, and let q3 = μ1/γ¯A1 denote
the probability that once in IA a person does not return to JA. Then, the probability that
a person who starts in IA1 and returns to IA1 after visiting JA1 exactly one time is q1q2q3,
244
exactly twice is (q1q2)2q3, and exactly k times is (q1q2)kq3, k = 1, 2, · · · . Then, the proba-
























D.4.2 The case of n = 2 age groups




0 0 0 0 kβ d1
N¯h
N¯1
0 0 0 0 hA1
0 0 0 0 kβ d2
N¯h
N¯2













γ¯1 0 0 0 0
0 AA1 0 0 0
−α1 0 γ¯2 0 0
0 −C1 0 AA2 0











⎟⎠ , hA2 =
⎛






















⎜⎝ γ¯A1 −pβdA1 N¯vN¯h
−γA1 pβdA1 N¯vN¯h + μ1 + α1
⎞
⎟⎠ , AA2 =
⎛
⎜⎝ γ¯A2 −pβdA2 N¯vN¯h













T1 0 0 0 0
0 A−1A1 0 0 0
θ1
γ2



































































Thus, FV −1 =
⎛
⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝




0 0 0 0 (1− k)hA1Tv






























where vk, hAk , hk, vAk and AAk (k = 1, 2) are given in (D.4.4) and (D.4.5) with α2 = 0.
Notice that for k = 1, 2, hAk is a 2 × 1 vector, vAk is a 1 × 2 vector, and AAk is a 2 × 2
matrix. Hence, the matrix FV −1 has dimension seven. It follows that





















vA1 · A−1A1 + vA2 · A−1A2 C1A−1A1
)
hA1Tv + vA2 · A−1A2 hA2Tv.
(D.4.24)
This leads to the formula for R0 =
√−E2(FV −1) given in (5.4.14).
The following shows the explanation of the expressions in (5.4.15), (5.4.16), and
(5.4.17):
For the explanation of P
IAk
IAk
in (5.4.15) (k = 1, 2), we let q1k = γAk/γ¯Ak denote the
probability that a person in IAk moves to JAk and q2k = ρk/(ρk + μk + αk) the probability
that a person in JAk moves back to IAk . Let q3k = (μk + αk)/(γ¯Ak) denote the probability




is equivalent to D.4.1 as explained in the case for n = 1 age groups.
For the explanation of P
JA1
IA1
in (5.4.16), we let q1 = γA1/γ¯A1 denote the probability that
a person in IA1 moves to JA1 , and q2 = ρ1/(ρ1 + μ1 + α1) the probability that a person in
JA1 moves back to IA1 . Let p3 = (μ1+α1)/(ρ1+μ1+α1) denote the probability that once
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in JA1 , a person does not return to IA1 . Then, the probability that a person is in JA1 , given


















ρ1 + μ1 + α1
γA1
γ¯A1
γ¯A1(ρ1 + μ1 + α1)






For the explanation of P
IA2
JA2
in (5.4.17), we now let q1 = γA2/γ¯A2 denote the probability
that a person in IA2 moves to JA2 , and q2 = ρ2/(ρ2 + μ2) the probability that a person in
JA2 moves back to IA2 . Let p3 = μ2/(γA2 + μ2) denote the probability that once in IA2 ,
a person does not return to JA2 . Then the probability that a person is in IA2 if that person
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